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Abstract
Sickle cell disease (SCD) is marked by excruciating chronic pain, commonly known as
pain crisis. SCD healthcare practitioners (HCPs) have been employing palliative care as a
mainstream treatment option to manage SCD pain crises using mainly opioid analgesics
for years. Due to the current opioid crisis, however, it has become imperative to explore
alternative regimens to manage the pain and associated comorbidities of SCD. Thus, the
goals of this study included exploring alternative treatment options for SCD pain crisis
management with the intent of decreasing SCD patients’ dependency on opioid-based or
related analgesics while reducing the frequency of pain crises as well as the number of
hospitalizations all geared toward improving quality of life for SCD patients in terms of
health status, living standards, and life expectancy. The study was also conducted to
analyze and understand the participants’ experiences and perceptions of alternative
treatment regimens, and is expected to offer a unique contribution to the literature.
The nature of this qualitative study was both descriptive and analytical, with a case study
design. The frameworks used were the health belief model, biopsychosocial-spiritual
model, and transtheoretical model. Data were collected from a sample of 11 participants,
with interviews conducted by phone and email due to COVID-19. The code and coding
technique was employed in data collection, processing, and analysis. The study findings
would benefit SCD patients, HCPs and caretakers as they learned of these alternative
regimens with the expectation of improving their pain management strategies.
Nevertheless, Findings confirmed the need for further research on alternative treatments
or interventions for SCD patients to prevent or reduce the frequency of pain crises and
associated complications and thus increase quality of life and effect social change.
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Chapter 1: Introduction to the Study
Sickle cell disease (SCD), according to the Centers for Disease Control and
Prevention (CDC, 2020b), is a group of inherited red blood cell disorders. SCD is marked
with many pain episodes for patients, usually called pain crisis. Pain crises represent the
main reason for frequent hospital visits and admissions among SCD patients, as well as
the reason for SCD patients’ dependence on opioid analgesics for managing pain.
SCD, at times referred to as the “forgotten disease,” is regarded as a neglected
public health condition. Serjeant (1997) described SCD as the most common globin gene
disorder, attributing it to a point mutation, GTG GAG, in the codon. The sixth amino acid
of the standard beta chain of the hemoglobin has glutamic acid, while the sickle beta
chain has valine (Serjeant, 1997). SCD is more prevalent among peoples whose ancestors
came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere;
Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy
(CDC, n.d.).
Pain crisis, one of the leading clinical hallmarks of SCD, generally occurs when
hard, sickled, curved, or crescent-shaped red blood cells (RBC) clog small blood vessels
(U.S. Department of Health and Human Services [USDHHS], 2020). This results in
obstructing the smooth flow of blood and oxygen to specific organs, resulting in
excruciating pain, especially in the joints, chest, and abdomen (USDHHS, 2020). Vasoocclusion (VOC) usually happens when blood circulation through the small blood vessels
becomes blocked by sickled cells, leading to ischemic injuries with pain and irreversible
organ damage (USDHHS, 2020). The pain of SCD also results from the lack of oxygen
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that occurs when sickle-shaped RBCs occlude blood vessels (USDHHS, 2020).
For years, the pain of SCD patients has been treated mainly with opioid analgesics
and other prescription drugs. However, with the current opioid crisis, it has become
crucial to research additional or new treatment options. Mahmood et al. (2020) declared
how necessary it is for adjuvant nonopioid therapies that can improve pain control to be
investigated, given the side effects of opioids. Thus, this study was conducted to explore
the perceptions and experiences of SCD patients and parents/caretakers related to
employing alternative treatment options for pain management. It was also conducted to
explore treatments with the potential to reduce the frequency of pain crisis and eradicate
dependency on prescription drugs or opioid-based substances.
Background of the Study
Naik and Haywood (2015) claimed that homozygous HbS was the first inherited
condition identified at the molecular level in 1949. However, they noted that issues such
as “hasty adoption of early mass screening programs for SCD, implementation of
targeted screening mandates for SCT in athletics, and concerns about stigmatization all
have led to the numerous controversies regarding research and policy decisions for SCT”
(para. 1). Further, they stated that
the historical background of SCD and SCT has contributed towards setting up the
standards on how research should be conducted in the modern era. These are
expected to help reduce stigmatization, ameliorate study conclusions, and inform
genetic counseling and policy decisions for SCT. (para. 1)
According to Enwonwu (1989), the sickle gene is attributed to a point mutation,

3

whereby GTG GAG in the codon switches with the sixth amino acid of hemoglobin,
resulting in a single nucleotide substitution (A to T). This causes a glutamic acid codon
(GAG) to convert to a valine codon [GTG] (Enwonwu, (1989).
The mortality rate for the SCD community is generally high, and SCD patients’
life expectancy is generally low. In the past, it was common knowledge that SCD patients
had short lifespans, with the notion that such patients could not live beyond the age of 20.
However, Shet and Thein (2019) claimed that the survival rate of SCD patients in wellresourced countries such as the United States has significantly improved in the past 60
years, with many newborn SCD patients now expected to live to adulthood. Neville and
Panepinto (2011) maintained that less than 30% of adults with SCD in the United States
have a life expectancy not exceeding 70 years, with causes of death attributed to acute
SCD-related complications such as pain, acute chest syndrome, stroke, pulmonary
hypertension, renal failure, and infections. The mortality rate of children with SCD in
developed countries, according to Neville and Panepinto, is as low as .5-1 per 100,000
children. However, according to Shet and Thein (2019), with all the improvement in
survival chances, the life expectancy of SCD patients still falls 20 to 30 years behind that
of the general public.
Excruciating pain crisis, the main reason for frequent hospital visits and
widespread use of opioid-based analgesics among SCD patients, is a typical characteristic
of SCD. As Matthie et al. (2019) asserted, acute, intermittent vaso-occlusive pain is the
hallmark of SCD and is associated with substantial morbidity, impaired quality of life
(QOL) and higher rates of healthcare utilization. Hence, instead of opioid analgesics,
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which have been the primary treatment option for managing these pains associated with
SCD for years, Matte et al. (2019) proposed two new therapeutic strategies. These are
pathophysiology-related new therapies and innovations in curative therapeutic options
such as hematopoietic stem cell transplantation and gene therapy (Matte et al., 2019).
These pathophysiology-related novel therapies have the potential to prevent sickling or
sickle red cell dehydration; treat SCD vasculopathy and sickle cell-endothelial adhesive
events; and promote antioxidant agents capable of reducing inflammatory responses to
pathogens (Matte et al., 2019). Though in the past, there was a notion that there was no
cure for SCD, all of these new therapies have proven to be promising. Yawn et al. (2014)
also strongly recommended hydroxyurea and transfusion therapy for the SCD
community.
The use of “complementary and alternative medicine (CAM), which Thompson
and Eriator (2014) defined as a group of diverse medical and health care systems,
practices, and products that are not presently considered part of conventional medicine,
has been on the rise in recent years. Examples of conventional CAM, according to
Thompson and Eriator, are prayer, acupuncture, massage therapy, meditation, and
relaxation techniques such as breathing exercises, guided imagery, and progressive
muscle relaxation. However, SCD patients who attempt to use CAM encounter many
challenges, such as lack of access to these methods, as well as to third parties or
insurance to cover CAM costs (Thompson & Eriator, 2014).
In the past, most of the therapy employed for SCD patients involved palliative
care using pharmaceutically based regimens, with few attempts or room for other
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treatment regimens such as self-care management and lifestyle modification. Matte et al.
(2019) claimed that the major objectives of therapeutic strategies targeting sickle cell
vasculopathy are to reduce or prevent vascular endothelial activation and damage. When
conducting the data collection and analysis for the pretest trial, one of the themes that
evolved was healthful eating, patients taking good care of themselves, and using dietary
supplements such as folic acid daily. According to an SCD patient who participated in
data collection for the current study by filling out a questionnaire and participating in an
unstructured interview, the frequency of her pain crisis had decreased over the past 4
years as she began eating a healthier diet (Hagan Asamoah, 2019).
Problem Statement
SCD is an inheritable blood disorder that mostly affects people of African, Asian,
Indian, and South American descent, as well as people of Middle Eastern regions (CDC,
2020b). SCD affects millions of people globally and about 70,000 to 80,000 individuals
in the United States (USDHHS, 2020). The disorder has an estimated prevalence of 1 in
every 500 African Americans and 1 in every 1,000 to 1,400 Hispanic Americans in the
United States (USDHHS, 2020).
Pain crisis can negatively impact the daily activities of SCD patients in diverse
ways, such as missed school days and workdays, high hospital bills, fear, stress,
depression, other mental disorders, and social isolation. The management of this chronic
pain has been approached primarily with palliative treatment, using mainly opioid
analgesics. Thus, Booker et al. (2006) posited that the nature of SCD pain is poorly
understood and that such pain is often sub optimally managed. In addition, SCD patients
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have reported dissatisfaction with healthcare providers’ lack of empathy and inadequate
management of chronic SCD pain (Booker et al., 2006). This dissatisfaction has led to
mistrust toward physicians and hence patients’ unwillingness to communicate their true
feelings due to fear of not receiving optimal treatment.
With the current opioid crisis, it has become imperative to explore alternative
regimens for managing SCD-related pain to decrease dependency on opioid analgesics. In
the quest to explore alternative treatment options for pain relief, it is critical to gather
information on the perspectives of members of the SCD community. The prescribing
habits or attitudes and neglect of SCD patients by healthcare providers (HCPs) and the
pharmaceutical industry, respectively, also need to be understood. It is also necessary to
gain insight into why HCPs treating SCD patients select options such as opioid analgesics
when there seem to be better treatments such as hydroxyurea, Endari, and acupuncture,
among others. In this study, I sought to address these gaps in the literature. This study’s
aim was to explore alternatives to orthodox opioid analgesics as therapies for SCDrelated pain, with a focus on therapies that have the potential to reduce the frequency of
pain crisis and the number of hospitalizations.
As Neville and Panepinto (2011) posited, there are few treatment options to
prevent the development of most SCD symptoms, especially painful vaso-occlusive
symptoms. These authors stated that for decades, the norm has been to manage SCD
symptoms mainly with traditional supportive care measures such as aggressive hydration,
anti-inflammatory medications, and narcotic analgesics. Matte et al. (2019) thus
suggested the need to develop new therapeutic options to manage the complexity and the
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various pathophysiology’s associated with the disease. There is a need to explore both
pharmaceutical treatments and nonpharmaceutical therapies/coping mechanisms such as
acupuncture, nutrition, massage, prayer, hot pad treatments, music for distraction,
hydroxyurea, Endari, and low-dose ketamine infusion. “According to Herman and
Chaudhry (2010), hydroxyurea has the potential to increase the production of fetal
hemoglobin and to help reduce the pain associated with the vaso-occlusive crisis" (para.
6). Palm et al. (2018) also proposed low-dose ketamine infusion as an adjunct analgesic
agent in patients with vaso-occlusive episodes, especially those who continuously report
severe pain despite high-dose opioid therapy and experience opioid-induced adverse
effects. The newly approved voxelotor (GBT-440) resembles an oral direct antisickling
agent, which can be beneficial in SCD as it blocks HbS intermolecular contacts,
preventing the generation of HbS fibers and red cell sickling (Matte et al., 2019). Vitamin
D has the potential to reduce the number of pain days in SCD patients and enable them to
achieve higher physical activity quality‐of‐life scores (Osunkwo et al., 2012).
With all of these evidence-based alternative therapies available, it is somehow
ironic that HCPs prescribing treatments for SCD pain limit their options mainly to opioid
analgesics, irrespective of their adverse effects. Interestingly, the cost and side effects of
these analgesics and hydroxyurea are almost the same. Most of the coping strategies that
patients can use to address pain, such as mindfulness, distraction, massage, diet, and hot
water pad treatment, do not necessarily incur costs. Therefore, there is a need to
understand why SCD prescribers do not recommend or prescribe such strategies for their
patients. Given this need, patients’ perceptions and experiences about the prescribing
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habits of their HCPs in managing pain and their knowledge of and interest in alternative
therapies were of paramount importance in this study. Through this study, I sought to fill
a gap in the literature by attempting to understand the prescribing habits of HCPs treating
SCD patients, assess the awareness and experiences of SCD patients concerning the use
of alternative regimens, and understand SCD patients’ perceptions of employing
alternative regimens for pain relief.
Purpose
The primary purpose for undertaking this study was to explore pain management
choices for SCD patients with the aim of creating awareness of and promoting alternative
treatment regimens among SCD patients and their parents/caretakers. These alternative
treatment options were explored with the intent of identifying and promoting therapies or
strategies that have the potential to decrease SCD patients’ dependency on opioid-based
analgesics. The focus was principally on therapies that are capable of reducing the
intensity, frequency, and duration of pain crisis episodes; associated comorbidities;
emergency room visitations; and hospitalizations.
The study findings may help in gaining insight into the perceptions of SCD
patients and their parents/caretakers on the prescribing habits or practices of SCD HCPs,
as well as the challenges and experiences that SCD patients encounter as they seek pain
relief. According to Shet and Thein (2019), gaps or lapses in providing resources and
adequately equipping HCPs with the required skills lead to various challenges in
providing effective management for the newly increased population of SCD patients.
Adegbola et al. (2012) noted that, apart from pharmacologic agents, SCD patients also
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employ such natural approaches as heat, massage, or phytochemicals from vegetable and
fruit juices, while others use alternative therapies due to fear of side effects associated
with orthodox treatment.
This study makes a unique contribution to the literature by promoting greater
understanding of the prescribing habits of SCD HCPs, assessing SCD patients’ awareness
of alternative therapies, analyzing the perceptions and experiences of patients regarding
the use of alternative regimens, and educating patients about their right to request other
treatment options from their HCPs. I used the qualitative method, employing interviews
to understand the prescribing habits of SCD HCPs and explore the perceptions and
experiences of SCD patients and their parents/caretakers on the use of alternative
regimens.
Significance
Currently, the standard treatment option for SCD pain crisis is the use of opioidbased analgesics, which can be very addictive. This approach is contrary to “the
pharmaceutical companies’ reassurance in the 1990s to the medical community that
patients would not become addicted to opioid pain relievers” (U.S. Department of Health
and Human Services [USDHHS], n.d.). The HHS declared opioid use a public health
emergency in 2017. A five-point strategy has been developed to combat the opioid
epidemic, which makes it critical to explore and employ alternative treatment options for
SCD patients (USDHHS, n.d.). This study may advance this effort by shedding more
light on why SCD practitioners choose less effective opioid treatments when they have
better options.
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The study may also assist in examining SCD patients’ and their
parents/caretakers’ awareness about the availability of other regimens, as well as in
promoting these regimens and then empowering and educating patients about their right
to request these alternative therapies during hospital visits. The findings of the study may
be used to recommend appropriate strategies and alternative therapies for proper
management of SCD pain crisis. Some of the social injustices and the racial and health
disparities that SCD patients face as they seek treatment for pain were also investigated.
This investigation was geared toward improving health status, living standards,
and life expectancy (quality of life [QOL]) for SCD patients and their parents/caretakers.
Consequently, the expected outcomes of the study were to effect positive social change
by improving the living conditions of SCD patients through better pain management
strategies, enhance SCD practitioners’ prescribing habits, and promote measures to
prevent or reduce the frequency of pain episodes. The study findings showcase the
prescribing habits of SCD HCPs and the perceptions of SCD patients and their
parents/caretakers on the nature of pain relief strategies and alternative regimens for pain
management.
Framework (Conceptual or Theoretical)
The health belief model (HBM), transtheoretical model (TTM), and
biopsychosocial-spiritual model of chronic pain (BPS-Spiritual) were combined to form
the theoretical/conceptual framework that guided this research. The HBM postulates that
individuals will decide to do a health screening for a health condition if they are made
aware of the level of seriousness of the health condition, if they are aware that they are at
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risk of the condition, if they deem it beneficial to do the testing, and if the barriers to
testing are low or manageable (Gustafson et al., 2007). HBM constructs may thus be
applied in educating the SCD community about a patient’s perceived susceptibility to and
the severity of prescription drug abuse or overdose, specifically regarding opioid
analgesics with time and hence the need to explore alternative regimens emphasizing the
effectiveness and benefits of these alternative therapies. Strategies to activate readiness
and enhance the SCD community with self-efficacy to embrace alternative regimens such
as coping strategies and disease-modifying agents (e.g., hydroxyurea and Endari) for
better pain management may be explored and promoted using the HBM constructs.
The TTM may also be employed to change patients’ perceptions about trying
alternative regimens rather than orthodox prescribed analgesics that have traditionally
been used. As Jensen et al. (2000) noted, “Patients’ readiness to adopt new beliefs and
coping responses to pain may predict response to multidisciplinary or cognitivebehavioral pain treatments that emphasize changes in beliefs and coping behaviors”
(para. 1). TTM constructs may be used to empower SCD patients to adopt behavioral
changes or lifestyle modifications, including specific diets (e.g., alkaline diets), healthy
eating habits, coping strategies, self-care management, and self-awareness/mindfulness,
among others. Such strategies are expected to help patients manage pain better. The BPSSpiritual model involves a holistic approach as it embraces the whole person,
encompassing the biological, psychological, sociological, and spiritual aspects of the
individual (Taylor et al., 2013). By integrating the constructs of the TTM, BPS-Spiritual,
and HBM, the conceptual lens of this study was established.
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Research Questions
RQ1. What are the experiences of the SCD patients or their parents/caretakers
regarding the current prescribing habits of their HCPs to manage SCD
pain, and how do they influence their choice of treatment?
RQ2. What are the experiences and attitudes of the SCD patients or their
parents/caretakers toward alternative treatment methods, and how do they
influence their choice of treatment?
RQ3. What is the stage of readiness for adopting alternative treatment methods
for SCD patients or their parents/caretakers?
RQ4. How does disease perception among adult SCD patients or their
parents/caretakers impact their willingness to try alternative treatment
methods?
Nature of the Study
This study was qualitative, with a case study design using narrative accounts from
interviews with participants. Patients were interviewed to assess their knowledge or
awareness of alternative therapies and get their perceptions of using such therapies.
Interviews were also used to understand and learn about the diverse strategies that SCD
patients are using to cope with pain, especially as the first line of defense to manage pain
even before they make it to a healthcare facility. Physicians were interviewed to find out
whether they encouraged or recommended other coping strategies to their patients,
especially self-care management, lifestyle modifications, and praying, and how effective
they deemed these strategies to be in controlling pain crisis. Additionally, physicians
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were interviewed on what their general prescribing habits or choices were and why they
adopted those habits or choices over others.
Case studies may be used to compare the effectiveness of different treatment
options by analyzing the experiences of participants who use alternative treatment
options against those of patients who do not. Guided by the critical research questions, I
used the qualitative approach in designing a thorough pain, psychological, and selfmanagement needs assessment for study participants to be administered through
interviews and surveys. The study employed both descriptive and analytical processes,
with interviews and questionnaires/surveys serving as data collection tools. Hence, the
research design that was employed for this study was qualitative case study. According to
Tetnowski (2015), a case study research design is a valuable tool for answering complex,
real-world questions. This rendered it the appropriate design to use for this study in
which I explored alternative treatment options, which can be deemed a “real-world”
challenge for the SCD community.
Possible Types and Sources of Data
Both primary and secondary data sources were considered for this research study.
Semistructured interviews (which were mainly phone interviews, given social distancing
practices due to COVID-19) and surveys were administered with selected participants to
determine the methods that they were currently employing for pain relief and their
effectiveness based on members’ experiences. Secondary data from previous studies and
other accredited organizations such as CDC and WHO, as well as online support group
platforms, were also reviewed, analyzed, and incorporated into the data. With the
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expectation that there might be live interviews and that human participants might thus be
used in collecting data for this study, I contacted the Institutional Review Board (IRB) to
determine essential procedures to be followed and the ethical considerations or
requirements that must be met. A purposeful sampling technique was employed to recruit
participants for the study.
Definitions
Gene mutation: “A permanent alteration in the DNA sequence that makes up a
gene, such that the sequence differs from what is found in most people” (USDHHS,
2020, p. xx).
Point mutations: A broad category of mutations that describe a change in a single
nucleotide of DNA, such that the “nucleotide is switched for another nucleotide. The
nucleotide may also be deleted, or a single nucleotide is inserted into the DNA that
causes that DNA to be different” from a typical or wild type gene sequence (National
Human Genome Research Institute, n.d.).
Pain crisis: An event in which the patient reports pain that is severe, uncontrolled,
and causes distress for the patient, family members, or both” (Moryl et al., 2008). SCD
pain crisis consists of chronic, intermittent, and unpredictable episodes of pain associated
with the vaso-occlusive crisis (VOC) that usually sends SCD patients to the emergency
room. Pain crisis may result in the interruption of blood flow to tissues due to clogging of
blood vessels, leading to pain, acute chest syndrome, stroke, priapism, and chronic organ
damage.
Vaso-occlusive crisis (VOC): Occurs when microcirculation is obstructed by

15

sickled RBCs causing ischemic injury to the organ supplied, resulting in excruciating
pain.
Hydroxyurea: An inhibitor of DNA synthesis and an antimetabolite that is used to
treat chronic and acute myelogenous leukemia and polycythemia vera, and that is used to
increase the concentration of fetal hemoglobin in patients with SCD.
SCD community: Consists of healthcare practitioners (physicians, nurses,
dieticians, and other HCPs) of SCD patients, their parents/caregivers, and other
stakeholders.
Target/study population: Adult SCD patients and SCD patients’
parents/caregivers.
Coping: A person’s cognitive and behavioral efforts in response to stressors that
determine how those stressors will affect physical and emotional well-being (Lazarus &
Folkman, 1984; Litt & Tennen, 2015).
Coping strategies: Psychological patterns that individuals use to manage
thoughts, feelings, and actions encountered during various stages of ill health. These may
include information seeking, self-management, catastrophizing, and wishful thinking.
Describe the extent to which individuals cope well with their pain, which may influence
the quality of life.
Self-management: The decisions and behaviors that patients with chronic illness
engage in that affect their health, including the care and encouragement provided to
people with chronic conditions and their families to help them understand their central
role in managing their illness, make informed decisions about care, and engage in healthy
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behaviors (Group Health Research Institute, n.d).
Spirituality/religiosity: Spirituality is a personal belief in God or a Higher Power,
which may receive expression through individual prayer, meditation, and meaning in self.
In contrast, religion is defined as involving organizational beliefs or adherence to
institutionally based belief systems or dogma (Arrey et al., 2016, para. 6).
Mindfulness: Described as a simple mental activity with the potential to reduce
pain and the need for pain medication. It also increases the ability to regulate pain,
emotion, and behavior mentally; alters the way in which the brain processes rewards;
restores positive feelings; can be learned in a class or at home; and is an accessible
alternative for managing pain (Voss et al., 2019).
Pain management: A broad and multidisciplinary approach that addresses
physical, psychosocial, and spiritual dimensions (Brennan et al., 2019).
Opioid analgesics: Commonly referred to as prescription opioids, medications
that have been used to treat moderate to severe pain in some patients. Examples are
morphine, codeine, oxycodone, hydrocodone, tramadol, and fentanyl (CDC, 2021).
Opioid crisis: Devastating consequence of the opioid epidemic, which has
resulted in increases in opioid misuse and related overdoses (HHS, n.d.).
Opioid dependence: Occurs when “the body adjusts its normal functioning around
regular opioid use,” which may result in unpleasant physical symptoms when the
medication is stopped (CDC, 2021, p. xx).
Perceptions: Immediate or intuitive recognition or appreciation of moral,
psychological, or aesthetic qualities. Is the insight, intuition, or discernment; awareness
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or consciousness; the process, act, or faculty of perceiving (Dictionary.com, 2020).
Assumptions
There are a few assumptions that were addressed in this study. First, there was an
assumption that SCD HCPs do not usually prescribe or recommend alternative therapies
for their patients because of a lack of awareness and knowledge about the efficacy of
these other therapies. Additionally, it was assumed that the SCD patients and their
families would quickly embrace the concept of alternative treatment regimens for pain
because of the current opioid crisis and all of the stigma and inconvenience associated
with opioid analgesics. Moreover, I assumed that members of the SCD community would
perceive exploring alternative treatment options as a step in the right direction. It was
also assumed that patients and their families had substandard experiences with managing
SCD-associated pains using the current treatment option, which justified the need to
explore alternative options.
Scope and Delimitations
The primary purpose of this study was to conduct research into alternative
treatment options for SCD pain management and patients’ perceptions and experiences
about such regimens. The scope of the study thus defined the parameters or boundaries
under which the study was conducted, which implied taking into account the sample size,
target population, time, and geographic area. For instance, I planned to recruit about 2025 study participants in order to attain saturation or gather enough information to be able
to draw a valid conclusion after the collected data had been analyzed.
Simon (2011) described delimitations as those characteristics that limit the scope
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and define the boundaries of a study, with examples being the choice of objectives, the
research questions, variables of interest, theoretical perspectives that the researcher
adopts, and target population. This study was delimited to SCD patients or their
parents/caretakers who were at least 14 years of age and could easily communicate in
English, preferably, or in Twi, an African dialect that I speak fluently. Delimitations also
determine the criteria for participant recruitment, the profession or organizations to
involve, unique characteristics of the sample/population, the philosophical framework,
methodology, and variables in the study that set the boundary base on which the findings
can be established (Simon, 2011). For instance, because of the specificity of the disease,
only people who had knowledge of or experience with SCD or the subject matter were
recruited to participate in the study.
As this was a qualitative study, the initial data collection tools were going to be
face-to-face interviews or a focus group. However, because of social and physical
distancing regulations due to COVID-19, the data collection tools were delimited to
mainly phone interviews, emails, video conferences or calls, texting, and messaging
using various social media platforms.
Limitations, Challenges, and/or Barriers
Time management was a significant challenge, so strategies for effectively
allotting specific and adequate time each day to work on the dissertation amidst other
activities or responsibilities needed to be developed. I also anticipated that financial
constraints would be encountered in covering all of the expenses that were accrued with
the study. For example, I was unable to afford the full services of an editor and procure
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other logistics necessary for the study.
The stigmatization associated with the SCD condition and community in terms of
longevity, morbidities, the claim of prescription drug abuse, restrictions in terms of
partner choices, and other social limitations deters many SCD patients or their families
from disclosing the condition. I expected that such stigma might serve as a significant
barrier to the data collection process. Moreover, correctly transcribing the collected data
might also pose a challenge, given that transcription is known to be time consuming and
labor intensive. I anticipated that social and physical distancing measures due to COVID19 might place some restrictions on the data collection tools that could be used.
Summary
SCD is described as an inherited “blood disorder in which abnormal red blood
cells damage the cerebrovascular system as well as organs such as the liver and spleen”
(Scott & Scott, 1999, p. 1). The hemoglobin of SCD patients is defective, so red blood
cells tend to cluster together and form long, rod-like structures that become stiff and
assume sickle shape after they give up their oxygen (WHO, 2016). This is the reason for
the excruciating pain, comorbidities or health complications, and numerous
hospitalizations associated with the condition.
In the United States, SCD affects around 72,000 people, most of whose ancestors
came from Africa (WHO, 2016). SCD occurs in nearly 1 in every 500 African American
births and 1 in every 1,000 to 1,400 Hispanic American births, while 1 in every 12
African Americans carries the sickle cell allele (WHO, 2016). SCD has a 10% mortality
rate for children within the first 5 years of their lives. In 2005, medical expenditures for

20

SCD children averaged $11,702 dollars for those with Medicaid coverage and $14,772
dollars for those with employer-sponsored insurance, with about 40% of both groups
having at least one hospital stay that year (CDC, 2016).
SCD is marked by frequent pain episodes and severe conditions such as chronic
anemia, fatigue, anxiety, depression, pulmonary hypertension, respiratory infections,
urinary tract infections, chronic arthritis, and necrosis, as well as neurophysiological
conditions such as strokes, seizures, and cognitive and psychological problems. Hospital
stays are frequent for SCD patients due to the severity of most of the health conditions
associated with the disorder. SCD patients are at high risk of being misunderstood and
misdiagnosed. SCD does not get the high-profile attention that other illnesses receive,
even though it is a critical health condition. Scott and Scott (1999) thus suggested the
need for continued research and public awareness on SCD. Pain crisis and VOC are the
clinical hallmarks of SCD, and for years these pains have been managed through
palliative care using mostly opioid analgesics. With the current opioid crisis, it has
become critical for different therapies to be investigated.
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Chapter 2: Literature Review
SCD is a genetic blood disorder that affects the hemoglobin (Hob) within red
blood cells (RBCs; WHO, 2006). SCD is associated with recurrent pain and
complications that are capable of interfering with many aspects of the patient’s life,
including education, employment, and psychosocial development (WHO, 2006). People
with SCD have RBCs containing an abnormal form of the oxygen-carrying protein
hemoglobin S (WHO, 2006). As WHO (2006) explained, “Children who inherit the
sickle-cell genes from both parents will develop the sickle-cell disease (SCD), while
those who inherit the gene from only one parent will have the sickle-cell trait (SCT)” (p.
1). CDC (2020) has characterized SCD as a significant public health concern and is
working toward raising awareness about the disease.
Neville and Panepinto (2011) noted that the incidence of SCD is higher than that
of most other severe genetic disorders such as cystic fibrosis and hemophilia. Globally,
there are approximately 300,000 SCD births annually, with about 10% to 40% of the
population in most African countries carrying the sickle-cell gene, resulting in an
estimated SCD prevalence of at least 2% (American Society of Hematology [ASH],
2016). According to USDHHS (2020), most people with SCD are of African ancestry or
identify themselves as Black. However, there are also many people with SCD who come
from Hispanic, southern European, Middle Eastern, or Asian Indian backgrounds.
USDHHS (2020) reported that there are about 100,000 Americans who have the disease,
with about 1 in 13 Black or African American babies born with sickle cell trait (SCT) and
1 in every 365 Black or African American babies born with SCD. The incidence of SCD
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among Hispanic American births is about 1 out of every 16,300 (CDC, 2020).
Pain management is one of the major challenges for SCD patients. This case study
was undertaken to explore alternative regimens that offer better pain management than
traditional opioid treatment. In this chapter, I will present a thorough review of existing
literature on such treatment options. This chapter includes a description of strategies
employed to review the literature, a synopsis of the literature on the various treatment
therapies investigated, a discussion of the conceptual and theoretical frameworks on
which the study was grounded, and a summary of the findings of the literature review.
Literature Search Strategy
Relevant published articles were comprehensively searched for using Walden
University Library’s electronic database. Several search engines were used to locate
recently published articles on the research topic with interest in those published between
2010 and 2020. However, it was necessary to make exceptions due to the scarcity of
articles on the research topic, so the research was based on articles that dated as back as
far as 1989, with most of the articles that contained information relevant to the research
questions having been published beginning in the early 2000s. Search engines that were
effective in retrieving appropriate articles were PubMed, Google Scholar, ProQuest, and
ScienceDirect. Secondary source data—mainly statistical data and other demographic
information for the study—were chiefly accessed from the websites of internationally
acclaimed organizations such as WHO, NIH, ASH, NHLBI, and CDC.
The key search terms that were used to locate relevant articles for the literature
review were alternative treatment choices/options, sickle cell disease, pathophysiologies,
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opioid analgesics, pain crises, vaso-occlusive events, self-care management,
spirituality/religiosity perceptions, experiences, coping strategies, nutrition,
micronutrients, prescribing habits, healthcare practitioners, theoretical framework, and
qualitative research design.
Etiology and Epidemiology
SCD is a genetic disease caused by a gene mutation. Although the mutation is
claimed to have originated from West Africa, it has become a global health concern due
to migration or globalization and an increase in interracial marriages (Serjeant, 1997). As
Serjeant (2013) wrote, “It is … speculated that the Hobs trait is a relatively new mutation
limited to West Africa where it occurs at high frequencies (> 20%) especially in central
Ghana and Burkina Faso, and only 2% in Nigeria” (para. 3). Frenette et al. (2019)
reported that it has been suggested that
SCD developed from a missense mutation within the β-globin gene leading to the
substitution of valine for glutamic acid on the outer surface of the globin molecule
rendering the sickle cell hemoglobin (“HbS”) less soluble and prone to
polymerization upon deoxygenating. (para. 4)
According to USDHHS (2020), mutations in the HBB gene, which provides
instructions for making beta-globin, cause two of the subunits of hemoglobin to develop
the various types of SCD. Sundd et al. (2019) hypothesized that a single amino acid
substitution in the β-globin chain leads to polymerization of mutant hemoglobin S,
impairing erythrocyte rheology and survival. As Manwani and Frenette (2013) noted,
“There is also a corroboration to all these with the claim that the development of SCD
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causes the encoding of the β-globin subunit leading to polymerization of deoxygenated
sickle hemoglobin and decreased deformability of RBCs” (p. 1). Further, Manwani and
Frenette explained, “There is a complex interplay of adhesive events among blood cells
that can obstruct the vasculature, producing episodes of pain, hemolytic anemia, organ
injury, and early mortality” (p. 1).
SCD is inherited in an autosomal recessive pattern (USDHHS, 2020). Thus, both
copies of the gene in each cell have mutations. This implies that the parents of an
individual with the autosomal recessive condition must each carry one copy of the
mutated gene, even though they may not show any signs or symptoms of the condition.
As USDHHS (2020) explained, the abnormal versions of beta-globin can distort RBCs
into a sickle shape, which can lead the cells to die prematurely, precipitating anemia.
These inflexible, sickle-shaped cells can also get stuck or clogged in small blood vessels,
which can result in serious medical complications (USDHHS, 2020), a typical example
being the SCD pain crisis. USDHHS (2020) described the main types of SCD as
hemoglobin Sβ0 thalassemia, Sβ+ thalassemia, SC, SD, SE, and SS.
According to the USDHHS (2020) at least one of the two abnormal genes causes
a person’s body to make hemoglobin S in each of the various types. The most common
and severe type is sickle cell anemia, whereby the person has two hemoglobin S genes
(i.e., hemoglobin SS; USDHHS, 2020.). The two other common types are the hemoglobin
SC disease and hemoglobin Sβ thalassemia, with hemoglobin SD and hemoglobin SE
being much less common (USDHHS, 2020). Other people, usually referred to as carriers,
do not have full-blown SCD but have one of the mutated genes; such individuals, who
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also have one normal gene, have normal RBCs. CDC (2020) asserted those with only one
mutated gene, called the SCT, obtained one sickle cell gene (“S”) from one parent and
one normal gene (“A”) from the other parent. These individuals usually do not exhibit
any of the signs of the disease and live a healthy life, but they can pass the trait on to their
children and may also have a few uncommon health problems that may be attributed to
the SCT (CDC, 2020).
According to CDC (2020), SCD patients usually start to have signs of the disease
during the first year of life, usually around 5 months of age. Early signs and symptoms of
SCD include swelling of the hands and feet, anemia, fatigue or extreme tiredness,
jaundice, infections, and delayed growth, with episodes of pain crisis evolving with time
(USDHHS, 2020). Karafin et al. (2019) claimed that chronic pain is prevalent in SCD,
with 30% of patients experiencing daily pain while 50% meet the criteria for chronic pain
syndrome. These researchers proposed that SCD patients have synaptic changes in the
central nervous system (CNS) that may contribute to the pathogenesis of chronic pain
based on their study findings (Karafin et al., 2019). The disease can also result in other
complications affecting the patient’s spleen, brain, eyes, lungs, liver, heart, kidneys,
penis, joints, bones, or skin as the years progress.
SCD is claimed to be a lifelong illness, but the severity of the disease varies
widely from person to person (USDHHS, 2020). Some patients may experience both
acute and chronic signs, symptoms, and complications (USDHHS, 2020). The acute pain
episodes or crises, which are described as sharp, intense, stabbing, or throbbing in their
intensity, are compared to those of postsurgical pain or childbirth (USDHHS, 2020).
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They can occur without warning when sickle cells block blood flow and decrease oxygen
delivery (USDHHS, 2020). The pain crisis is one of the main reasons that SCD patients
have frequent hospital visits or hospitalizations.
Clinical Manifestations or Pathophysiology of Sickle Cell Disease
SCD is associated with various complicated clinical manifestations. The ASH
(2016) has stated that the severity of the numerous complications associated with SCD
can render every stage of life extremely difficult and a challenge for patients. Shet and
Thein (2019) asserted that in developed countries, the burden of disease has now shifted
to adults with SCD as the disease has evolved into a debilitating condition with numerous
complications associated with long-term chronic diseases coupled with all of the
comorbidities that are attributed to aging.
According to CDC (2020a), SCD patients usually start to exhibit signs of the
disease during the first year of life, usually around 5 months of age, with the symptoms
and complications of the disease being different for each person, ranging from mild to
severe. CDC (2020) asserted that SCD infants do not show symptoms at birth because of
how baby or fetal hemoglobin protects RBCs from sickling. This characteristic seems to
degenerate when the infant is around 4 to 5 months of age, resulting in the baby or fetal
hemoglobin being replaced by sickle hemoglobin, at which point the cells begin to sickle
(CDC, 2020). Thus, SCD is described as a disease that worsens over time (CDC, 2020).
The Physicians Committee for Responsible Medicine and Unbound Medicine (PCRM,
2019) affirmed that SCD children who have been frequently hospitalized usually show
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weak linear growth, lean body mass, and reduced fat-free mass. Some of the common
complications of SCD outlined by CDC (2020) are as follows:
•

Pain episode or crisis: The main reason that most SCD patients go to the
emergency room or hospital. These pain crises occur when sickle cells
traveling through small blood vessels get stuck and clog the blood flow. This
results in pain that may range from mild to severe, which starts unexpectedly
and can last for any length of time. According to the Sickle Cell Data
Collection (SCDC, n.d.) program, in California, people with SCD seek care in
the emergency department an average of 3 times per year from their late teens
to their late 50s.

•

Hand-foot syndrome: An early symptom of SCD characterized by swelling in
the hands and feet. May also present with a fever, which is claimed to be
caused by the sickle cells getting stuck in the blood vessels and blocking the
flow of blood in and out of the hands and feet.

Painful vaso-occlusive events are the most common complication experienced by
both children and adults with SCD. As Sundd et al. (2019) reported, “Erythrocyte
abnormalities in SCD patients clinically manifest as hemolytic anemia, cycles of micro
vascular vaso-occlusion leading to ischemia-reperfusion injury, infarction with VOC
events and intravascular hemolysis promoting inflammation and redox instability” (para.
1). Moreover, SCD may result in continuous small- and large-vessel vasculopathy and
molecular, cellular, and biophysical processes that can cause acute and chronic pain and
end-organ injury and failure (Sundd et al., 2019). Manwani and Frenette (2013)
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characterized “recurrent and unpredictable episodes of vaso-occlusion” as “the hallmark
of SCD” (p. 1). HbS induces RBC membrane damage because of the cells’ deformed
shape.
This leads to calcium influx into the cell which may cause crosslinking of the
membrane proteins activating channels that allow for the efflux of potassium and
water from the cell thereby causing RBC dehydration worsening the sickling
which may triggers VOC crisis. (Herman & Chaudhry, 2010, para. 2)
Thus, obstruction of the RBCs may develop, reducing blood flow to the vital organs and
triggering ischemia, necrosis, and pain (Herman & Chaudhry, 2010).
Pain crisis is also claimed to result from damaged blood vessels, which become
irritated, activating molecules in the blood called selectins, also known as “sticky factors”
(Novartis Pharmaceuticals Corporation, 2019). These sticky factors are known to cause
blood cells to stick to blood vessel walls and to each other (Novartis Pharmaceuticals
Corporation, 2019). As more blood cells get sticky and adhere to each other and vessel
walls, they form clusters in the bloodstream, in a process termed multicellular adhesion
(Novartis Pharmaceuticals Corporation, 2019). These clusters build up and become
blockages, making it difficult for blood and oxygen to flow generally in the vessels; this
process is known as vaso-occlusion (Novartis Pharmaceuticals Corporation, 2019). When
the blood cell clusters get more prominent, they result in episodes of sudden,
unpredictable, and intense pain called pain crises or VOC (Novartis Pharmaceuticals
Corporation, 2019). Bone infarction, necrosis, as well as bone marrow degeneration
occur over time with repeated episodes of VOC (Herman & Chaudhry, 2010). As
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Herman and Chaudhry reported, it has been claimed that “pain episodes can affect any
bone marrow-containing structure such as the ribs, sternum, vertebral bodies, and skull”
(p. 2). The life-threatening complications of bone marrow infarction in SCD patients
include pulmonary fat embolism and acute chest syndrome (ACS).
Leger et al. (2018) pointed out that “SCD patients experience poor health-related
quality of life (HRQOL), inadequate coping, and poor self-care management skills when
compared to other chronic conditions that trigger episodic care leading to poor health
outcomes” (p. 24). Further, Leger et al. noted, “SCD pains and other associated
complications can negatively impact the physical, social, emotional, psychological, and
spiritual domains as well as the level of self-efficacy, sufficiency, and sleep quality of
affected patients and their family members” (p. 24). Other complications such as silent
strokes can cause cognitive deficits, which can significantly impact the daily living
activities of SCD patients, including disease management (Leger et al., 2018). According
to Setty et al. (2003), nocturnal oxyhemoglobin desaturation contributes toward CNS
complications associated with SCD and high rates of painful crises. “SCD is described as
a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to
infections, damages to organs and VOC” (Nur et al., 2011, p. 1). SCD leads to reduced
QOL and life expectancy, with oxidative stress deemed responsible for most of these
pathophysiologies (Nur et al., 2011). Other health challenges that SCD patients usually
battle include fatigue, functional limitations, emotional effects, exhaustion from sleep
deprivation, stress, and depression, which can affect their pain coping skills, self-care
management, and QOL (Leger et al., 2018).
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Encapsulated bacterial infections may present as splenic sequestration of sickle
cells resulting in splenic congestion, as manifested by splenomegaly and reduced immune
function (Herman & Chaudhry, 2010, para. 2). “SCD patients are thus more prone to
getting bacteremia with pathogens like Streptococcus pneumonia, Haemophilus
influenzae, and Neisseria meningitides which may result in life-threatening sepsis”
(Herman & Chaudhry, para. 2). Pulmonary and cardiovascular complications are
common health challenges in the SCD community. According to Herman and Chaudhry ,
neurological complications such as strokes and silent strokes are common with SCDVOC and ACS, which may present with fevers, infarction, pulmonary fat embolism,
hypoxia, and chest pains. Myocardial infarction may also happen due to VOC of the
coronary arteries, and occasionally right ventricular (RV) dysfunction may develop due
to pulmonary arterial hypertension in SCD patients (Herman & Chaudhry, 2010, para.2).
Hemolysis is also another common clinical complication associated with SCD because of
how mechanically weak the sickle cells are, according to Herman and Chaudhry. These
authors also declared that when inflexible cells are trapped in the spleen and get
phagocytized by the reticuloendothelial system, extravascular hemolysis results, causing
a reduction in the red cell survival time. Herman and Chaudhry posited that a normal
RBC survives for an average of 90-120 days, whereas a sickle cell survives for only 1020 days. The sickle cell causes increased hemolysis complications as cholelithiasis due to
excessive bilirubin production (Herman & Chaudhry, 2010).
Amer et al. (2006) posited that oxidative stress also plays a significant role in
clinical manifestations of SCD, such as hemolysis, hypercoagulable state, recurrent
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bacterial infections, and VOC incidences in SCD. The oxidative stress of SCD‐RBC is
attributed to the inherent instability of HbS and the high concentrations of iron and iron‐
containing compounds, such as haemin and Hob, in the plasma of the patients due to
hemolysis and blood transfusions (Amer et al., 2006). According to Silva et al. (2013),
sickle erythrocytes might be the trigger for multiple sources of reactive species, and SCD
is intimately linked to chronic and systemic oxidative stress. These may require
antioxidant therapies, which are deemed promising approaches for SCD treatment as they
may constitute valuable means for preventing or delaying the development of organ
complications. Edwards et al. (2005) also declared that the tissue damage associated with
SCD increases patients’ risk for other medical complications such as delayed growth and
sexual maturation, acute and chronic pulmonary dysfunction, stroke, aseptic necrosis of
the hip and shoulders, retinopathy, dermal ulcers, and severe chronic pain.
In general, SCD patients who transition from recurrent, acute pain to chronic,
persistent pain may end up with more significant QOL impairment and higher rates of
healthcare utilization (Matthie et al., 2019). Elander et al. (2003) observed that SCD
patients with pain-related symptoms usually experience impaired activities and
psychological disturbance than those with non-pain-related symptoms. Taylor et al.
(2013) claimed the “BPS model of SCD pain can be used to hypothesized three
categories of variables which are disease-related, psychosocial, a readiness that acts
together overtime to explain the response to pain such as disability, distress, healthcare
utilization in SCD" (Smith et al., 2005, para.9). These authors stated some of the diseaserelated variables are SCD genotype, hematocrit, fetal hemoglobin (HbF) level, SCD
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complications and comorbidities, treatment variables (e.g., hydroxyurea, opiates,
antidepressants), and pain location (Taylor et al., 2013).
Conditions That Trigger Pain Crisis
Examples of such conditions are extreme temperatures unusually cold and hot
weather or conditions, high altitude, illness, physical and psychological stress,
temperature changes, dehydration, or not drinking enough fluids, infections, pregnancy,
alcohol, low oxygen tension, and extreme physical exercises or exertion.
Impact of the Opioid Crisis on Sickle Cell Disease Patients
The emerging opioid crisis has taken a significant toll on most people who suffer
from chronic pain. However, the community most impacted by this crisis is SCD patients,
thus making it necessary to employ alternative regimens. Ezenwa et al. (2016) claimed
that SCD patients are also more likely to be accused of drug-seeking behavior and are
directly or indirectly called drug addicts as compared to other populations with chronic
pain. According to Su et al. (2019), opioids remained the most frequently prescribed
medications for SCD, and there have been no significant changes over time in opioid
prescribing. "Nevertheless, there is also evidence that SCD patients on chronic opioid
therapy as a primary management strategy experience greater pain, poorer functional
outcomes, and higher healthcare utilization than those who are not on opioids" (Matthie
et al., 2019, p.1). Such patients also have a new challenge to deal with the increasing
restrictions on opioid access due to the current opioid epidemic in the U.S. (Matthie et al.,
2019). Sinha et al. (2019) conducted a qualitative study using a semistructured interview
over the phone with 15 Africa American women. The participants reported how their
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opioid prescriptions had become more restrictive, more closely monitored, and
increasingly challenging to fill in pharmacies of late (Sinha et al., 2019). The participants
also reported increased stigmatization about opioid use and how their medical care was
being affected by the physician's exclusive focus on reducing pain medication use (Sinha
et al., 2019). Based on the experiences of the participants as deduced from the research
findings, the opioid epidemic has negatively affected patients' care by increasing barriers
to access to opioids and decreased opioid dosing. In contrast, they still have to deal with
the challenge of the lack of access to alternative therapies (Sinha et al., 2019). The
researchers observed an emerging interest among the patients to use alternative therapies
such as marijuana to manage their pains (Sinha et al., 2019), confirming how critical it is
to explore alternative therapies.
Elander et al. (2003) posited that there is not enough evidence about substance
dependence among SCD patients even though there are concerns about dependence on
prescribed analgesia, which may compromise pain management. "Pain-related symptoms
can be an indicator of how the pattern of frequent acute pain in SCD may make patients
vulnerable to perceptions of drug dependence whereas non-pain-related symptoms depict
more stringently defined dependence on analgesia with SCD" (Elander et al., 2003. para.
1).
Pharmacotherapy of Sickle Cell Disease
For years, one of the primary pain management strategies that have been
employed for SCD patients has been palliative care treatment. The WHO (2019) defined
palliative care as an approach that improves the quality of life of patients who are battling
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a life-threatening illness like SCD and their families. Palliative care involves employing
strategies like prevention and relief of suffering using early detection of pain episodes,
appropriately assessing and treating pain and other problems, as well as enhancing the
physical, psychosocial, and spiritual aspects of patient care (WHO, 2019). Opioid
analgesics have been the main pharmaceutical product that has been used in this case.
Neville and Panepinto (2011) described SCD as a chronic, debilitating disorder with
multiple symptoms rendering it difficult or challenging to treat. These authors elaborated
on how there are few treatment options to prevent the development of most of these
symptoms especially painful VOC. Neville and Panepinto (2011) claimed this is because
most of these regimens are mainly managed with traditional supportive care measures
like aggressive hydration, anti-inflammatory, and narcotic analgesics which have been
the norm for decades. Palm et al. (2018) also confirmed that the primary treatment
currently employed for these episodes is supportive, using fluids and intravenous opioid
and anti-inflammatory medication.
However, Manwani and Frenette (2013) proposed symptomatic management and
prevention of painful VOC using the fetal hemoglobin–reactivating agent Hydroxyurea.
This original non-opioid pharmaceutical product seems to have the potential to reduce the
frequencies of VOC episodes. “It is also suggested that managing the VOC crisis with
rehydration therapy to reverse the dehydration and hypoxia asserting that rehydration
allows for increased RBC water and electrolyte uptake” (Herman & Chaudhry, 2010,
para.6). “Hydroxyurea, which is capable of increasing the production of fetal
hemoglobin, is recommended since the mutation is in the beta-globin, upregulation of
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gamma-globin chains reduces the pain associated with VOC as fetal hemoglobin carries 2
alpha and 2 gamma-globin chains (Herman & Chaudhry, 2010, para.6). Su et al. (2019)
proposed the need to increase the rate of prescribing of hydroxyurea for SCD children. Su
et al. (2019) claimed there are safety and efficacy of starting Hydroxyurea in infancy and
that the rate for prescribing Hydroxyurea for adults remains infrequent and considerably
lower than opioids.
Nevertheless, usually, acute SCD painful episodes are managed with morphine
(an opioid), while the chronic pain is managed using NSAIDs {like Ibuprofen} (Herman
& Chaudhry, 2010). Transfusions can prevent SCD-related strokes as it reduces sickled
cells. Also, oral hydration therapy to hydrate RBCs and oral analgesics to manage pain is
recommended for Priapism, according to Herman and Chaudhry. Palm et al. (2018) also
proposed low-dose ketamine infusion as an adjunct analgesic agent in patients with VOC
episodes especially those who continuously report severe pain despite high-dose opioid
therapy and also experiences opioid-induced adverse effects. These researchers review a
retrospective case series of five patients admitted to the intensive care unit (ICU) with
prolonged VOC episodes who were treated with a continuous infusion of low-dose
ketamine (5µg/kg/min) after insufficient pain control with opioid analgesic therapy (Palm
et al., 2018). It was observed that these patients experienced a lower reported pain score,
reduced opioid-induced adverse effects, and decreased opioid dosing requirements with a
median reduction of 90mg morphine (Palm et al., 2018). Jennings et al. (2013) also
attested that oral antagonist ketamine has analgesic properties.
Cell Transplant (HSCT) is also highly recommended for SCD patients under the
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age of 17, or those with prior SCD related organ damage like stroke, acute chest
syndrome, frequent painful episodes and multiple sites of osteonecrosis (Herman &
Chaudhry, 2010). According to a randomized control trial conducted by Orringer et al.
(2001), a Purified Poloxamer 188 used in concomitant with Hydroxyurea for the
treatment of acute vaso-occlusive crisis resulted in a decrease in the duration of painful
episodes.
A newly approved pharmaceutical product, Voxelotor (GBT-440), has been
developed to inhibit HbS Polymerization, enhance blood oxygen saturation and reduces
hospitalization-induced VOC crisis (Nwabuko et al., 2019). Matte et al. (2019) also
described Voxelotor (GBT-440) as an oral direct anti-sickling agent that can be beneficial
in SCD as it blocks HbS intermolecular contacts, preventing the generation of HbS fibers
and RBC sickling. Crizanlizumab, another new investigational biologic therapy
manufactured by Novartis yet to be approved by the U.S. Food Drug Administration
[FDA], is expected to help in the prevention of VOC or pain crisis (Nwabuko et al.,
2019).
Physicians Committee for Responsible Medicine and Unbound Medicine, PCRM
(2019) proposed some preventive strategies as comprehensive and multidisciplinary care
that should incorporate education of both patient and family to help prevent
complications of the disease. Other preventive strategies are regularly administering
influenza, meningococcal and pneumococcal vaccines, and pneumococcal prophylaxis to
children with SCD until age 5, especially those with a history of splenectomy or severe
pneumonia (PCRM, 2019). Antibiotic prophylaxis and early immunization were used for
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managing infections such as Pneumococcus and Meningococcus infections (Herman &
Chaudhry, 2010) Also, a daily dose of 1mg Folic acid and an iron-free multivitamin to
ensure adequate intake of nutrients that are usually deficient in SCD patients is
recommended by PCRM (2019). Brousseau et al. (2004) observed decreases in the length
of stay (LOS) during a pain crisis for 19 SCD children admitted at the hospital in a
single-arm study conducted to determine the effect of intravenous (IV) magnesium
sulfate on the LOS.
Challenges That the Sickle Cell Disease Community Faces
Cyril-Olutayo et al. (2019) proclaimed that the management of SCD had been a
real challenge since its discovery in 1910 by Dr. Herrick. The CDC (2020) claimed that
between1989 and 1993; there was an average of 75,000 hospitalizations due to SCD in
the United States, costing approximately $475 million dollars. The CDC (2020) also
reported that medical expenditures for children with SCD averaged $11,702 dollars for
those with Medicaid coverage and $14,772 dollars for those with employer-sponsored
insurance in 2005. About 40% of children from both groups had at least one hospital stay.
The American Society of Hematology (ASH, 2016) also asserted on how SCD is
associated with high treatment costs. An average person with SCD that lives to the age of
45 may incur a total lifetime health care costs estimated to be about $1 million dollars,
with annual costs ranging from over $10,000 dollars for children to over $30,000 dollars
for adults (ASH, 2016). The Agency for Healthcare Research and Quality in 2004
reported that 83,149 adults were hospitalized for SCD with approximately $488 million
dollars in associated costs. For the community or group in the society who are more
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susceptible or at high risk of having SCD, these costs are a challenge or burden
considering the financial or socio-economic status of most of these families dealing with
the SCD condition.
Multiple follow up and specialty clinic appointments coupled with pain episodes
which constantly interrupt life activities are the main reasons for stress that leads to more
absences from work, school, and fear of job loss or class placement is also another major
challenge (Leger et al., 2018). Most SCD patients may also not have a primary care
provider or individual health care plan, a cause of depression for them that can affect
their pain coping skills, self-care management, and quality of life (Leger et al., 2018).
Preoccupation with their illness may also cause the SCD patient to have poor health
outcomes from negative medical experience (Leger et al., 2018).
Patients in some low or middle-income countries or communities may not have
access to some vital health services like penicillin prophylaxis, broad-spectrum
antibiotics, healthcare facilities, practitioners, and health insurances (Leger et al., 2018).
SCD patients also have to deal with the stigma associated with the condition in terms of
longevity, all the morbidities, the claim of prescription drug abuse, restrictions in terms of
partner choice, and other social limitations.
Shet and Thein (2019) asserted that the gaps or lapses in providing resources and
adequately equipping SCD healthcare practitioners with the required skills lead to various
challenges in providing effective management for the newly increased population of SCD
patients. Taylor et al. (2013) claimed that there is a lack of research on the occurrence
and characteristics of chronic pain, especially in adults with SCD. Su et al. (2019)
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maintained that barriers in access to specialist care remain a challenge for SCD patients.
Adherence to medication or treatment regimen can be a significant challenge for many
SCD patients, especially the children. According to Modi et al. (2009), forgetfulness was
the primary barrier to adherence, and caregiver reminders were the primary strategies
identified by both caregivers and adolescents, with the adolescents reporting significantly
more barriers for pain management. Modi et al. (2009) recommended multidisciplinary
treatment teams to facilitate dialogue with patients and their families about adherence
barriers and strategies, which is necessary because both caregivers and adolescents seem
to experience similar barriers and strategies across multiple components of the SCD
treatment regimen.
Issues of Healthcare Disparities and Social Justice That Impact the Sickle Cell
Disease Patient: Understanding Practitioners’ Prescribing Habits
For years, SCD patients has had limited options for a treatment regimen for the
management of SCD-related chronic excruciating pains. The mainstream treatment for
these pains has been with opioid analgesics. Even though there are both pharmaceutical
and non-pharmaceutical products that SCD-HCPs could have explored for their patients,
their prescribing habits have been mainly for these opioids- related analgesics
irrespective of all the stigmas that are associated with them. For instance, hydroxyurea, a
pharmaceutical product that claims to have the potential to reduce the frequency of these
pain episodes and its consequent hospitalizations, is rarely prescribed for SCD patients
even though it has been in the market for more than twenty years. Aside from these
questionable prescribing habits of SCD practitioners, the pharmaceutical manufacturing
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companies seemed to have neglected the SCD community for so many years and have
barely been manufacturing any products for this community. For instance, hydroxyurea
has been the only pharmaceutical product manufactured or approved for SCD for about
20 years. Stone (2015) asserted that no drugs were approved between 2010 and 2013 for
the treatment of SCD pain, while five new ones became approved for cystic fibrosis.
Nwabuko et al. (2019) described SCD as one of the diseases of public health importance
that requires political, legislative, and cultural attention. These authors asserted that
legislation on SCD prevention would enable proper auditing, surveillance of the blood
types of the population for precise mapping, budgeting, and allocation of resources.
Currently, there is a shortage of SCD practitioners, and there are few
Oncologists/Hematologist who goes out of their way to show interest in the SCD patient.
The situation is so bad that for a big metropolis like Dallas/Fort Worth foe instance, it
takes six months to get an appointment for an SCD patient to see a physician. When a
patient misses an appointment, it takes another six months to reschedule or get another
appointment. Su et al. (2019) maintained, however, that hematologists/oncologists
accounted for a higher proportion of visits by children than adults, while emergency
medicine visits were higher in adults than children. CDC (2020) affirmed that the SCD
patient has limited access to comprehensive team care than other people with genetic
disorders like hemophilia and cystic fibrosis. Ironically, most SCD departments are
attached to oncology/hematology departments in most major healthcare facilities, with
most of the practitioners being oncologists/hematologists, which indicates awareness of
the gravity of SCD in healthcare. However, SCD patients still do not receive much of the
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attention or assistance their counterparts are receiving. With the current statistics or
prevalence of the disease globally and the annual expenses per each case, SCD should be
deemed as a major public health concern (CDC, 2020) and thus warrant recognition.
However, Suzette Oyeku, a sickle cell expert at The Children's Hospital at
Montefiore/Albert Einstein College of Medicine maintained that "there is shockingly
little data on sickle cell epidemiology in the United States due to the limited national
surveillance data on the condition" (Stone, 2015, para. 18). Stone asserted that “the
difference in access to care and research dollars for SCD might be due to racism and
economic differences claiming that there are several sources for disparities in funding and
treatment of SCD as compared to other diseases” (paras. 15 &18). Meanwhile, Strouse, a
researcher from Johns Hopkins, who made this observation, did not attribute these
differences to racism or social justice issues, but instead to media savvy (Stone, 2015).
Booker et al. (2006) posited that the nature of SCD pain is poorly understood and
is often sub-optimally managed. Stone (2015) also maintained that health care workers
are prone to underestimate the patients' pains and most often treat patients as drug
seekers. There are also now the humiliating drug screens by feds with the claim of
ensuring that patients are taking the narcotics and not selling those (Stone, 2015). Leger
et al. (2018) asserted that there is a lack of provider knowledge or irrational fear of
"addiction" that leads to improper triage or inadequate pain management. Stone declared
that the pain crises associated with SCD remain undertreated, which may reflect racial
and gender biases. Taylor et al. (2013) proclaimed that SCD patients that experience
chronic pain are often underserved, and their pain remains undertreated, which may result
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in increased healthcare costs associated with emergency room visits, hospitalizations, and
lost work productivity.
According to Leger et al. (2018), there is enough evidence that there is a
significant delay in average time to administer initial analgesia in the ED compared to the
recommended 15–20 minutes; and only a few patients received the recommended pain
relief agents at the recommended dose and routes. Ezenwa et al. (2016) also declared that
SCD patients usually receive inadequate and untimely treatment for pain control. They
are also more likely to be accused of drug-seeking behavior and labeled as drug addicts
as compared to other populations with chronic pain (Ezenwa et al., 2016). It is a norm for
SCD patients to receive their first pain medication 30 minutes later than others like renal
colic patients presenting with similar symptoms in the ER, increasing the tendencies for
such inequities to result in health disparities with time (Ezenwa et al., 2016). Lee et al.
(2012) asserted that "ER healthcare providers often respond with inadequate pain control
because of overestimating drug dependence and their perceptions of drug-seeking
behaviors by patients' with SCD" (para. 5). Furthermore, these authors added that
"misconceptions by ED providers, combined with lack of a regular primary care provider
and poor self-care management of SCD, are factors contributing to the patient's repeated
use of the ED for pain management (Lee et al., 2012, para. 5). There is also a stigma from
society, including even among healthcare professionals that SCD patients are more prone
to develop opioid-based analgesia addictions than other diseases with similar symptoms
(Booker et al., 2006). This stigma influences prescribing and nursing behaviors and has
resulted in feelings of mistrust towards the physician to the point of affecting adult
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patients' willingness to communicate their true feelings for fear of not receiving optimal
treatment (Booker et al., 2006). Elander et al. (2004) also affirmed how the treatment of
painful episodes in SCD could result in disputes between patients and HCP. This raises
concerns about patient behaviors with the suspicion of either drug-seeking due to
analgesic dependence and misuse or pseudo-addiction caused by under- treatment of pain
(Elander et al., 2004).
According to Adegbola et al. (2012), the perceived disrespect from HCPs
increased emotional pain and worsened the physical pain for the SCD patient. Patients
also reported dissatisfaction with HCPs lack of empathy and inadequate management of
the chronic SCD-related pain, resulting in non-therapeutic patient-HCP relationships
(Booker et al., 2006). Ratanawongsa et al. (2009), however, claimed that the negative
perception of SCD patients on provider attitudes affects the quality of patient-provider
communication and care during VOCs. Thomas and Cohn (2006) also declared that the
poor communication between SCD patients and their HCPs causes suspicion and mistrust
and results in most patients feeling labeled negatively by the healthcare system and thus
skeptical of opening themselves to an unsympathetic system. These researchers organized
pilot courses on communication skills and cultural awareness strategies for HCPs to use
in challenging situations such as patients acting hostile and aggressive towards them. It
occurred that the training had a positive and enduring impact on practitioners' perceived
ability and confidence in communicating with their patients (Thomas & Cohn, 2006). The
authors thus concluded that the training model employed might help reduce mistrust and
increase empathetic responses in healthcare professionals towards patients (Thomas &
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Cohn, 2006).
Nutrition as an Alternative Treatment Option in Sickle Cell Disease Pain
Management: Nutrients, Herbs, Fruits, and Veggies With Analgesics, AntiInflammatory, and Vasodilation Potentials
The position of nutrition in SCD pain management can be a beneficial alternative
treatment regimen that needs critical investigation. Thompson and Eriator (2014) asserted
that the majority of SCD patients live with chronic pains, which has resulted in many of
them resorting to the use of complementary and alternative medicine (CAM). PCRM
(2019) posits that SCD patients’ have more significant than average requirements for
both calories and micronutrients, but most patients are deficient in essential
micronutrients. According to Hyacinth et al. (2010), because of the challenge in finding a
cure for SCD after 100 years of its discovery, there has been a growing interest in the
nutritional problems of the disease resulting in many researchers seeking nutritional
alternatives as a means of decreasing morbidity and improving quality of life for SCD
patients. These authors claimed that the SCD patient usually does not meet or fulfill the
recommended dietary allowances (RDAs) when compared to the general population,
irrespective of the fact that efficacy of macronutrient supplementation proved to be
evidence-based (Hyacinth et al., 2010). Likewise, micronutrients occur to be insufficient
among the SCD community, according to Hyacinth et al., (2010). These authors thus
recommended the need to establish specific RDAs for SCD patients, much like the
specific RDAs developed for pregnancy and growth within the general population SCD
(Hyacinth et al., 2010). PCRM (2019) also recommended that diets rich in fruits,
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vegetables, whole grains, and legumes (plant foods) have the potential to provide a higher
proportion of essential nutrients than a typical Western diet, and have the appropriate
supplementation to prevent deficiency and decreases disease exacerbation. Hyacinth et al.
(2010) cited, for example, that recent findings of vitamin D deficiency among the SCD
community may attribute to incomplete ossification and bone disease, one of the
significant complications of SCD. According to PCRM (2019), iron overload and
oxidative stress may cause the depletion of antioxidant vitamins.
Most of the herbs, fruits, and veggies that we use daily possess analgesics, antiinflammatory, and vasodilation potentials that can play significant roles in managing the
pains associated with SCD pains. Cyril-Olutayo et al. (2019) commented on how
medicinal plants have been used traditionally in Africa for the management of SCD,
whose treatment has been mainly palliative. These authors claimed that the following
herbs or medicinal plants Zanthoxyllum xanthoxyloides, cajanus cajan, carica papaya,
cnidoscolus aconitifolius have ant sickling effects which can prevent and reverse sickling
of RBC (Cyril-Olutayo et al., 2019). These researchers conducted a study on the
medicinal plant, Telfairia occidentalis (fluted gourd or pumpkin), a nutritious vegetable
rich in vitamins, proteins, antioxidants. It was observed that this herb could treat SCD as
it is capable of preventing and reversing the sickling of RBC, stabilizes the RBC
membrane, reduces HbS red cell density, increases their PCV, prevents and alleviate
SCD crisis in infants and adults (Cyril-Olutayo et al., 2019).
Osunkwo et al. (2012) conducted a pilot study where SCD patients who were
administered high‐dose vitamin D achieved higher levels of serum 25‐hydroxyvitamin D,
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experienced fewer pain days per week and had higher physical activity quality‐of‐life
scores. Based on these findings, researchers suggested that vitamin D possesses the
potential to reduce the number of pain days in SCD patients (Osunkwo et al., 2012).
Amer et al. (2006) claimed that exposing or treating SCD patients with antioxidants such
as N‐acetyl‐cysteine, vitamins C and E, decreased their oxidative stress or damage to
RBC and platelets, thereby alleviating symptoms associated with their pathology.
PCRM (2019) recommended the importance of staying hydrated or drinking
enough fluid during strenuous exercises as sickling of erythrocytes increases in SCD
patients who exercise in the heat without consuming fluids, compared with those who
stay well-hydrated. Omega-3 fatty acid (n-3FAs) supplements are recommended for the
SCD-child patient as they are low or deficient on alpha-linolenic acid and the long-chain
omega-3 polyunsaturated fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic
acid [DHA]) according to this committee.
ω-3 FAs have the potential to increase the fluidity of RBC membranes, which
may prevent sickle cell crises. Both EPA and DHA are known to have significant
therapeutic benefits of reducing severe anemia (PCRM, 2019). Based on a doubleblinded, olive oil-controlled clinical trial Tomer et al. (2001) conducted, it was observed
that treatment with dietary ω-3 FAs for one year reduced the frequency of pain episodes
that requires hospital visits from 7.8 events during the preceding year to 3.8 events per
year as they reduce prothrombotic activity in SCD. Matte et al. (2019) also maintained
that a phase II multicenter randomized, double-blinded placebo-controlled study in SCD
patients reported that ω-3 fatty acid supplementation reduced pain episodes in SCD

47

subjects.
Franceschi (2000) speculated that dietary magnesium (Mg) pidolate
(pyroglutamic acid) supplementation has the potential to inhibit K–Cl co‐transport and
reduce dehydration. Franceschi (2000) claimed that blocking the transport pathways that
promote loss of potassium (K) is a potential therapeutic strategy for SCD as it prevents
erythrocyte dehydration, one of the causes of pain crisis. Prasad et al. (1999) claimed that
frequent hemolysis in SCD could attribute to zinc deficiencies in these patients. Zinc
deficiency is known to impact T‐helper1 (TH1) functions adversely, cell-mediated
immunity, and causes decreased interleukin (IL)‐2 production (Prasad et al., 1999). These
researchers proposed that zinc supplementation has the potential to improve the T‐helper
function and decrease the incidence of infections in patients with SCD (Prasad et al.,
1999). Datta et al. (2019) also maintained that there is evidence that zinc supplementation
may be beneficial in reducing the risk of infections and the painful VOC in SCD patients.
According to Nwabuko et al. (2019), folic acid supplementation, L- Glutamine,
Glutathione oxidase inhibitor, Thiocyanate-containing foods, Vitamin B containing diet,
seaweeds, and other food supplements are recommended, since they are rich in
antioxidants. Matte et al. (2019) asserted that a “multicenter, randomize, placebocontrolled double-blind phase III clinical trial with L-glutamine (0.3g/Kg twice a day)
supplementation reduced the mean number and length of hospitalization, associated with
the increased median time to the first crisis” (p. ). Agbai (1986) claimed that the
prevalence of SCD is relatively rare in Africans than in the African-American population
in the United States. In contrast, SCT, the non-anemic, heterozygous condition, is about
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three times more common among indigenous Africans than in African-Americans. The
ratio of SCD to SCT is 1 out of 50 for African-Americans and less than 1 out of 1,000 for
tropical Africans, according to Agbai (1986). This researcher attributed this etiological
disparity to an anti-sickling agent, thiocyanate (SCN-) found abundantly in staple African
foods, such as the African yam and cassava (Agbai, 1986). The author claims that staple
American foods have negligible SCN-concentrations. In contrast, non-staple foods in the
American diet, such as carrots, cabbage, and radishes, have SCN- levels far below the
African yam and cassava (Agbai, 1986). SCD remains regarded as congenital deficiency
anemia that can be improved by prophylactic diets with high SCN- contents (Agbai,
1986). The researcher thus concluded that “thiocyanate deficiency anemia” is a
nutritionally correct clinical status for those born with the homozygous sickle
hemoglobin genome and that subjects become more susceptible if they subsist on SCNdeficient food contents (Agbai, 1986). However, other thiocyanate rich foods that may
easily be located in the US include turnips, broccoli, Brussels sprouts, and cauliflower.
According to Al‐Momen (1995), most of the patients that have severe SCD may
suffer from unrecognized vitamin B12 deficiency. Ohnishi et al. (2000) posited that dense
RBCs in SCD patients tend to adhere to neutrophils, platelets, and vascular endothelial
cells, which could trigger VOC and thus subsequent painful crisis. Nutritional antioxidant
supplements, hydroxyl radical scavengers, and iron-binding agents could inhibit the
formation of such dense cells (Ohnishi et al., 2000). Some of the nutritional supplements
found to be capable of inhibiting dense cell formation by 50% aged garlic extract, black
tea extract, green tea extract, Pycnogenol, α-lipoic acid, vitamin E, coenzyme Q10, and β-
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carotene (Ohnishi et al., 2000). Grapefruits, for instance, are high in potassium content
rendering them useful vasodilators that contribute to the widening of blood vessels and
the relaxation of smooth muscles in the cells enabling smooth flow of blood in the
vessels.
Coping Mechanisms/Strategies, Lifestyle Modifications, and Sickle Cell Disease Pain
Management
Employing coping strategies that may range from simple strategies like hot pad
massaging, relaxation, and prayers to more sophisticated ones like selfawareness/mindfulness, healthful eating habits Acupuncture, among others. These can be
effective approaches to dealing with the SCD pain. Neville and Panepinto (2011)
proposed that “even though there is the need for new treatments for SCD, especially for
disease-modifying agents, it is also imperative to explore new approaches for improving
treatment with the existing modalities”(p. 11)
Dampier (2019) posited that because of the multifactorial nature of both pain and
VOC, it is imperative to explore simultaneously targeting multiple mechanisms, which
may be the optimal approach for effective preventive therapies. Lee et al. (2012)
proposed the coordination of interdisciplinary health team members to reduce pain
episodes and any associated catastrophic complications like renal failure, pulmonary
disease, and cardiovascular events. “Because of the complexity of chronic pain in SCD
patients, a multidimensional perspective is needed which embraces the whole person by
focusing on biological, psychological, sociological, and spiritual factors” (Taylor et al.,
2013, para. 8). Angst et al. (2009) proclaimed that patients with chronic pain that engages
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in an interdisciplinary treatment program such as physiotherapy, psychotherapy, part of a
coping pain group, acquire information and education about the pathophysiology of
disabling pain mechanisms and management, regular medical consultations, and drug
therapy reported decreases in mean pain severity. They also depicted improvement in
social functioning compared to patients receiving standard care as inpatient rehabilitation
and drug therapy (Angst et al., 2009). Williams and Tanabe (2016) suggested that
patients should be able to use non-pharmacological interventions to alleviate pain with
some degree of success. These researchers also claimed three categories of nonpharmacological therapies, which are peer-support groups, educational/psychoeducational, and skill-based (Williams & Tanabe, 2016). Adebowale (2014) asserted that
though there is no cure for SCD, there are cost-effective treatment options for the pain
and other aspects of the disease, such as early intervention with analgesics, antibiotics,
rest, proper nutrition, folic acid, high fluid intake and supplementation. Elander et al.
(2003) observed that SCD patients with pain-related symptoms that impaired activities
sought a more typical lifestyle. According to Lim et al. (2019), interventions should
emphasize the negative impacts of emotion-focused avoidance coping and integrate other
empirically supported coping strategies to improve HRQOL for SCD children presenting
with high intensity of pain. Elander et al. (2019) posited the need for a brief measure of
patient satisfaction with treatment for pain to help improve the treatment of painful
episodes caused by SCD, especially during and after the transition from pediatric to adult
care.
Self-care management can be an effective coping strategy that SCD patients can
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employ to help better manage pain episodes. According to Matthie et al. (2019), selfmanagement is vital to SCD management even though its role in chronic pain
management is not proven and thus proposed the need to develop and implement
effective strategies for the prevention and management of chronic pain. Edwin et al.
(2011) recommended the critical importance of self-management, especially selfawareness, to enhance the quality of life for the SCD community as they are costeffective, and consistent with sound ethical principles and good conscience. Tam et al.
(2019) designed an electronic teaching module (ETM) for educating adult patients on
VOC self-management and treatment options for SCD. Tam et al. (2019) claimed the
ETM increased the knowledge of patients in SCD. The educational ETM has the potential
to provide an immediate impact on health literacy for an underserved patient population
and potentially improve disease management and disease-specific outcomes (Tam et al.,
2019). Jenerette and Murdaugh (2008) proposed that vulnerability factors, such as sociodemographics, negatively affect health care outcomes. These authors suggested the use of
interventions to increase self-care management resources to improve the health care
outcomes of SCD patients. Examples of such self-care management resources, according
to the authors, are assertiveness, self-efficacy, coping behaviors, social support, self-care
ability, self-care actions, and communication skills. Jenerette and Murdaugh also asserted
that because of the high cost involved in medical interventions for SCD patients, self-care
management is critical and may be the best alternative option to decrease the health care
costs as well as improve the health status and quality of life for persons living with SCD.
Tanabe et al. (2010) organized a workshop on best self-management practices with the
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Sickle Cell Disease Association of America with seven adult SCD patients as
participants. Some of the themes that emerged were self-awareness, emotional support,
career selection, and success factors, nourishment, advocacy, knowledge, physical, and
complementary and alternative medicine (Tanabe et al., 2010). The most common
reported self-management strategy was self-awareness, with emphasis on journaling and
body awareness (Tanabe et al., 2010). Additionally, spiritual support, friends, family, and
professional counseling continued to be forms of emotional support, and another reported
the best self-management practice (Tanabe et al., 2010).
Matthie et al. (2015) maintained that home self-care contributes to proper pain
management, prevent pain crisis. Matthie et al. (2015) suggested that empowering health
care providers (HCP) with a better understanding of self-care would enable them to
provide or equip patients with the resources and skills they required to be able to
participate in their disease management. Some of the benefits that SCD patients may
acquire from self-care interventions are social support, SCD self-efficacy, and access to
education (Matthie et al., 2015). According to Masuda et al. (2011), acceptance and
commitment therapy (ACT) promotes acceptance of severe sensations, emotions, and
thoughts, which enhances functioning and quality of life for SCD adolescents and their
parents. “These authors proposed that ACT interventions can be useful conceptual and
therapeutic additions to the treatment of pediatric patients with SCD and the family”
(Masuda et al., 2011, p. 9). According to Simmons et al. (2019), mindfulness-based
intervention (MBI) is feasible and acceptable for persons with SCD experiencing chronic
pain. Simmons et al. (2019) claimed that MBI could be used to provide non-
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pharmacologic, behavioral pain management options for practitioners that care for SCD
patients and chronic pain.
Spirituality has been one of the coping mechanisms that have been employed by
the SCD community to manage pain. According to Wachholtz and Pearce (2009), chronic
pain is a sophisticated experience that results from the interrelationship between
biological, psychological, social, and spiritual factors. These authors affirmed that many
patients that experience chronic pain uses various religious/spiritual forms of copying,
such as prayer and spiritual support, to manage their pain. Wachholtz and Pearce (2009)
proposed that health care professionals should participate in the exploration of spiritual
matters that may contribute to the pain experience of their patients. Taylor et al. (2013)
also posits that because spirituality/religion is central to the SCD community, they can be
incorporated to any model of chronic pain as it is proven that spirituality/religiosity is
associated with decreased pain intensity in patients. “It was concluded from a study
findings that adopting positive religious strategies are associated with significantly fewer
hospital admissions after adjusting for other demographic and diagnostic variables”
(Bediako et al., 2011, p.1). Cotton et al. (2009) claimed that patients who engage in
higher levels of religion and spirituality recover from illness more quickly, are less
depressed and enjoy better HRQOL. In a study conducted by these researchers, most
SCD adolescents described employing a “collaborative” religion and spirituality coping
style (Cotton et al., 2009). They reported depending on God for support and on prayer for
symptom relief, believing in God to “strengthen” them in such situations with those who
believe in God, rating religion as necessary in their lives (Cotton et al., 2009). Patients
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who attend religious services are also found to be less likely to engage in risky health
behaviors and have better mental health outcomes thus less depression and anxiety
(Cotton et al., 2009).
Acupuncture has been one of the coping strategies or non-pharmaceutical therapy
that has been used for pain relief and can be explored for SCD pain management. Tsai et
al. (2015) proposed Acupuncture has the potential to decrease pain and anxiety as well as
reduced PED visits and hospitalizations for SCD pain when used to treat the acute and
chronic SCD pains of a child patient. Based on a retrospective study they conducted, Lu
et al. (2014) concluded that the physical insertion of the needle during the administration
of Acupuncture might be useful in alleviating pain and proposed the possibility of using it
as an adjuvant for pain management for the SCD population. According to Wick, (2019)
complementary and integrative therapies (CIM) or complementary and alternative
medicines (CAM) such as vitamins, minerals, homeopathy, meditation,
acupuncture/acupressure, or deep breathing techniques involves a holistic, patientfocused approach to health care in managing pain and anxiety.
Other non-pharmacologic therapies or approaches such as massaging and relaxing
can be an effective alternative regimen for SCD pain management. Bodhise et al. (2004)
asserted that deep tissue/pressure massage therapy technique, including neuromuscular
trigger point treatment with acupressure for SCD patients, has sound effects on pain relief
and quality of life. Rees et al. (2003) proposed that because a majority of painful episodes
are managed at home, SCD patients and parents should be educated as to when to seek
medical help from their HCPs, health visitors, and hemoglobinopathy counselors. This is
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necessary because most patients only go to a hospital only when oral analgesia is
insufficient, or symptoms suggest a severe complication (Rees et al., 2003). Furthermore,
educating SCD patients would help prevent or combat most of the complications
associated with VOC or pain crisis.
Exploring Preventative Measures to Combat Sickle Cell Disease
Incidence/Prevalence
SCD prevalence continues to be increasing recently and becoming more
widespread globally due to globalization and an increase in migration. It has resulted in
interracial marriages rendering it a significant public health concern even though it has
not received much recognition as other health conditions. In the quest of controlling its
incidences and hence prevalence, countries like Ghana with a high prevalence of one in
every three Ghanaians having the hemoglobin S or C gene has proposed such extreme
preventative strategies like prenatal diagnosis (PND) and selective abortion which
presents with a whole lot of ethical concerns (Edwin et al., 2011). Other standard
preventative measures that are employed globally to control SCD incidences are genetic
counseling and testing, as well as new-born screenings. Edwin et al. (2011), for instance,
proposed preconception genetic testing and strategic reproductive choices, PND and
education for carrier parents, and holistic management for the SCD community in Ghana.
Nwabuko et al. (2019) recommended the need to put in place proper documentation,
which may ultimately lead to the establishment of local and national Surveillance
Epidemiological End-Result (SEER) statistics for SCD. These authors claimed SEER
statistics for the SCD community would guarantee proper case ascertainment,
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epidemiology, incidence rate, prevalence, birth rate, mortality rates, and the ABO Rhesus
blood types for SCD patients. Nwabuko et al. (2019) maintains this could be life-saving
as it promises to reduce the protocols of blood grouping required for emergency medical
interventions, especially in cases of severe anemia due to road traffic accidents, medical
and surgical conditions that would require urgent blood transfusions. Rees et al. (2003)
also proposed the following guidelines to be adopted for rapid admission to hospitals,
which include "a written protocol for quick assessment of pain and rapid, safe
administration of analgesia and personalized care plans made available to on‐call medical
staff. These authors also suggested that patients should be able to carry
hemoglobinopathy cards that state their diagnosis and baseline hematological data. This
would make it possible to initiate an analgesia therapy within 30 minutes of arrival in
hospital after a rapid initial assessment and to enable the pain to be brought under control
within 60 minutes of starting analgesia (Nwabuko et al., 2019).
As part of the measure to combat SCD, Nwabuko et al. (2019) also proposed the
need for a Public Health awareness campaign on SCD and campaign language should be
culturally friendly, relevant, and understandable to mitigate the challenges of health
literacy and culture barriers. The authors made use of mass media (radio, TV adverts),
social media (i.e., Facebook, Whatsapp, Blog, Flicker, Twitter and Instagram, etcetera) as
the vehicles for disseminating information. Radio and TV adverts are imperative, but they
are non-existent. There is hardly anything like commercials on any radio or TV station on
any aspect of the disease, not even to promote an SCD medication, unlike other chronic
conditions like cancers, diabetes, hypertension, CVDs, and more. Adebowale (2014)

57

claimed there is an increase in the percentage of carriers and the high possibility of a
continuous increase in number if not controlled. This author thus proposed incorporating
social welfare counseling in social, religious, health and educational sectors and other
techniques when educating carriers especially individuals yet to get married, towards the
prevention and eradication of the disease (Adebowale (2014). Because of "the huge
burden of SCD coupled with the associated high morbidity and mortality rates globally, it
is imperative to invest more in ways of reducing the prevalence of the disorder" (Aneke
& Okocha, 2016, para.1).
Unaddressed Aspects of Sickle Cell Disease Pain Management: Impact on
Psychological and Mental Health
A significant effect of pain crises on SCD patients, especially the children and
their HRQOL that is usually overlooked and not addressed, is on their mental health. The
impact of pain crisis on the psychological or mental health of SCD patients and their
caregivers is a critical aspect of the disease phase that is most often not taken into
consideration by SCD health practitioners. Anie et al. (2010) described SCD as a global
health problem with psychosocial implications. “Chronic pain in adults with SCD is
described as a complex multidimensional experience that includes biologic, psychologic,
sociologic, and spiritual factors” (Taylor et al., 2013, p.1). These authors gave some of
the psychosocial variables like stress, mental health status, coping behaviors, social
interactions, cognitive dysfunction, functional and socioeconomic status.
The pain crisis has the potential of inducing extreme stress and depression on both
patients and caregivers as they strive to bring it under control. Many children with SCD

58

suffer a lot of psychological and emotional distress due to the isolated lifestyle they tend
to adopt due to all the health challenges they go through. Most of them complain about
how they are the ones who are always sick and have to stay away from school as
compared to their colleagues and why they cannot do most of the things that other kids do
like playing outside, running, playing in the snow among others. One patient retorted,
“this disease is severe and can be very depressing at times” after recounting her
challenges with SCD. The stigma from society and the healthcare sector towards the SCD
community can also be another source of stress and psychological distress for many SCD
patients and their families. Elander et al. (2003) declared psychological disturbance as a
theme associated with non-pain-related symptoms. Edwards et al. (2005) asserted that
because of the chronicity of SCD with its frequent hospitalizations for pain and other
medical management, it has the potential to significantly impair psychosocial
functioning, alter intra- and interpersonal relationships, and reduced QOL for the patient.
Thus these authors concluded that due to this significant role of psychosocial issues in the
trajectory and management of SCD, understanding the pathophysiology of SCD without
thoroughly understanding the equally important psychosocial influences is
misunderstanding SCD (Edwards et al., 2005). According to Taylor et al. (2013), factors
other than biological factors, such as psychological and sociological factors examples
being SCD genotype, HbF levels, comorbidities, depression, stress, mental health status,
coping behaviors, social interactions, cognitive dysfunction, and functional and
socioeconomic status are common among SCD adults with chronic pain. Reader et al.
(2019) conducted a systematic review to assess the relationship between pain in terms of

59

frequency, intensity, duration, impairment, coping, and emotional functioning in children
with SCD. The researchers observed a strong relationship between increased pain
frequency and higher depressive and anxiety symptoms, moderate-to-strong associations
between pain-related impairment and depressive symptoms, small-to-strong associations
between pain-related impairment and anxiety with pain-coping strategies, and
maladaptive cognitive strategies depicting the strongest association with emotional
functioning. Mackey (2019) declared how stressful it could be for an SCD caregiver
without any coping strategies. Wang et al. (2011) asserted that coping strategies provide a
protective role in mitigating caregiving stress (Mackey (2019). “Interventions for
children with SCD reporting high pain intensity should put more emphasis on negative
impacts of emotion-focused avoidance coping and integrate other empirically supported
coping strategies to improve HRQOL” (Lim et al., 2019, para.1).
With HBM, Pantaleao et al. (2019) hypothesized that cues to action and perceived
pain burden enhances the relationships between psychosocial factors such as stress that
caregivers experience communicating about SCD to their child or HCPs during ER visits.
“These authors thus suggested that caregivers of children with SCD could benefit from
interventions that enhance stress-management and communication skills with their child
and HCPs” (Pantaleao et al., 2019, para. 1). Sadeghloo et al. (2019) maintained that
positive thinking training could be an effective strategy for improving the quality of life
of parents with ill children. Pecker and Darbari (2019) asserted that psychosocial and
affective comorbidities are common and can impact disease outcomes in SCD. Pecker
and Darbari (2019) thus proposed that addressing such comorbidities should be an

60

integral part of the management of SCD. According to Da Silva et al. (2019), the
treatment of chronic pain, including pharmacological and non-pharmacological
treatments, can have an impact on brain function. Though these researchers asserted that
this trend is not well established with SCD patients, however, neuroimaging evidence
indicated abnormal neural processing related to chronic pain and psychosocial
comorbidities in SCD beyond ischemic stroke and cerebral hemorrhage (Da Silva et al.,
2019). Consequently, the authors proposed behavior therapy as a mechanism to improve
psychological symptoms as well as chronic pain and quality of life for the SCD
community (Da Silva et al., 2019). Connolly et al. (2019) also claimed that SCD youth
that battles persistent pain are at risk for psychosocial and neurocognitive impairments as
the persistent pain may tend to be an important indicator of disease burden. Therefore,
these authors suggested that disease management may be enhanced by assessing
cognitive and psychosocial functioning by incorporating interdisciplinary treatments to
address any impairments associated with persistent pain (Connolly et al., 2019).
Perceptions and Experiences of the Sickle Cell Disease Community Regarding
Alternative Treatment Options for Pain Management
There is a gap in the perceptions and experiences of the sickle cell disease
community on alternative treatment options for pain management that is the focus for this
study. Few studies have attempted to address the perceptions and experiences of parents
and patients and even other stakeholders of the SCD community on alternative treatment
options. "Parents perspectives on care and the relationships between coping, family
functioning, and health care utilization have not been given much prominence in the SCD
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literature neither has much attention being given to pediatric sickle cell intervention
efforts" (Mitchell et al., 2007, p.8). Atorkey (2015) also declared that the literature is
insufficient on SCD patients' perceptions and beliefs and their impact on patients'
treatment compliance. Smith et al. (2018) also maintained that there is little is known
about parent perceptions of managing SCD pain episodes in young children.
Theoretical Foundations: Health Belief Model, Transtheoretical Model, and
Biopsychosocial-Spiritual Model of Chronic Pain
"The theoretical framework is described as the foundation from which all
knowledge is constructed both metaphorically and literally for a research study" (Osanloo
& Grant, 2016, p. 1). "According to these authors, the theoretical framework serves as the
structure and support for the rationale for the study, the problem statement, the purpose,
the significance, and the research questions and provides a grounding base for the
literature review, the methods and analysis" (Osanloo & Grant, 2016, p. 1). The Health
Belief Model (HBM), Biopsychosocial-Spiritual Model of Chronic Pain, and the
Transtheoretical Model (TTM) would form the theoretical foundations for this study.
Taylor et al. (2013) described three models of pain associated with SCD:
biomedical model, the bio- psychosocial model for SCD pain, and the Health Beliefs
Model. The constructs of HBM would thus be employed to assess and enhance the SCD
community, especially patients' and parents' experiences and perceptions on exploring
alternative treatment regimens in place of opioid analgesics through interviews.
According to Gustafson et al. (2007), health screening behavior is usually influenced by
several factors such as the individual's perceived susceptibility to the condition, perceived
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seriousness of the disease, perceived benefit of the specific action, and barriers to the
behavior. Hence, the construct perceived susceptibility can be used to provide
information on the mode of operation of these opioids, that they are purposely for
maintenance, relieve SCD chronic pains associated and help patients to deal with it
without really doing anything to change the disease state. Perceived severity would be
used to determine the target audience's experiences and perceptions of the seriousness or
consequences of prescription drug abuse or overdose and consequences such as the
possibility of addiction and side effects. Perceived benefits could be employed to
promote alternative regimens like some of the disease-modifying agents such as
hydroxyurea and endari, which are claimed to have the potential to reduce the frequencies
of pain episodes. Perceived barriers would be used to analyze the target audiences'
experiences with and perceptions of tangible and psychological costs to trying alternative
treatment regimens and other health disparities like unequal distribution of social and
health resources such as inadequate healthcare facilities, practitioners and services. With
cues to action, the community's awareness of SCD symptoms and approach to pain
management can be assessed base on which appropriate strategies to motivate the
community to embrace an alternative regimen could be proposed. Self-efficacy could
contribute towards evaluating patient's abilities to confidently manage pain episodes by
employing coping strategies like self-awareness for early detection of pains and
symptoms of associated comorbidities like stroke, infections of organs in the body, and
mindfulness for better pain management. Taylor et al. (2013) referred to an individual's
readiness to utilize care and include perceived threats that result from the non-utilization
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of healthcare and perceived benefits and barriers to healthcare utilization as readiness
variables.
The constructs of TTM can be employed to investigate patients' opinions and
experiences with their HCPs prescribing habits and then the possible strategies to
empower them to enforce changes where necessary. Prochaska and Velicer (1997)
asserted that the Trans-theoretical model health behavior change involves progress
through six stages of change: pre-contemplation, contemplation, preparation, action,
maintenance, and termination. At this pre-contemplation stage, SCD patients/parents may
have no intention of taking action, thus adopting any of alternative treatment options or
coping mechanisms like self-care management practices as they may doubt their
effectiveness. By creating awareness, SCD patients/caretakers may contemplate trying
some of these alternative treatment practices soon. SCD patients/patients may prepare to
try some of these alternative treatment practices. SCD patients may need to take action
through empowerment to request for their HCP to prescribe other regimens aside from
opioid analgesics and also try self-care management practices for a short period. SCD
patients/prescribers adopt alternative treatment regimens or practices and continue to be
maintained for the long-term, depending less on opioids for pain management. Finally,
SCD patients/prescribers might decide to rely more on alternative treatment regimens or
practices. It may require further studies to accomplish these behavioral changes in the
SCD community, ultimately.
Taylor et al. (2013) developed the Bio-psychosocial-Spiritual Model of Chronic
Pain to incorporate spirituality using the bio-psychosocial (BPS) multidimensional
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approach previously developed by Turk and Gatchel ((2018) purposely for SCD patients
who deemed spirituality/religiosity as an essential aspect of chronic pain management.
Taylor et al. (2013) proposed the BPS-Spiritual model for adults with chronic pain from
SCD since it embraces the whole person. The model accommodates the biological,
psychological, sociological, and spiritual factors relevant to adults with SCD (Taylor et
al., 2013).
Use of the Biopsychosocial-Spiritual Model of Chronic Pain for Sickle Cell Disease
Pain Management
According to Taylor et al. (2013), the BPS model has been used effectively in
other chronic pain populations and interdisciplinary treatment programs like
physiotherapy, psychotherapy, and coping pain support groups. It has also been used to
provide information and education about the pathophysiology of pain mechanisms and
management of chronic disabling pain, regular medical consultations and drug therapy.
Taylor et al. (2013) claimed there were decreases in mean pain severity and improvement
in social functioning compared to patients receiving standard care like inpatient
rehabilitation and drug therapy. These researchers also asserted that because
spirituality/religion plays a critical role in the SCD community, it is necessary to
incorporate an aspect of this dimension to any model of chronic pain in adults with SCD
as spirituality/religiosity has been associated with decreased pain intensity (Taylor et al.,
2013). They are promoting the BPS-Spiritual model because of its holistic approach since
it embraces the whole person, thus the biological, psychological, sociological, and
spiritual aspects of a person (Taylor et al., 2013). According to Turk and Gatchel (2018),
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the overall goal of the BPS model of chronic pain is to help the patient become an active
participant in life management skills and learn new ways of thinking about and coping
with chronic pain (Taylor et al., 2013).

Summary
CDC (2020b) claimed that there are millions of people with the SCD condition
globally and more prevalent among people with ancestors or background from subSaharan Africa; Spanish-speaking regions in the Western Hemisphere such as South
America, the Caribbean, Central America; India; and Mediterranean countries such as
Saudi Arabia, Turkey, Greece, and Italy. SCD is also common in areas where the
prevalence of malaria is high and is claimed that people who carry the sickle cell trait are
less likely to have severe forms of malaria (CDC, 2020b).
According to a study that Mitchell et al. (2007) conducted, employing both
quantitative and qualitative methods with 53 parents of SCD children confirmed that
positive patient coping was related to positive family functioning and lower health
utilization. The study participants, however, requested the need for comprehensive health
care approaches that meet the physical and psychological needs of patients and families
(Mitchell et al., 2007). The participants of an exploratory study conducted by Anie et al.
(2010) claimed that society, in general, had a negative image of SCD, and reported
negative perceptions and attitudes. “These researchers concluded that employing
psychosocial interventions in SCD would help to reduce negative thoughts and feelings
about the condition and encourage the acquisition or maintenance of coping strategies”
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(Anie et al., 2010. p. 5). Based on the findings of a survey conducted by Smith et al.
(2018) on 51 parents of 2- to-6-year-olds SCD patients, 82% of the parents who reported
using medications to manage their children’s pains claimed moderate satisfaction with
current management strategies and resources. However, they expressed interest in
additional pain management education that could enhance better parent and child-coping
skills.
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Chapter 3: Research Method
Introduction
The purpose of this study was to qualitatively explore the perceptions and
experiences of the SCD community on the use of alternative treatment options for pain
management instead of opioid analgesics. The findings contribute insight into the
prescription habits of SCD practitioners and variables (such as cost, availability of/access
to alternative regimens and other health services, knowledge, and more) that influence
patients’ and HCPs’ choices of treatment options. It also throws light on how patients’
experiences and perceptions impact their choice of treatment regimens. The case study
approach was employed to address these issues of interest in the study. The subsections
within this chapter address the research design and rationale, participants, my role as the
researcher, methodology, data collection, instrumentation, validity, ethical procedures,
and trustworthiness.
Research Design and Rationale
One of the significant purposes of this study was to assess the experiences and
perceptions of alternative treatment options for pain management, employing a
qualitative approach. Astalin (2013) characterized qualitative research as “a systematic
scientific inquiry that seeks to build a holistic, largely narrative, description to inform the
researcher’s understanding of a social or cultural phenomenon” (p. 1). With SCD being a
genetically inheritable disease that affects a specific population in society, there are
certain cultural norms and practices that may influence the perceptions of members of the
SCD community and their approach to SCD management or treatment. This rendered
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qualitative research the appropriate approach to use to execute this study.
"Creswell (2015) declared that the real beauty of qualitative research is that the
possibilities for data collection are very extensive, noting that sources may include openended interviews, open-ended observations, and public and private documents such as
private diaries, newspaper articles, and meeting minutes”. Astalin (2013) also affirmed
that qualitative research can be conducted with a combination of observations,
interviews, and document review. The specific qualitative research design used for this
study was the case study design, which can be carried out using various data collection
tools. As Alpi and Evans (2019) explained,
Case study research is a qualitative approach where the investigator explores a
real-life, contemporary bounded (a case) or multiple bounded systems (cases)
over time, through detailed, in-depth data collection involving multiple sources of
information reports a case description and case themes. (p. 2)
A case study has also been described as “an intensive, holistic description and analysis of
a bounded phenomenon such as a program, an institution, a person, a process, or a social
unit” (Yazan, 2015, p. 6). Astalin (2013) also asserted that case studies can be used to
holistically analyze people, events, decisions, periods, projects, policies, institutions, and
other systems by one or more methods. Given the diverse nature of the study population
in terms of geographic location, educational level, and disease type, among other
characteristics, I reasoned that it might not be realistic to adopt a specific tool or source
of information; rather, several tools and sources might be needed for data collection. For
this reason, I judged case study to be the best design for this study. “Yazan (2015) noted,
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This type of qualitative approach is accredited with certain distinctive attributes
which are particularistic which implies it focuses on a particular situation, event,
program, or phenomenon; descriptive because it yields detailed, thick description
of the phenomenon under study and Heuristic as it illuminates the reader's
understanding of the phenomenon under study”. (p. 6)
Alpi and Evans (2019) claimed that rigor in case studies depends on the research
design and its components, which include the study questions, propositions, unit of
analysis, logic linking the data to propositions, and criteria for interpreting the findings
(Yin, 2017). Other features of case studies include the use of multiple sources of data, a
case study database, and a transparent chain of evidence linking the questions asked, the
data collected, and the conclusions drawn, according to Yin (2017). Common sources for
data for case studies include interviews, documentation, archival records, direct
observations, participant observation, and physical artifacts (Alpi & Evans, 2019).
Nevertheless, this study might be considered a microcase or microlevel case study
because it was conducted within a brief time frame; it was expected to be simple and
straightforward; it described an apparent problem of interest; and the study findings or
reporting were expected to be very brief and focused on specific points to depict the
clarity of the “lesson” inherent in the case (Alpi & Evans, 2019).
Research Questions
RQ1. What are the experiences of the SCD patients or their parents/caretakers
regarding the current prescribing habits of their HCPs to manage SCD
pain, and how do they influence their choice of treatment?
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RQ2. What are the experiences and attitudes of the SCD patients or their
parents/caretakers toward alternative treatment methods, and how do they
influence their choice of treatment?
RQ3. What is the stage of readiness for adopting alternative treatment methods
for SCD patients or their parents/caretakers?
RQ4. How does disease perception among SCD patients or their
parents/caretakers impact their willingness to try alternative treatment
methods?
As is the norm with case study research designs, multiple data sources were
employed in addressing the research questions. These included phone interviews, video
conferences, emails, and shared or archived stories of patients. As noted earlier, face-toface interviews and focus group methods were not possible in this study because of social
and physical distancing restrictions due to COVID-19.
Role of the Researcher
According to Sutton and Austin (2015), qualitative research studies enable
researchers to access the thoughts and feelings of research participants, making it
possible to gain a better understanding of the meaning that people ascribe to their
experiences. I have been personally involved with SCD communities for about 19 years,
and one of my initial significant concerns for the community was the prescribing habits
of its HCPs. I have never been comfortable with or approving of the choice of
pharmaceutical products, especially opioid analgesics, for pain management, especially
for younger patients, and I have been seeking better treatment options for years.
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Professionally, I have had the privilege to work in specialty pharmacies for the
past 14 years, where terminal or extreme diseases and health conditions such as cancers,
autoimmune and genetic diseases, and skin conditions are the principal focus. However,
SCD was never considered or included in these categories of health conditions. As I
became more aware of how ineffective some of the pharmaceutical treatments for SCD
patients can be and of the adverse or side effects and other complications associated with
them, my concern heightened. Another interesting observation I made was that as more
and newer medications were continually being developed and approved for other
conditions, there were barely any for SCD. Stone (2015) affirmed that no drugs were
approved between 2010 and 2013 for the treatment of SCD, whereas five new
medications were approved for cystic fibrosis. As I switched to the public health sector
professionally, my interest in alternative treatment options for SCD evolved into seeking
more preventative measures employing natural products such as nutrients and other
mechanisms that may be deemed more efficacious in pain management.
With all of these factors at play, there was a possibility that I would influence the
data collection process in a way that might threaten the quality of the data and introduce
bias. However, it was my responsibility as the researcher to ensure that the quality of the
study met the required standard and that bias was avoided or limited as much as possible.
According to Greenbank (2003), a researcher’s morals, competency, and personal and
social values have an essential influence on the research process. As such, Greenbank
maintained that it is imperative for researchers to describe relevant aspects of themselves,
including any assumptions, expectations, and biases, to be deemed qualified to conduct
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research. As Sutton and Austin (2015) asserted, qualitative study requires reflection on
the part of researchers, both before and during the research process, purposely for
providing context and understanding for readers. Sutton and Austin stated that to remain
reflexive, researchers should not be ignorant or avoid the possibility of their own biases,
as reflexivity requires researchers to reflect upon and clearly articulate their positions and
subjectivities in terms of worldview, perspective, and biases. With such information,
readers can have a better understanding of the filters through which questions were asked,
data were gathered and analyzed, and findings were reported (Sutton & Austin, 2015).
Greenbank (2003) posited that researchers should provide rational explanations
for their actions to justify their research methods. Greenbank also proposed that
researchers should adopt a participatory strategy or approach to research that involves
conducting a pilot study and feeding back preliminary findings to research participants
for comment and modification. I conducted a pilot study and received great feedback
from the participants, some of which I incorporated into the design of the instrument that
I used to collect data.
Methodology
Target Population
The population of interest for this research was SCD patients, as well as parents
and caregivers of younger SCD patients. SCD, a genetic disorder, is known to be more
prevalent among minority populations of African, Hispanic, Middle Eastern, and Asian
descent. Study participants varied in gender, ethnicity, race, age, socioeconomic status
(SES) or income level, educational level, geographic location, culture, and even

73

particular type of SCD (SS, SC, beta thalassemia, etc.), which might influence the type of
treatment regimen that best suits each patient. According to Asiamah et al. (2017), it is
necessary for a researcher to provide a proper definition or specification of a population
of interest because this guides others in appraising the credibility of the sample, sampling
technique(s), and outcomes of the research. Asiamah et al. also asserted that because the
study population forms the primary source of data, they can influence the research
credibility based on the researcher’s understanding, definition, and choice of it.
Inclusion Criteria
To be selected to participate in this study, individuals needed to meet the
following conditions:
•

knowledgeable in or experienced with SCD or the subject, specifically SCD
patients and parents/caregivers

•

interested in being interviewed or ready to be interviewed to share their
story/experiences and express their views

•

able to speak, read, and write in English or the Twi language of the Akan
people of Ghana, West Africa, in which I can easily communicate

•

14 years of age or older

•

stakeholder in the SCD community

Exclusion Criteria
The following groups were excluded from participating in the study:
•

young patients under the age of 14 years
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•

non-English-speaking community members who did not speak the Twi
language of the Akan people of Ghana, West Africa

Sampling Procedures
I performed sampling to select a portion of the SCD community to participate in
the study. However, because of social and physical distancing restrictions due to COVID19, this study was not limited to a specific location, given that interviews could be
conducted by phone or through online/social media platforms and tools such as email,
Skype, and WhatsApp. Marshall (1996) stated that it is necessary to choose a study
sample for any research project because it is impractical, inefficient, or unethical to study
whole populations, noting that the purpose of a study determines the sampling method
selected.
I used purposeful sampling, a very strategic sampling technique, for this study.
Purposeful sampling was deemed an appropriate sampling technique because of the
characteristics of the study population, the purpose of the study, and the need to be
tactful, judgmental, and specific in selecting participants for the study. The participants
who were included in the study were those who had experience with alternative treatment
options and were intellectually capable of constructively expressing their views.
Participants included parents/caregivers and patients, whom I contacted by email, text,
messaging, and social media. According to Palinkas et al. (2015), purposeful sampling is
widely used in qualitative research for the identification and selection of information-rich
cases when resources are limited. It is appropriate for identifying and selecting
participants who are exceptionally knowledgeable or experienced with a phenomenon of
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interest (Creswell & Plano Clark, 2011; Patton, 2002).
Purposeful sampling was also consistent with the case study design. According to
Seawright and Gerring (2008),
case selection should be a primary role of the case study researcher as in so doing
it also sets out an agenda for studying those cases which implies case selection
and case analysis are intertwined to a much greater extent in case study research.
(p. 2).
“However,” Seawright and Gerring wrote, “to prevent the dangers of selection bias
introduced whenever researchers choose their cases in a purposive fashion … perhaps
case study researchers should choose cases randomly” (p. 3).
Sample Size
Onwuegbuzie and Leech (2007) asserted that selecting sample size in qualitative
studies requires careful deliberation, as it determines the extent to which the researcher
can make each of the four types of generalizations, irrespective of a small sample size.
While Onwuegbuzie and Leech posited that sample sizes in qualitative research should
not be so large that they render it difficult to extract thick, rich data, other authors have
postulated that sample sizes should not be so small that it becomes difficult to achieve
data saturation (Flick, 1998; Onwuegbuzie & Leech, 2007). Mason (2010) for instance,
affirmed that qualitative samples must be large enough to assure that almost all relevant
perceptions are captured, noting that if a sample is too large, the data become repetitive
and superfluous. Mason cautioned that even though the guiding principle for sample size
in qualitative research is the concept of saturation, various issues also affect it as there is
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a point of diminishing return to a qualitative sample so adding more data does not
necessarily lead to more information. (p. 1). Mason added that sample sizes for
qualitative studies are generally much smaller than those in quantitative research.
Because qualitative research designs are very labor intensive, it can be time consuming
and impractical to analyze large samples (Mason, 2010). Based on the findings of the 560
studies whose contents were analyzed for their sample sizes, it was deduced that the
mean sample size was 31. Taking all of these factors into consideration, I determined that
the sample size for this study would be between 20 and 25 participants.
Instrumentation
Salkind (2010) described instrumentation as the tools or means with which
researchers attempt to measure variables or items of interest in the data collection
process; an instrument is a device used by investigators for collecting data. For this study,
instruments that I used in the data collection process included phone and face-to-face
interviews, videotape, audiotape, email, texting, and archived data review, among others.
Salkind (2010) also asserted that instrumentation incorporates construction and
assessment as well as conditions under which the designated instruments are
administered.
Acharya et al. (2009) designed a questionnaire to explore knowledge, attitudes,
and beliefs about SCT and SCD, and this is one of the instruments that was adopted for
this study. Al-Azri et al. (2016) also developed an instrument to test knowledge and
health beliefs regarding SCD, and it might also be emulated. Other researchers such as
Chakravorty et al. (2018) have validated questionnaires developed through stakeholder
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consultations, focus group discussions, and construct validation of questionnaires through
cognitive testing and assessment of construct validity by a nationwide pilot survey, which
were also used. Sample questionnaires that have been used by reputable entities such as
the U.S. Food and Drug Administration (FDA, 2014) and the Thalassemia International
Federation via Survey Monkey were also used for data collection. Because of the
geographical distribution of the study population and COVID-19, all data were collected
remotely online, by phone, by email, by text, or through social media tools such as
Facebook Messenger, among others.
Procedures for Pilot Studies
In (2017) claimed a pilot study is executed to test all the procedures of the main
study and validates the feasibility of the study by assessing the inclusion and exclusion
criteria, data collection methods, storage and testing of the instruments for measurements
in the study, and the training of researchers and research assistants. A mock pilot study
has already been done when taken course RSCH - 8450H. Three participants, an SCD
patient, a parent, and a pharmacist, were selected for the pilot study. A questionnaire was
administered to them, followed by a semi-structured face-to-face interview with the
patient and pharmacist. Fortunately, one participant is a sickle cell anemia disease (S.C.)
patient and the father of the patient, so their responses were based on first-hand
experiences, and their responses can be deemed to be valid and reliable. The other has no
SCD or any relatives who have the condition, so basically did not have much experience
in SCD, which impacted her responses and even her interest and approach to answering
the questions. The research instruments used for this exercise were unstructured
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interviews and a questionnaire composed of twenty-three questions, some of which were
prepared by me, and others were sample questions from some renowned establishments
like the U.S. Food and Drug Administration (FDA, 2014) and The Thalassemia
International Federation on survey monkey. Perfect responses, feedback, and suggestions
were received from them, which helped to decide on the topics or subsections to include
in the literature review. The pharmacist reviewed the questionnaire with me, and we went
through the questions together. The necessary modifications suggested or realized would
be incorporated into the interview questions or questionnaires for the final study.
Procedure for Recruitment and Participation
Various strategies to recruit study participants were considered. Local SCD health
facilities especially those I am already acquainted with example, UT Southwestern
health, the Texas Oncology's SCD departments and The Sickle Cell Association of Texas
Marc Thomas Foundation (SCATMTF) among others were contacted. Permission was
sought from the administration and leaders, respectively from those that were interested
and also in a good position to participate due to COVID to recruit study participants.
Working group members or leaders of online SCD communities and platforms like
Generation S, oneSCDvoice, Raremark and others were also approached for permission
and help to recruit members to participate in the research. Other social media platforms
like Facebook, and others were also used to recruit study participants. Last but not least,
acquaintances known to have the disease or relatives with SCD were contacted for
participation when it became necessary to employ snowballing sampling too due to
COVID-19.
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Since most of these communities are remote, most of the contact were done
through emails, text messages and phone calls. Monetary gifts were used to motivate
participants where necessary. A letter of consent was designed and issued to participants
to explain to them the study procedures, their roles to get their agreement or approval to
participate. The Walden Institutional Review Board (IRB) approval was obtained before
participants were recruited and allowed to participate.
Data Collection Method
Emails, text messages, and phone calls were sent out to the participants that were
purposively selected to participate in the data collection. Different categories of
participants were anticipated based on the geographic distribution of the SCD
community, and due to COVID, the data collection was conducted mainly through phone
interviews, by emails, and other social media platforms using questionnaires. Most of
interviews conducted, lasted between 40 to 90 minutes. A consent form was issued to
participants to explain the terms and conditions of the whole process, what their role in
the study is, that it is a voluntary process, how their information would be protected and
used, among others. Thus, it was used to explain to the participants as much as possible
the intent of the study. Participants were made to sign the consent form electronically by
emailing back “I Consent” before they were allowed to participate in the study. The data
was collected solely by me. The entire data collection process lasted for about a month
and half. At the end of the data collection, the responses of some selected study
participants especially the adult SCD patients were reviewed with them to guarantee that
their views and contributions are correctly captured or documented. Since saturation was
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attained with the 11 study participants, it was no longer necessary to gather any more
information from archived data and patients shared stories from online SCD communities
or groups such as Generation S sponsored by Novartis Pharmaceuticals Corporation,
oneSCDvoice, Raremark.
Data Analysis Plan
Several strategies were employed in the processing and analysis of the data that
were collected. An example is a content analysis, which, according to Bengtsson (2016),
is purposely for organizing and obtaining meaning from the data collected in order to
draw realistic conclusions from it. The principles of content analysis was used to seek out
individual words, code them and developed themes from the data through which the
necessary interpretations and inferences were made when all participants’ responses and,
audio-recordings collected and taken were studied and analyzed (Hagan Asamoah, 2018).
Another strategy that was used for the data analysis is a narrative analysis whereby
participants responses were used to retell or reformulate participant's stories to be able to
give a better presentation of their perceptions and present the findings in a format that
meet the expected requirements and expectation of a doctoral dissertation (Hagan
Asamoah, 2018). Manual transcription was employed in transcribing and coding of all the
enormous amount of data that were collected during the research using Microsoft Word
Processing and Excel to aid in the process.
Issues of Trustworthiness
"Trustworthiness depicts how a research study has been conducted competently
and ethically using a set of standards, relaying to the reader that the study has merit and
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worth and that the results are credible and good to guide further research and practice"
(Rallis & Rossman, 2009, p. 281). Guaranteeing the trustworthiness of the data collected
is a vital aspect of the research process. Some of the ways the issues with trustworthiness
were handled are by letting the dissertation chair and committee member review the
questionnaire and the interview questions and also conducted a pilot study to test their
efficacy and quality. The trustworthiness of the study implies how best the data collected
or the findings can be trusted. Another way to ensure trustworthiness was establishing a
rapport with the study participants and thus gained their trust and confidence which
guaranteed reliable responses. "To guarantee trustworthiness, qualitative researchers must
demonstrate that their data analysis has been conducted in a precise, consistent, and
exhaustive manner through recording, systematizing, and disclosing the methods of
analysis with enough detail to enable the reader to determine whether the process is
credible" (Nowell et al., 2017, p. 1). Shenton (2004) claimed that the trustworthiness of
qualitative research is often questioned by positivists because their concepts of validity
and reliability cannot be addressed in the same way in naturalistic work" (p. 1).
Employing the Guba constructs, Shenton (2004) proposed four criteria to address
trustworthiness, which are credibility/ internal validity, transferability/external
validity/generalizability, dependability /reliability and conformability/objectivity.
Credibility/Internal Validity
Shenton (2004) declared to resolve credibility; researchers need to demonstrate
that a true picture of the phenomenon under scrutiny is being presented. Triangulation
was thus employed to enhance credibility by administrating the same research questions
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to different study participants, collect the data from different sources using different
methods affirming case study as appropriate for the study. Member checks was also
employed by letting participants review their responses to interviews or questionnaires
for correctness. I had the responsibility to provide detailed descriptions of the
participants' standpoints or perceptions as honestly and thoroughly as possible, that my
viewpoint was integral reflecting in the report (Rallis & Rossman, 2009). These authors
suggest that this can be achieved by designing the study in such a way that the data are
gathered over a significant time, or, very intensively if over a short period of time and to
triangulate using employing different data collection methods such as interviewing,
observing, and document review (Rallis & Rossman, 2009). I also documented the
process of gathering, analyzing and interpreting the data by keeping a log or journal and
writing analytic memos, recording the intellectual journey of my study and thus proving
to my readers and users of my findings that it was carefully and thoughtfully conducted
(Rallis & Rossman, 2009).
Transferability/External Validity/Generalizability
It was expected that enough detail of the context of the fieldwork for the findings
should be provided to be deemed justifiably to be able to apply it to other settings
(Shenton, 2004). My findings in this study were presented in such a way that they could
be used or applied in other settings. To achieve or guarantee the transferability of my
study findings, Rallis and Rossman (2009) proposed complete descriptions of the
conceptual framework that were used, the design of the study, the data collection
methods, provide details of the implementation, themes, and categories and the
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interpretations and conclusions. I used a common coding scheme, The Code and Coding
Technique, to ensure and compare my findings with conflicting and similar literature
(Sinkovics et al., 2008). I also tested the equivalence of the research topic example by
pre-testing the definition of the concept (Sinkovics et al., 2008). A full description was
adopted by giving detailed descriptions and interpretations of the data that were collected
and any other situations that were observed during the study. I saw to it that the study is
reproducible so that other researchers can duplicate or repeat it later.
Dependability/Reliability
Data auditing was done to enhance the dependability of the data. According to
Silverman (2003), reliability can be ensured by using standardized methods to write filed
notes and proper transcripts for interviews and textual studies and by comparing the
analysis of the same data by several observers. Thus the responses of different
participants were compared to check for consistency. The research report should be
logical, transparent, and consistent and allows for replication (Sinkovics et al., 2008).
Confirmability/Objectivity
I had the responsibility to take the necessary steps to demonstrate that the findings
were really from the data collected and not my views or proclivity to avoid bias.
Objectivity was achieved by making use of an external audit, such as allowing
participants to review and react to data and my interpretations (Sinkovics et al., 2008). I
was alert and coherent of my background assumptions, the definition of behaviors, in the
literature review in order not to over-represent the problem (Sinkovics et al., 2008).
Though I actively participated in or was in charge of the data collection and preparation, I

84

still was detached enough which enabled me to make good observations (Sinkovics et al.,
2008). I was conscious of my actions, perceptions, and thoughts so as not to influence the
outcome of the study to avoid bias.
Ethical Procedures
Rallis and Rossman (2009) claimed that an unethical study is not a trustworthy
study (Rallis & Rossman, 2009). Thus, I had the responsibility of conducting the study
ethically, with deep sensitivity to the needs and interests of the study participants (Rallis
& Rossman, 2009). This was achieved by employing vigilance and thoughtfulness
throughout the entire research, which included an approach to critical gatekeepers,
selecting study ethically by using Walden's and other professional codes of ethics or
standards for conduct that are based on moral principles (Rallis & Rossman, 2009).
Ethical principles were used to guide the research in addressing any issues that rose from
the study in order to meet the goals of the research as well as to maintain the rights of the
research participants (Orb et al., 2001). Because the data were collected remotely or
digitally and considering the vulnerability of the study population, sensitivity was a
priority based on how private, sacred, or stressful the management of SCD is, how much
potential there is for stigmatization, and how politically controversial the issues (opioid
crisis and prescription drug abuse) are (Tiidenberg, 2020). Hence, the possible
consequences from participating in the study to both me and the study participants were
taken into account (Tiidenberg, 2020).
Summary
In this chapter, the study design and methodology were laid out. Several sub-
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sections were addressed or defined, such as the study design and the rationale, who the
study population or target audience were, method that was employed to select
participants, thus the sampling population using purposive sampling while employing tact
in order to prevent bias and also snowballing sampling was also incorporated due to
COVID-19. The data collection and analysis processes that were used, considering the
study design were also discussed. Also, the necessary procedures and steps that need to
be followed to ensure the study's trustworthiness and that the appropriate ethical
standards and expectations would be fulfilled are presented in this chapter.
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Chapter 4: Results
Introduction
This case study research was undertaken to investigate SCD patients’ and their
parents/caretakers’ experiences and perceptions about employing alternative treatment
options (both pharmaceutical and nonpharmaceutical products) in lieu of opioid
analgesics for pain management. The study was built on the premise by such researchers
as Majumdar et al. (2013) that CAM is effective in controlling SCD pains. Poor
management of these pains usually results in poor QOL for patients and their families, as
it usually impacts the psychological, sociological, physical, and spiritual aspects of the
individual’s life. It renders basic daily activities such as working and attending school
very difficult to do and results in frequent hospital visits or hospitalizations, which may
be associated with high hospital costs and hence financial burdens. Jalalian and
Anokwuru (2017) suggested the need to provide healthcare plans for SCD patients to
reduce hospital admission costs for patients who stay in the hospital for extended periods
of time and promote more preventive therapies such as bone marrow transplantation
(BMT), use of traditional medicine, and use of community care. It was based on some of
these presumptions that I conducted this study.
The primary data collection instrument for the study was semi-structured
interviews supplemented by reviewing patients’ or family members’ shared stories. The
subtopics treated in this chapter include the pilot study, setting, demographics, data
collection, data analysis, evidence of the trustworthiness of the data, and study results.
The chapter concludes with a summary.
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The study was guided by these research questions:
RQ1. What are the experiences of the SCD patients or their parents/caretakers
regarding the current prescribing habits of their HCPs to manage SCD
pain, and how do they influence their choice of treatment?
RQ2. What are the experiences and attitudes of the SCD patients or their
parents/caretakers toward alternative treatment methods, and how do they
influence their choice of treatment?
RQ3. What is the stage of readiness for adopting alternative treatment methods
for SCD patients or their parents/caretakers?
RQ4. How does disease perception among adult SCD patients or their
parents/caretakers impact their willingness to try alternative treatment
methods?
Pilot Studies
After receiving IRB approval, I performed a pilot study with two participants, a
57-year-old parent and an 18-year-old patient. I conducted semi-structured face-to-face
interviews at their home as practice, as well as to gain logistical insights and test the
effectiveness or correctness of the data collection instrument. Malmqvist et al. (2019)
proposed three aims of a pilot study: (a) to gather data to provide guidance for a
substantive study adapted to modify research procedures and instruments, (b) to help
researchers effectively utilize observational and video-recorded data, and (c) to test a
theoretical model as a tool of analysis. These authors also emphasized that the importance
of a pilot study, especially in case study research where semi-structured qualitative
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interviews are used, is to enable researchers to be better informed (especially for novice
researchers; Malmqvist et al., 2019). Pilot studies also help researchers to prepare to face
the challenges that are likely to arise in their substantive studies and to gain more
confidence in the instruments to be used for data collection (Malmqvist et al., 2019).
Malmqvist et al. added that proper analysis of the procedures and results from a pilot
study helps to identify any weaknesses of the instrument so that they can be corrected.
Thus, a carefully organized and managed pilot study has the potential to increase the
quality of research, as the results can inform subsequent parts of the research process
(Malmqvist et al., 2019). Accordingly, I conducted this pilot study to evaluate the
effectiveness or appropriateness of the interview questions, any anticipated challenges,
and mistakes that needed to be corrected before administering the instrument to the main
study participants.
Setting
Due to COVID-19, data collection was conducted virtually, mainly through phone
calls, employing semi-structured interview techniques. Additionally, some of the
interview questionnaires were administered through email or text, based on participants’
choices. Thus, the study settings were the homes or residences and offices of the study
participants, as well as my home. The semi-structured interviews were therefore
conducted under very comfortable conditions. The participants were assured of the
privacy and confidentiality of the whole process before we proceeded with it.
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Participant Demographics
The target population for this study consisted of patients, parents, and caretakers
in the SCD community. A recruitment flyer was posted on popular social media
platforms such as Facebook, as well as on the social media sites of partner organizations
such as SCATMTF and Raremark. Through Raremark, I also got linked to the Living
with Sickle Cell, Inc organization, where some of the study participants were recruited. I
also sent the recruitment flyer to all of my contacts using WhatsApp, Messenger on
Facebook, LinkedIn, and email.
Snowball sampling had to be employed in recruiting participants as the pandemic
made it difficult to find potential participants. The recruitment of study participants was
done basically virtually due to COVID-19; hence, I had to also depend on some of the
study participants to recruit other participants. Several people or support groups
expressed interest after randomly posting on the social media of some online SCD
support groups, with some of the leaders promising to assist in recruiting members from
their groups. Initially, there were about 35 leads or potential participants expressing
interest when the recruitment flyer ad was launched.
Employing the techniques of purposive and snowball sampling, I selected 11
individuals to participate in the study based on their experiences, availability, time
constraints, time zone, financial constraints, and location (some of the groups that I
contacted were international groups). All of the participants who were purposively
selected to take part in the study were located in the United States, but they were located
in various states (Texas, Virginia, Massachusetts, South Carolina, and Florida).
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It seemed that the state in which a participant was located played a major role in
their ability and confidence in managing their pain and disease based on the health
services and the support systems of the state. For instance, one participant who relocated
from Virginia to South Carolina stated that “in South Carolina the hospitals do not know
sickle cell disorder well and the doctors … do not treat the disease well, so they always
sent her child home after an ER visit or hospitalization with fever and pain”. She claimed
that in Virginia, health services or doctors were more knowledgeable, so the recovery
time for her child during crisis tended to be a lot shorter. She also maintained that her
relationships with HCPs in South Carolina were not as good as they had been Virginia.
She expressed the view that HCPs in South Carolina just do not care but rather they treat
cancer patients, way more than they do with SCD patients. Another participant from
Virginia claimed to have a very good relationship and rapport with their HCPS and noted
that a support group based there had lobbied with the government for SCD patients to be
treated the same as cancer patients. This participant’s main complaint was about the fact
that Virginia HCPs treated all SCD patients the same way and did not try to tailor
treatment plans based on the type of SCD or conditions of the patient. Further, the
participant observed that because of trust issues between HCPs and patients, patients
preferred to rely on support groups for emotional support.
All participants were African or African American; no patient from any other race
responded to the recruitment ad posted on social media. This was consistent with SCD’s
higher prevalence among Black people or people of African descent. Of the 11
participants, three were males and the remaining eight were females. However, there

91

were 12 patients altogether, as one mother who took part in the study had two SCD
patients. Among the patients, seven were males and five were females. The SS type
(70%) was predominant and these participants with the SS-type seemed to have a good
understanding of the condition possibly because they seemed to have frequent pain
episodes and the associated complications. The ages of the study participants ranged from
23 to 70 years. However, the SCD patients’ ages, based on information provided by
patients or their parents, ranged from 6 to 70 years. Four of the study participants were
patients, and seven were parents/guardians of SCD patients under the age of 18. All of
the seven parents/caretakers who participated in the study were females or mothers,
suggesting that mothers are more involved in taking care of their sick children and
managing their pain. Most of the participants had some form of education; seven of them
claimed to have some graduate degrees three had a college degree, and one had a
vocational/trade school diploma. The income level of almost all of the participants fell
below the middle-class level and may be considered low or even very low income; only
three of the participants could be categorized as coming from a middle-class family.
Saturation was reached at about the 10th participant, but to avoid sampling bias
and skewed data, I decided to recruit an extra participant, specifically one with a type of
SCD (SC) other than SS, as 70% of the study participants were SS patients and only 30%
were SC patients at the point of saturation. There were no participants representing the
other types (e.g., beta-thalassemia, etc.). Table 1 gives a summary of the study
participants’ demographics.
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Table 1
Demographic Profile of Study Participants

Role
Parent

Age
of
child
with
SCD
18

Gender
Female

Gender
of child
Female

SP2

Patient

23

Male

SP3

Parent

12

SP4

Parent

SP5

Study
particip
ant
(SP)
SP1

Socioeconomic
status
(SES)
Low

Household
income
$30,001–
40,000

Educational
level
College/some
college

NA

$30,001–
40,000

College/some
college

Low

Black/
African

SS

Female

Female

$5,001–
10,000

Graduate

Low

Black/
African
American

SS

9

Female

Male

$70,001–
100,000

Graduate

Middle

Black/
African
American

SS

Patient

28

Male

N/A

$5,001–
10,000

Graduate

Low

Black/
African

SS

SP6

Parent

6

Female

Female

$40,001–
50,000

Graduate

Low

Black/
African
American

SS

SP7

Parent

16

Female

Male

$10,001–
20,000

Vocational/tra
de school

Low

Black/
African
American

SS

SP8

Patient

70

Male

N/A

$10,001–
20,000

Graduate

Low

Black/
African

SC

SP9

Parent

19

Female

Female

More
than
$100,000

Graduate

High

Black/
African

SC

SP10

Patient

25

Female

N/A

$20,001–
30,000

College/some
college

Low

Black/
African
American

SS

SP11

Parent

13,
17

Female

Male

50,001–
60,000

College/some
college

Middle

Black/
African
American

SC

Race/
ethnicity
Black/
African

Type
of
SCD
SS
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Data Collection
Employing virtual techniques and tools, data collection was conducted using
open-ended semi-structured interview questions. The design of the interview instrument
was guided by an instrument used by the U.S. FDA at a public meeting conducted by the
agency to hear perspectives from SCD caretakers and other patient representatives on the
most significant effects of their disease and available therapies. The interviews were
conducted virtually from the comfort of my and the participants’ residences using phone
or video calls, texting, and email. I audio-recorded the phone interviews and reviewed the
recordings to capture any information missed during interview transcription.
Data Analysis
Bernard (2011) described data analysis as the search for patterns in data and for
ideas that help explain why those patterns are there in the first place. As proposed,
content analysis was employed alongside other feasible methods for data analysis. Babbie
(2001) also described content analysis as the as a means to examine recorded human
communications, characterizing it as essentially a coding operation, with coding being
the process of transforming raw data into a standardized form. Ryan and Bernard (2000)
also asserted that content analysis is one of the major coding traditions whereby the
researcher produces a matrix by applying a set of codes to a set of qualitative data (e.g.,
written texts, etc.), with the assumption that the codes of interest have already been
discovered and described beforehand. Though the codes used were not previously
described as proposed by these researchers, they were developed based on the interview
questions formulated based on the research questions.
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Thus, the code and coding technique was employed in data collection, processing,
and analysis. According to Strauss (1987), any researcher who wishes to become an
expert at doing qualitative analysis must learn to code well and easily, as the excellence
of a research study rests in large part on the excellence of the coding. The code and
coding technique was deemed appropriate for this study because it makes it easy to link
the data back to the research questions and propositions, rendering the interpretation of
the output from a case study subtler and easier to understand (Miles & Huberman, 1994).
According to these researchers, the code and coding technique uses the case-oriented
approach strategy referred to as “partial ordered displays” to analyze a case study, which
allows for the quick identification of segments relating to the research questions and any
potential themes (Miles & Huberman, 1994).
Coding the data was imperative because, as Miles and Huberman (1994) put it,
codes were used as labels to assign symbolic meaning to the descriptive or inferential
information compiled during the study. Atkinson (2002) described coding as assigning
“tags” or “labels” to the data collected, by which the data are organized and managed.
Richards and Morse (2007) also asserted that coding is a key part of a qualitative data
analysis, and at times is considered to be synonymous with the analysis or an early form
of analysis, as it serves as an interpretive process of moving from the data to the idea, and
from the idea to all the data pertaining to that idea.
The coding of the data was done concurrently with the data collection, which
helped to speed up the process. Hartley (2004) asserted that when the data collection and
analysis are developed together in an iterative process, it can become a strength for the
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study. Miles and Huberman (1994) also argued that it enables the researcher to go back
and forth between thinking about the existing data and generating strategies for collecting
better data and also makes analysis an ongoing, lively enterprise that contributes to the
energizing process of the research.
According to Kohlbacher (2006), the analysis of case study data requires a careful
description of the data and the development of categories in which to place behaviors or
processes. The data should be organized around certain topics, key themes, or central
questions and then examined to see how well they fit or fail to fit the expected categories
(Kohlbacher, 2006). Yin (2003) also claimed that data analysis consists of examining,
categorizing, tabulating, testing, to address the initial propositions of a study, while
Neuman (1997) argued that data analysis entails a search for patterns in data, which, once
identified, are interpreted in terms of a social theory or the setting in which they occur,
resulting in a more general interpretation of their meaning.
Yin (2003) proposed three general analytic strategies for analyzing case study
evidence: relying on theoretical propositions, thinking about rival explanations, and
developing a case description. With any of these strategies, these five specific techniques
for analyzing case studies can be practiced that include: (a) pattern matching, (b)
explanation building, (c) time-series analysis, (d) logic models, and (e) cross-case
synthesis (Yin, 2003). Thus, I executed the following steps to analyze the data.
Step 1: Data Processing
Each study participant’s responses or data were carefully processed before being
analyzed. All scribbled notes from interviews or questionnaires and interview recordings
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were converted into expanded write-ups as proposed by Miles and Huberman (1994),
with data entry using Microsoft Word and then data organization and analysis using
Microsoft Excel. According to Miles and Huberman, a write-up is an intelligible product
that anyone can read, edit for accuracy, comment on, code, and analyze using several
methods.
After the write-ups, codes were generated based on the research questions. A code
is defined as “a word or short phrase that symbolically assigns a summative, salient,
essence-capturing, and/or evocative attribute for a portion of language-based or visual
data” (Saldaña, 2015). According to Atkinson (2002), a code might be used to identify a
word, a phrase, a sentence, or a paragraph important to the research from which meanings
are ascribe to the chunks of data of a research (Miles & Huberman, 1994). Hedlund-de
Witt (2013) also described a code as a lower level of data analysis on the way to labels,
categories, themes, and theory. Hedlund-de Witt (2013) asserted that the act of coding
requires that the researcher wears an analytic lens that is based on perception and
interpretation of what is happening in the data. Saldaña (2013) asserted that the level of
personal involvement of a researcher as a participant observer either as a peripheral,
active, or complete member during fieldwork filters how he perceives, document, and
thus code his data which depends on the types of questions that are asked as well as the
types of responses that were received during the interviews.
Once the initial codes were generated, the actual coding process began which
involved examining chunks or segments of data from the case studies and associating
them with one or more of the initial codes as proposed by Atkinson, (2002). Two main
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cycles of coding were employed for this study that included a first and second cycles
coding. Microsoft Excel was also used to code and analyze the data.
Step 2: The First Cycle of Coding
Basically, it is the initial coding process of the interview transcripts.
Saldaña (2013) described the first cycle coding methods as codes initially
assigned to the data chunks and involves applying provisional and tentative codes.
Hedlund-de Witt (2013) asserted that the magnitude of the data coded during the
first cycle coding can range from a single word to a full sentence, an entire page
of text, or a stream of moving images which can be repeated numerous times
before the second cycle coding.
A combination of descriptive and in vivo coding strategies were employed
in this initial coding cycle. According to Miles and Huberman (1994), a
descriptive code assigns labels, most often nouns to data to summarize it in a
word or short phrase that serves as the basic topic of a data-passage. Hedlund-de
Witt (2013) also claimed that descriptive coding summarizes the primary topic of
the excerpt/datum. It serves as the first step of the data analysis. Thus, some of the
descriptive codes created during this stage were role, gender of child, household
income, educational level, SES, coping strategies, support systems among others.
In vivo coding was used to code significant or outstanding statements by
participants. According to Hedlund-de Witt (2013), in vivo coding occurs when a
code is taken verbatim directly from the data and placed in quotation marks and is
used to highlight “participant-generated words or phrases.” Thus, it is a word -to-
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word coding of participants usually placed in quotation marks. Examples are
opioids treat or help with the pain faster: “fast acting” and religion: “prayers have
powers”.
Step 3: The Second Cycle of Coding
A second cycle coding was conducted to reorganize, classify, prioritize, integrate,
synthesize, consolidate and conceptualize the huge data and codes compiled during the
first cycle coding as proposed by Onwuegbuzie et al. (2016). Hedlund-de Witt (2013)
asserted that second cycle coding methods are basically for reorganizing and reanalyzing
the data coded through first cycle methods. They are used to explore the
interrelationships across multiple codes and categories in order to develop a sense of
thematic, conceptual, and/or theoretical organization and coherence from the first cycle
codes (Hedlund-de Witt, 2013).
The principle of focused coding was applied in the second cycle coding. Adu
(2016) claimed that focused coding helps in identifying “the most frequent or significant
initial codes” by looking for: (a) code frequencies, (b) codes relationships, (c) central
codes, and (d) building categories around them. According to Hedlund-de Witt (2013),
focused coding is usually executed subsequent to initial coding, and it searches for the
most frequent or significant initial codes to develop the categories or themes that would
be considered to be more important. Patel (2014) also asserted that focused coding
categorizes coded data based on thematic or conceptual similarity. Thus, using focused
coding, the significant codes derived from the first cycle coding were categorized based
on conceptual similarity using the Bio-psychosocial-spiritual model of chronic pain
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developed by Taylor et al. (2013). Pattern coding was also employed to group the codes
into a smaller number of categories, themes, and then constructs/concepts After the
second cycle coding, a code-weave was conducted where the primary codes, categories,
themes, and/or concepts were compiled into a few sentences. The results are illustrated in
Table 2.
Step 4: Codes to Categories
After the two levels of coding, several major categories emerged from the coded
data. As Dey (1999) declared, the codes formed are used to compute the categories from
which meanings were imputed to the data. Saldaña (2013) asserted that when codes are
clustered together according to similarity and regularity, they actively facilitate the
development of categories and thus analysis of their connections. Thus, the coding
enabled me to organize and group similarly coded data into categories or “families”
because they share some characteristic. Some categories contained clusters of coded data
which were refined into subcategories as suggested by Saldaña (2013). Hence, about 40
major categories/subcategories were clustered together under about 15 major cluster of
themes. An example from the original code, Pain Management, emerged various
categories/subcategories such as Medications and Coping Strategies.
Category: Medications
Subcategory 1: Pharmaceuticals
CODE: Prescribed
CODE: Over the Counter
Subcategory 2: Purpose
CODE: Management/Purpose
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CODE: Prevention
Step 5: Emergence of Themes
According to Saldaña (2013), a theme is an “outcome of coding, categorization,
and analytic reflection, not something that is, in itself, coded” (p. 13). Rallis and
Rossman (2003) also described a category as a word or phrase describing some segment
of the data that is explicit, whereas a theme is a phrase or sentence describing more subtle
and tacit processes. Using Microsoft Word and Excel, similar statements or responses by
participants were organized to clusters of categories from which 15 major themes were
developed. Examples of the clusters of categories formed are pain management, coping
strategies, religion, ideal treatment, knowledge of symptoms, effectiveness, support
system, abuse of prescribed medications, participants experience and perceptions. Table 3
depicts some of the clusters of categories, themes developed and associated research
questions. Figure 1 also illustrates how the entire coding process was executed.
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Table 2
Categories, Consolidated and Emerged Concepts
Significant
initial codes
Pain crisis

Emerging codes/
categories
Frequency
Symptoms
Impacts
Triggers
Hospitalizations

Pain
management

First line of defense
maintenance

Medications

Type: Pharmaceutical/
nonpharmaceutical
Prescribed/OTC
Management/prevention
Abuse of medical
prescription drugs
Prescribing habits of
HCPs
Side effects
Opioid analgesics
Effectiveness

Research
question
RQ 4

Emerged
concepts
Biopsychological

Almost all the participants employ some
form of homecare/selfcare as simple as hot
baths/pads and pain killers as first line
defense for pain management especially
before they head to the hospital during a
crisis. Most use these also on daily bases for
managing pains. Most of the participants
declared they uses natural products like fruits
and veggies, herbal products like shea butter,
chlorophyll and nutraceuticals like vitamins
and pharmaceutical products like
Hydroxyurea and painkillers daily for
prevention and maintenance of pains.

RQ 4

Biopsychological

Patients uses both pharmaceutical/
nonpharmaceutical
Prescribed/OTC products; mostly prescribed
for the management/prevention of pain crisis.
Most of the participants did not think SCD
patients abuse prescription medications but
rather there was this notion by some few
participants that some patients are compelled
to take more of their prescribed medications
because SCD HCPs seemed not to really
understand the caliber of the SCD-related
pains, they tend to under-prescribe for their
patients confirming what previous studies by
Booker et al. (2016) and others proposed.
Most of the participants also think HCPs still
chooses to prescribe opioid analgesics over
other potential medications because they are
effective and fast acting and help to alleviate

RQ1

Consolidated data
Most of the participants reported of
decreased frequency in pain crisis most of
them attributing it to enhanced awareness of
symptoms, increased in self-confidence and
improved knowledge on signs and symptoms
as well as the proper management of pains.
Most of the participants reported only 1 – 2
times hospitalization per year with only one
patient reporting more than 10 times of
hospitalization and another one 3-5 times.
The oldest participant, a 70-year old SC
patient reported his last crisis related
hospitalization was in 1994 attributing this to
increased awareness and proper management
of symptoms and so was a similar story of
another SC patient. This also depicts how the
pain crisis and associated complications are
tied to the type of SCD a patient has. Almost
all participants reported how pain crisis
usually results in them either not going to
school, work and limiting their social
activities and impact them psychologically
and financially.
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Significant
initial codes

Emerging codes/
categories

Consolidated data
the pain quicker. Most of the patients are
also taking Hydroxyurea for prevention or to
reduce the frequency of pain crisis and
attribute the reduction in their pain episodes
to it. However, one patient who claimed has
being using it for 4 years; said Hydroxyurea
increases the chances of getting infections;
and because it is supposed to be a
chemotherapy it is affecting his hair growth;
and also reduces his appetite. Another parent
claimed it rather helps to prevent infections.
Overall, there was no serious side effects
reported for any of the other medications
nevertheless the possibilities of side effects
were the main reason most of the participants
were skeptical in trying other or new
treatment options.

Research
question

Emerged
concepts

(table continues)

Coping
strategies

Natural products
Self-care management
Self-awareness
Effectiveness

Participants gave various coping strategies
they have been employing to manage their
pains. This ranges from natural products,
self-care management and selfawareness/mindedness. Most common
strategies mentioned were keeping hydrated
by drinking more water, taking hot showers
or using hot pads, eating healthy, doing or
managing stress, distraction, rest, massaging,
prayers. Unique or new strategies learned
were aromatherapy, shea-butter because of
its anti-inflammatory properties, chlorophyll,
air purifier, alkaline water, fasting etc.

RQ2
RQ3

Biopsychological

Alternative
treatment
options

Experiences
Perceptions
Effectiveness

Participants have had diverse experiences
with their pain management but overall.it
seems they have had success stories. Most of
them have already tried alternative regimens
and there was a split. Whilst some feel they
are very effective and even though they have
contributed towards the reduction in the
frequency of their pain crisis episodes, others
thought they were not that effective as the
orthodox ones (opioid analgesics) they have
been using. Almost all of them are open to
exploring alternative regimen but few
thought there is no need for change or try
new treatments if what they are already using
(opioid analgesics) is working.

RQ 2
RQ 3

Biopsychological

Religion

Prayers
Meditation
Effectiveness

All of the participants claimed to pray and
also rely on others praying for/with them
especially during crisis. Whilst some of them
put more energy or focus on them because
they deemed it effective, others however
claimed they are not that effective as one of
them put it because prayers do not actually
take the pains away. Another patient rather
maintained or insisted on the effectiveness or
the role prayers played in managing his pains
declared that he prays a lot and think that if
not for God have been dead a long time ago.
He claimed prayers help a lot to soothe the
pains especially during hospitalizations
before the analgesics administered to him

RQ 2

Spiritual
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Significant
initial codes

Emerging codes/
categories

Consolidated data
start to work on him, he depends on prayers
to help him stay calm and comfortable. He
said there are always a hospital chaplain and
a sister who usually prays with him during
such times and it has been very effective.
Others also attest to how helpful prayers
have been to them.
Few uses other religious activities like
fasting, yoga and other spiritual artifacts.

Research
question

Emerged
concepts

(table continues)

Support systems

Type
Knowledge
Usefulness

Most of the participants belong to support
group or have a form of a support system
especially family members and
religious/spiritual leaders/members that they
lean on especially during crisis and also
information and resources. One parent stated
that she used to feel very lonely and unsure
of herself but since she joined a support
group she does not feel like that anymore and
she now feel more confident especially in
managing her son’s pains and in handling
other related issues . Another parent who
happened to be a leader of a support group
also claimed that when it comes to emotional
or psychological issues related to SCD, most
patients prefer to turn to their support group
for help instead of their HCP team. However,
one patient stated that he does not like
joining support groups hearing and being
around other SCD patients negatively
impacts him: it usually make him more
depressed.

RQ 2

Sociological
Psychological

Ideal treatment

Purpose
Safety
Feasibility
Affordability

Various views were given concerning what
an ideal treatment should be but most wanted
treatments that are safe, capable of
preventing or eliminating pain crisis, easy to
administer or use, less invasive on organs; no
or less side or adverse effects and affordable.

RQ 1
RQ 3
RQ 4

Biopsychological

Financial

SES
Insurance policy/coverage

Aside from a couple of the participants can
be classified as from middle class families,
almost all of the participants were of low
SES, with average annual income of $20,000
to $300,000 dollars which can be a strong
determining factor in the choice of treatment
options, health services to engage in etc. One
of the major triggers of pain crisis and with
such low SES or income levels stress and
their associated health issues are inevitable
among SCD patients and their families.
Participants had varied educational levels
with some of them even at the graduate level.
It was observed that participants with higher
educational levels have better control of the
disease as they use more sophisticated or
better management strategies than those with
low educational level. Actually, the oldest
patient/participant, a 70 year old SC patient
nicknamed “the model patient” used to be a
Language Professor at Harvard University
whose last pain crisis that resulted in

RQ 1
RQ 2
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Significant
initial codes

Emerging codes/
categories

Consolidated data
hospitalization was in 1994 attributes his
current good health status to healthy eating
habits. He claimed his pain crisis frequency
reduced drastically when he learned of the
importance of taking folic acid daily, eating
healthy and drinking alkaline water which he
has been doing for the past 15 years.

Research
question

Emerged
concepts
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Table 3
Categories, Emerged Themes, and Research Questions
Categories

Knowledge
Knowledge
Effectiveness
Perceptions
Experiences
Perceptions
Alternative treatment
options
Pain management
Perceptions
Alternative treatment
options
Pain management
Pain management

Emerged themes

Research questions

Knowledge about other treatment
options
Knowledge on SCD
Effectiveness of the medication
Personal reasons such as lack of
concern/care and benefits
Participants’ experiences
Accommodating attitude
Effectiveness/efficacy, Safety/side
effects, Cost/affordability
Type: Coping strategies/other
regimens
Participants’ perceptions
Resistance to change

RQ 1

Ideal treatment
Research
Knowledge/Awareness/Confidence in
managing pains

RQ 4

RQ 1
RQ 1
RQ 1
RQ 2
RQ 2
RQ 2
RQ 2
RQ 3
RQ 3

RQ 4
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Study Results
This study was conducted purposely to investigate and analyze various alternate
treatment options study participants have been using, how effective and safe they have
been, and if they can be applied or recommended for others. Hence, the experiences and
perceptions of participants on alternative treatment options were explored as well as other
related issues like practitioners prescribing habits, access to health services, challenges
among others. About 15 themes evolved during the data processing and analysis which
were aligned with the research questions.
Research Question 1
By addressing RQ1: What are the experiences of the SCD patients or
parents/caretakers regarding the current prescribing habits of their HCPs to managing the
SCD pain, and how does this influence their choice of treatment; participants gave
diverse views on why their HCPs prescribe certain type of medication and why they
mostly chooses to go with whatever their HCPs prescribe or recommend for them. Some
of the themes that emerged under this question were:
▪

effectiveness of the medication

▪

knowledge about other treatment options

▪

knowledge on SCD

▪

personal reasons such as lack of concern/care and benefits

Theme 1: Effectiveness of the Medication
Participants claimed their HCPs are accustomed to prescribing certain
medications because of their effectiveness in managing pain. According to SP1, HCPs

107

especially choose to prescribe opioid analgesics over others because they “help with the
pain faster”; thus they are fast-acting. SP7 also affirmed that opioids are very effective
which makes HCPs opt to prescribe it more. SP6 also asserted that HCPs prescribed
opioids especially because they know how quick the opioids will help to alleviate the
pain. SP2 claimed HCPs are open to prescribe varied medications, but they prescribed
mainly opioid analgesics because pains are the main issue or challenge with SCD; it is
also based on the type of the disease a patient has which determines the type of
medication that may need to be prescribed for the patient. SP3 also maintained that HCPs
prescribed specific medications based on the condition the patient is going through and
employ different medications too with that effect.
Theme 2: Knowledge/Awareness About Other Treatment Options
Most of the participants confirmed that their HCPs are aware of other treatments
and may occasionally discuss with and recommend some of these treatments to them.
However, they are mostly pharmaceuticals. SP2 stated that HCPs at times expressed
concern about polypharmacy because of the various medications they keep prescribing,
but they still just keep switching (prescribing) to new medications without doing anything
about it. Thus most of the medications prescribed are not that effective so they keep
prescribing and trying new medications. SP2 happened to be one of the patients whose
condition is still on the worse side and still gets frequent pain crisis (more than 10 times
in a year), more hospitalizations, and associated complications. SP3 also asserted that
HCPs choose to prescribe specific medications because of insurance issues. SP3 stated, “I
am sure they would way more if Medicaid covered it.”
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However, some of the participants believed their HCPs are not really aware or
have little knowledge of other treatments, their mode of operation, and their
effectiveness. According to Sohail Rana of the Center for SCD Howard University,
misinformation abounds concerning Hydroxyurea so many physicians do not prescribe it
or do not provide adequate information about it. SP4 declared, “HCPs have less
awareness of other meds and are misrepresented.” According to SP11, the HCPs are only
interested in bone marrow, stem cell therapies, or clinical trials, but patients are not given
much information to help them to understand the role of these therapies in their pain
management.
Theme 3: Knowledge on SCD
Most of the participants stated that their HCPs do not really have enough
knowledge or really understand the caliber of the SCD pain thus tend to under prescribe
in terms of dosage and strength of medications as well as influencing their choice of
medications to prescribe. According to SP4, “HCPs knowledge on SCD is about a level
of 7; they treat all SCD cases or patients the same way. They don’t try to tailor treatment
plan based on the type or conditions of the patient.” According to SP11, HCPs prescribe
only specific medications because of lack of knowledge in the disease and in other
medications all because of a lack of education and recommended strongly that SCD
HCPs need to be educated more on the disease itself and on alternative treatments. SP11
added how some Caucasian SCD patient acquaintances are being constantly denied SCD
related health care or services specifically medications or treatment because HCPs do not
think they have the disease because of the stigma that it is “a disease for predominantly
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Black people or people of Africa descent and other minorities.” This attests to the
observation or notion made in the literature review regarding globalization and interracial
marriages. SCD is no longer an “only Black people disease” but it now transcends races
and has now become a global issue hence the need for the public health sector to give
more attention to it. According to the WHO (2020), approximately 5% of the world’s
population carries trait genes for hemoglobin disorders, mainly sickle-cell disease and
thalassemia. It is speculated that currently, nearly 90% of the world's sickle cell disease
population lives in these three countries: India, Democratic Republic of Congo, and
Nigeria with the prevalence of cases higher in India confirming that SCD is no longer a
Black only disease.
Theme 4: Personal Reasons Such as Lack of Concern/Care and Benefits
Some participants also maintained that their HCPs prescribed specific
medications because of personal reasons such as lack of empathy and benefits. SP3
claimed HCPs know about other treatments but being African American and poor makes
them choose specific medication for her child. SP3 stated, “Also, they ask about
participants concerns but you can tell they do not care.” Thus, financial status of the
participant plays a major role in this. Eight out of the 11 (73%) considered to be of low
SES and the remaining three, middle class or SES, this may help to highlight the trend of
HCPs’ prescribing habits or choice of medications especially when it comes to the newly
approved SCD medications as cost may play a major role in this. For instance, SP11
maintained that their family cannot afford the new medications especially endari. The
family is among one of the three middle class families and one of the participants who
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insisted that the SCD patients still need their opioid analgesics. The new medication,
adakveo, for instance costs between $7,000 and $9,500 dollars per month but is claimed
to be covered under the medical benefit and so is oxbryta which costs] $10,417 dollars a
month. It is estimated that the average sickle cell disease patient is estimated to face
nearly $1 million dollars in total lifetime health care costs with annual costs of more than
$30,000 dollars for adult patients (Novartis International, 2019). Nevertheless, SP10 also
argued that “HCPs choose to prescribe certain meds because they may receive additional
money (kickbacks) from the drug maker to promote those medicines versus other
therapies.”
Research Question 2
In response to RQ2: What is the experience and attitude of the SCD patients or
parents/caretakers toward alternative treatment methods, and how does this influence
their choice of treatment? Participants have had diverse experiences with their pain
management using alternative treatment methods but overall, it seems they have had
success stories. Most of them have already tried alternative regimens, and there was a
split. Whilst some feel they are very effective and even have contributed toward the
reduction in the frequency of their pain crisis episodes, others thought they were not that
effective as the orthodox ones (opioid analgesics) they have been using. Themes that
were developed included:
•

accommodating attitude

•

participants’ experiences/perceptions

•

type: coping strategies/other regimens
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•

effectiveness/efficacy, safety/side effects, cost/affordability

Theme 1: Accommodating Attitude
Most of the participants claimed they are open to try other regimens. SP1 stated
that being open to other options and would like her daughter to try them to see which one
helps better. SP1 also felt alternative regimens are necessary so that patients would have
a lot of options to choose from. SP4 was open to any evidence-based treatments and
thought they should be incorporated into SCD treatment plans. SP5 supported the use of
other treatment methods to curb pain crisis. SP7 was open but did not deem it not
applicable to her now because medications her son was taking were working pretty well.
Maybe in the future when her son gets older and then there is the need to explore other
options, they will then do so. SP10 also supported that everyone should try and explore
other options, and HCPs should be encouraged to prescribe or try these new/other
therapies more due to the belief there are better therapies than what is currently being
used.
Theme 2: Participants’ Experiences/Perceptions
Almost all the participants seemed to have tried some form of alternative
treatment ranging from homecare/selfcare to religiosity. Most commonly used regimens
aside from pharmaceuticals were natural products including: (a) diets; (b) drinking more
water” (c) nutraceuticals; (d) herbal products most unique ones stated were chlorophyll
and shea butter; (f) homecare/selfcare management like applying hot pads, taking hot
baths/showers, applying shea butter, and coconut oils; (g) listening to music and watching
wrestling; and (h) massaging, yoga, rest, and religion especially prayers. SP2 stated being
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very successful with alternative treatments especially diets, less stress, staying hydrated,
and rest. SP2 recommended more African foods. SP2 stated, “I always encourage as
much natural treatment as possible before making opioids an option.” Both SPs5 and 6
claimed that they have not tried any other regimen. SP5 mentioned not yet trying out any
other regimen due to not having used nonpharmaceutical medications before. SP11
admitted to giving chlorophyll to her two sons with SCD, and it has been very effective
as it helps by increasing blood level and the formation of new hemoglobin cells which
may reduce or get rid of sickled cells. It was observed that educational level played a
major role in the participants’ experiences and readiness to explore alternative treatment
options as most of the participants who were in support of using alternative interventions
were mostly of higher educational levels (graduates) with most of them confirming that
they do their own research on alternative therapies that offer better treatment options. It
was also observed that these participants have better control over their condition.
Theme 3: Type: Coping Strategies/Other Regimens
SP1 declared that her daughter takes hot baths especially at the onset of a pain
crisis which she claimed works well and is very effective. SP1 attributed success to
saying a lot of prayers, using heating pads, getting a lot of massages, and listening to
music as a distraction during pain crisis. SP1’s daughter also uses biofreeze during crisis,
and for prevention she uses hydroxyurea and also takes iron vitamins daily. SP1 also
talked about praying always for her daughter, which has been very helpful and added
“prayers have powers.” SP2 stated discussed using massage therapies including breathing
exercises such as yoga, but most of them were not very effective. SP2 added doing these
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therapies early before the pain intensifies might help a bit, but if the pain has already
intensified, they usually do not work or help. SP2 tries to stay hydrated by drinking a lot
of water and staying warm, eating healthful diets, uses prayers, hot pads therapy, music,
and acupuncture as well as other pharmaceutical products. SP2 recommended eating
African food products (which are mainly plant foods). SP2 stated,
I pray a lot because if not for God, I do not think I will still be here. Praying has
been very effective for me especially during hospitalizations and when my meds
are not working, prayers help a lot by helping me to relax and somehow soothe
the pain. My sister usually prays with me whilst I wait for a doctor and at times
too I get the opportunity to communicate with the hospital chaplain who may at
times pay him a visit which is also always helpful. Yes, even at the hospital there
is always a chaplain to pray and counsel me which helps to release fear. I also
always try to avoid stress, a major trigger for pain crisis.
SP3 asserted that staying hydrated is beneficial. SP3’s daughter drinks more
water, 100% juices, and smoothies which includes adding vegetables without her
knowing it. SP3’s daughter eats healthy and balanced diet (fruits and veggies) especially
diets high in iron, takes nutraceuticals/ vitamins such as omega 3 daily, and practices skin
care by applying skin moisturizers like shea butter, coconut lotions, and creams after
showering and washing hands and face. SP3 also added, “I do pray. I believe God can
work through the doctors, but they would have to care about their patients first.” SP4 also
affirmed using or applying shea-butter on his son’s body daily especially during pain
episodes because shea-butter has anti-inflammatory properties. SP4’s son also drinks
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chlorophyll liquid daily (purchased from Amazon) because it increases the oxygen level.
SP4 also always uses an air purifier in the child’s room so to ensure the optimum or
maximum amount of oxygen. SP4 also believes in prayers which seemed to help a lot.
SP5 uses massages with hot water and application of hot ointment at the joints
with pains, drink lots of water, eats hot foods always, and avoids stress and fatigue. SP5
also takes folic acid, Vitamin B complex, motivite, zincovite, and ibuprofen. Concerning
employing religiosity however SP5 stated, “I do not believe it…superstitions.” SP6
claimed they currently do not use any alternative therapies at home but daughter plenty of
water to ensure hydration. When that does not control her pain, then they head to the
emergency room. SP6’s daughter also takes hydroxyurea daily to suppress pain crises and
prevent infections. SP6 stated, “I do think religion and spirituality play an important role
regarding the impact on managing pains.” They have been using prayers and confiding in
spiritual/religious leaders. SP7 employs distraction by watching wrestling which helps
her son to calm down during crisis and incorporates massaging, hot pads, and listening to
soft music. SP7 also depends on and always call their Pastor and his wife and church
elders to pray with/and for them during crisis. However, she felt, “Prayers are not
effective because they do not make the pain go away.” SP8 eats more fruits, vegetables,
and herbs such as lemon and avocado. SP8 maintains a diet low on peanut and meat
because of the high oil content. SP8 employs prayers and fasting which due to the claim
it helps with detoxification of the body. SP8 also drinks mainly alkaline water especially
when taking medications and uses the Kangen machine that sieve/filter the water which
increases the pH level to that of alkaline. SP8 has drank alkaline water for the past 15
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years and claimed it has been very effective and believe has contributed a lot to the
current improvement or good health. SP8’s last pain crisis that resulted in a
hospitalization and a blood transfusion was in 1994.
SP9 rests by sleeping more at times, employs massaging with hot ointments like
Bengay or warm cloths, prays a lot, and engages in some religious activities which
includes going to church or consulting with a pastor to pray for her daughter. Faith has
played a major role, including using distractions, and eating healthy.
SP10 employs rest, drinking water, applying heating pad, and using aromatherapy
with essential oils with a diffuser as it helps with relaxation and to not think about the
pain. SP10 also takes multivitamins, folic acid tablets, and uses Epsom salt. SP11 also
gives chlorophyll liquid to her sons which helps increases the blood level, helps form
new HgB, and may reduce or get rid of sickled cells. SP11 consults/confides in
spiritual/religious leaders during crisis and relies on her Christian faith.
Theme 4: Effectiveness/Efficacy, Safety/Side Effects, Cost/Affordability
The effectiveness/efficacy, safety/side effects, and cost/affordability are some of
the factors that participants consider before they employ/explore a regimen. Overall,
there was no serious side effects reported for any of the other remedies, but the possibility
of side effects were the main reason most of the participants were skeptical in trying
other or new treatment options. SP2 declared being open to alternative treatments but
usually request about side effects. SP3 talked about loving and using a lot of natural
treatments (produce) but thought they should be used only in extreme cases and if it there
are no other options. SP2 elaborated that lots of treatments have side effects and destroy
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vital organs like the liver. SP2 maintained that alternative treatment options are effective,
but they come with a price and side effects. SP5 declared that some of the alternative
regimens really help because constant intake of them (folic acid, Vitamin B complex,
motivite, and zincovite) help to boost the immune system that will eventually produce
good red blood cells in the blood without it being sickled or curved which apparently
helps in reducing the number of pain crisis. SP9 also asserted that most of the alternative
regimens can be very effective as they may offer better treatment options such as
reducing the frequency or intensity of pain crisis. SP10 discussed being open to new
therapies if they are safe to use in the body and had the perception that they are not very
effective.
Research Question 3
RQ3: What is the stage of readiness for adopting alternative treatment methods
for members of the SCD patients or parents/caretakers? Almost all of the participants
were open to exploring alternative regimen but few thought there was no need for change
or try new treatments if what they are already using (opioid analgesics, etc.) are working.
Themes developed were:
•

participants’ perceptions

•

resistance to change

Theme 1: Participants’ Perceptions
The majority of the participants expressed an interest in trying new therapies and
contributed diverse views to that effect. SP4 embraces any treatments that are evidence
based. SP5 supported the use of using other treatment methods to curb pain crisis. SP5
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stated, “Well, I will promote any new therapy positively if it is approved by food and
drugs authority and if the aim in which it was used will be achieved. Purposefully!” SP6
recommended that SCD doctors/nurses should be willing to try new/other therapies so
there can be many options available for different families and their choices. SP8
maintained that alternative treatments are very important and must be encouraged as due
to drastic improvement of his health and overall living conditions since starting to eat
healthy and drinking alkaline water. SP9 thought SCD HCPs should try other options like
diets, nutrients, hot pads, massaging, prayers, and others that can also help with managing
pains and may even possess the potential to reduce the frequencies of pain crisis. SP9
stated, “Alternative treatment options should be promoted since there is still no cure that
works for all patients.”
Theme 2: Resistance to Change
Some of the participants seemed to be at the contemplation stage of the TTM and
though claimed to be open to using alternative interventions, they still did not see the
need to stop or switch from opioid analgesics as it works perfectly for them. SP1 claimed
being open to other options but expressed hesitation to change when the one you are
currently on is working. SP7 also claimed to be open to other regimens but did not deem
them necessary for her son now due to medications or treatment plans (opioid analgesics)
her son is on are working pretty well. SP7 added, however that may be in the future when
her son gets older, and there is the need to explore other options they will then do so. SP7
felt that is a decision that her son needs to make himself so they will continue with the
current treatment until her son gets older to make his own personal decision about
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preferred regimens to use. SP11 asserted that there is no need to change or stop the
current treatment regimen due to opioids such as morphine and hydrocodone working.
SP11 added that blood transfusions are effective because they increase the blood level
and help patients get better as they may get rid or reduce the production of sickled cells,
but they have the side effect of iron overload.
Research Question 4
By addressing RQ4: How does disease perception among SCD patients/caretakers
impact their willingness to try alternative treatment methods? Almost all of the
participants claimed to have a pretty good knowledge of the disease including its
signs/symptoms and some of the associated comorbidities which influences their choice
of treatment options. Some of the themes that emerged under RQ4 were:
•

knowledge/awareness/ confidence in managing pains

•

ideal treatment

•

research

•

education/creating awareness

Theme 1: Knowledge/Awareness/Confidence in Managing Pains
Most of the participants claimed having an awareness of symptoms, increase in
self-confidence, and improved knowledge on signs and symptoms as well as the proper
management of pains. SP1 discussed having a pretty good knowledge about the
symptoms of SCD. SP1 felt her daughter’s HCPs are also very knowledgeable or
understand the condition very well. SP1 felt very confident in managing her daughter’s
chronic pains from day to day. SP2 talked about being confident in managing pains
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which affects his concentration especially during classes and easily causes him to be
angry at onset of crisis. His HCPs are pretty knowledgeable about SCD and always
discuss with and prescribe alternative medications although they are also concerned about
the possibility of polypharmacy with the numerous medications they keep prescribing for
him to help keep his pain crisis and condition under control. S6 declared that her
daughter's HCP understands her daughter's condition well and is always researching new
techniques and treatments. Though she claimed to know her daughter’s symptoms (and
gave few of them ( pain in her arms, legs, chest, and stomach), she also stated that she
does not have the confidence to manage her daughter’s pains and uses whatever her HCP
recommends or prescribes for her. SP7 claimed to be pretty confident with managing her
son’s pains after joining a support group because she used to feel very lonely and scared
with no one to relate to. SP7 stated it is now better due to having gained enough
knowledge about the disease after joining the support group as they are always sharing
diverse information and resources including effective pain management strategies.
Theme 2: Ideal Treatment
Participants offered various views on what an ideal treatment should be which
included treatments that are safe, capable of preventing or eliminating pain crisis, easy to
administer or use, less invasive on organs, have no or less side or adverse effects, and are
affordable. SP1 wished for a medicine that will eliminate pain crises. SP3 wished for a
treatment that will help save patients’ eyesight, a common complication for SCD patients
and ways to deal during times of an epidemic and flu season. She added, “Flu shots can
sometimes make them sick.” SP4 claimed that gene therapy currently being employed
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now as a cure for SCD involved using inactive HIV cells and also ends up wiping out the
immune system which renders it unsafe and thus wishes if another mechanism can be
developed that would be less invasive on organs with no or less side or adverse effects.
SP6 hoped for a treatment that is able to manage pain crisis more effectively at home.
SP9 wished for a treatment capable of curing or eliminating SCD and its associated
complications entirely that are affordable and feasible/conducive. SP10 wanted treatment
that is easy to administer at home and convenient. SP11 hoped for an interdisciplinary
transitional team including a pediatrician and an adult SCD HCP team for patients as they
transition to adulthood due to that being the stage most patients encounter most
complications due to lack of adult SCD HCPs.
Theme 3: Research
Participants requested for more research to be conducted about SCD for the
appropriate treatments to be developed for its management. SP2 suggested that more
research is really done about the source of the pain so that they can tackle the problem
from its source and produce medications to that effect. SP5 also proposed that there
should be more research on other alternatives.
Education/Creating Awareness
The majority of participants stated that they do not think their HCPs are that
knowledgeable about SCD and really understand the caliber of the SCD pains which tend
to influence their prescribing habits or decisions by often under prescribing for its
management and may also seem to lack knowledge or awareness on alternative therapies.
Some of the participants recommended for the need for their HCPs to be educated on
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SCD and alternative remedies or interventions. SP2 maintained that most none SCD
HCPs have little knowledge on SCD and this makes it worse during hospital visits and
requested for a better communication system between patients’ SCP practitioners during
hospitalization especially on treatment options. SP3 suggested,
Schools should have a partnership with SCD treatment centers just in case of a
crisis at school or for information and that teachers treated my daughter like she
was diseased for the longest until I told them what it was she has.
Thus educational personnel also need to be educated on SCD and the necessary
steps to take when a student is going through pain crisis during school hours. SP4
claimed HCPs have less awareness about alternative therapies for SCD. SP11 attested to
this fact and declared that “HCPs tend to prescribe certain type of meds due to lack of
knowledge in the disease and other meds all because of lack of education.” SP11 thus
recommended for HCPs to be educated more on the disease and diverse treatment
options.
Evidence of Trustworthiness
Connelly (2016) described trustworthiness or rigor of a study as the degree of
confidence in data, interpretation, and methods used that guarantees the quality of a
study. Amankwaa (2016) also asserted that for a study to be considered credible,
researchers need to establish the protocols and procedures used for the study. Elo et al.
(2014) inferred that it is “imperative to scrutinize the trustworthiness of every phase of
the analysis process, including the preparation, organization, and reporting of result
which gives a reader a clear indication of the overall trustworthiness of a content analysis
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study” (p. 1). By employing these guidelines, much work and efforts were taken to plan
or prepare and execute each stage of this study starting from the choice of study
methodology and analysis plan, recruitment of study participants, data collection,
compilation and processing, data analysis, and reporting of the study designs. Care was
taken to guarantee that all the necessary details and relevant data or information gathered
were reported and presented in a systematic order. According Elo et al., a prerequisite for
a successful content analysis is that the data can be reduced to concepts that describe the
research phenomenon by creating categories, concepts, a model, conceptual system, or
conceptual map. Thus, by following these suggestions the data collected were all
subjected to a number of steps of coding from which categories and themes were
developed and finally organized or grouped into the concepts based on the conceptual
framework, biopsychosocial-spiritual model of chronic pain proposed by Taylor et al.
(2013) and illustrated in Table 3. The necessary criteria required to guarantee
trustworthiness which are credibility, dependability, confirmability, transferability and
authenticity were applied to this study.
Credibility
Credibility is considered as the most important criterion and is described as the
truth of the data or the participant views, the interpretation and representation of them by
the researcher (Cope, 2014; Polit & Beck, 2012). According to Cope, when a researcher
describes their experiences and verify the research findings with the participants, the
credibility of the study gets magnified or better. Several steps were taken to achieve
credibility. Though I had a bit of shortcomings as my data collection was done solely
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virtually, I did not distance myself from the entire process but saw to it that I was
personally and actively involved in all the stages from the recruitment stage to the
reporting. I recruited mostly by posting the recruitment flyers in support groups on
Facebook and sending the flyer to all my contacts through texting and e-mail. I also
reached out to the leadership of the groups through email mostly establishing a
relationship and building a rapport with them. Some of them volunteered to be study
participants themselves and also recommended specific participants based on their
conditions when I decided to incorporate snowball sampling. When I noticed that my data
were getting skewed as almost all the participants were basically of the SS-type; I
reached out to some of the leaders and one gave me information about some of their
group members who have the SC-type. Though not all the leads provided agreed to
participate in the study, one of these members became one of my best participants, a
parent with two SC-type patients who provided so much information that could not be
obtained from just any literature review. I also created a rapport with the participants who
responded to the recruitment advertisement. Apart from emailing the consent forms and
questionnaire to them, I also sent personalized emails which made them feel comfortable
and made it easy for us to communicate including participants easily reaching out for
clarification as often as they had questions they needed clarification on. The phone
interviews were conducted professionally. I saw to it that it was not done rigidly but
always created this relaxing environment or mood, rendering them more like
conversations which made the participants more relaxed and enabled me to gain their
trust. Almost all of them felt so comfortable and opened up providing more detailed
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information than I expected. Therefore, almost all of the phone interviews surpassed 1
hour instead of the 45 minutes averaged interview time allotted to each participant. I
employed member checking frequently during the interview process especially with
salient points that I wanted to get right and any new information learned during the
interview. I often summarized points and restated them as I understood them which gave
participants the opportunity to make the necessary corrections or additions when needed.
I also incorporated member checking with the participants who answered the
questionnaire independently by reaching out to them for more information or clarification
on any. However, not all of the participants responded to my emails when I reached out
for more information or clarification of a response which proved to be a major setback of
the study.
I also incorporated audit trails into the study. Cohen and Crabtree (2006) defined
“an audit trail as a transparent description of the research steps taken from the start of a
research project to the development and reporting of findings and are records that are
kept regarding what was done in an investigation”(p.1). As proposed by Cope (2014),
credibility is strengthened by the researcher when reporting a qualitative study by
demonstrating their engagement, methods of observation, and audit trails.
Dependability
Polit and Beck (2012) described dependability as the constancy of the data over
similar conditions. This can be observed when another researcher concurs with the
decision trails at each stage of the research process or if the study findings were
replicated with similar participants in similar conditions. Dependability was portrayed in
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this study by the similarities observed in some of the alternative treatment options like the
natural regimens and coping strategies participants have used for pain management.
Confirmability
According to Cope (2014), confirmability refers to how the researcher is able to
prove that the data collected is a true representation of participants’ responses and not the
researcher’s biases or viewpoints and depicts that the findings were derived directly from
the data which can be portrayed by providing rich quotes from the participants that depict
each emerging theme. This principle was applied when reporting the study results or
findings by using significant statements or direct quote from participants based on the
emerging themes.
Transferability
Cope (2014) described transferability as the ability to apply study findings to
other settings, groups, or individuals not involved in the study to enable readers to
associate the results with their own experiences. Transferability is portrayed in this study
by the similarity of the experiences with alternative treatment options among the study
participants even though the participants were from five different states. This
demonstrates how readers and individuals from other states not represented can easily
relate to the experiences of the study participants. However, it was revealed through the
participants that location plays a major role in the kind of health services that patients
received as well as the level of knowledge of SCD HCPs which may also influence the
treatment administered. For instance, SP4 declared that her son’s condition improved
when she relocated from New York to Virginia because of how well the SCD community
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is handled there in terms of health services and support. SP11 asserted that a support
group in Virginia advocated for the SCD community to be exempt so that HCPs would be
able to prescribe as much as opioid analgesics for their patients as they required without
any restrictions. SP2 who is from Texas also maintained that the kind of treatment or
health services offered are based on location of the health care facility. Since Houston is
very good in the level of services as compared to Dallas and may even offer
psychological services to patient when needed, SP2 relocated from Dallas to Houston.
SP3 who also relocated from Virginia to South Carolina strongly attested and stated,
In South Carolina the hospitals do not know sickle cell disorder well and send my
daughter home with fever and pain. In Virginia it is way better first in and
recovery time is a lot shorter. Doctors in South Carolina do not treat sickle cell
well here. They usually do not try to keep her healthy as possible.
Authenticity
Cope (2014) declared that “authenticity is the ability and extent to which the
researcher expresses the feelings and emotions of the participants’ experiences in a
faithful manner by adopting a descriptive approach through which readers grasp the
essence of the experience through the participant quotes” (p. 1). Once again, authenticity
of the study findings was also depicted by using significant statements or direct quotes by
study participants when reporting the study results and throughout the entire data
analysis.
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Summary
The purpose of this qualitative study was to explore the experiences and
perceptions of patients and parents/caretakers on alternative treatment options for SCD
pain crisis management with the intent of decreasing SCD patients’ dependency on
opioid-base or related analgesics. Due to COVID-19, data collection was strictly virtual
with most study participants recruited through social media platforms such as Facebook
and Whatsapp for some SCD support groups and also through snowball sampling. About
half of the participants who contacted me expressed their interest to participate after
seeing the recruitment flyer on social media. The data collection format or process
occurred in two categories: (a) independent completion of the interview and (b) a phone
interview. Six participants opted to do the interview independently and requested for the
questionnaire to be emailed to them while the remaining five participants opted for phone
interviews. I sent consent forms to the participants via e-mail or text message. Consent
was required before they were allowed to participate. The interview responses reflected
the participants’ level of understanding and knowledge on SCD which was also positively
correlated with participants’ educational level.
I employed the code and code technique to perform a thorough data analysis of
the data collected. Overall, about 15 emerging themes were developed under the
overarching theme alternative treatment options based on participants’ responses. The
majority of the participants declared that they are aware of alternative treatments or
interventions and expressed interest in exploring such interventions. However,
participants’ interest to try alternative interventions especially nonpharmaceutical
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products or options were more influenced by their perceived susceptibility to SCD,
perceived knowledge on the seriousness of the disease, perceived benefit of the
alternative remedy, and perceived barriers to that intervention as proposed by the HBM.
For instance, participants were more concern about effectiveness, side effects, and at
times cost before they tried an alternative treatment option.
Though the majority of the participants claimed they were open to alternative
interventions like self-care management, natural remedies, and other coping mechanisms,
some of them were still at the contemplation stage as they considered the
effectiveness/efficacy and safety of these alternative interventions while some resisted to
change with the claim of their current treatment plan (mainly opioid analgesics) being
effective. The other group of participants exhibited readiness to change and were even
already using some form of alternative therapy or intervention (self-care management,
various forms of coping strategies, and religion). Concepts developed were based on the
conceptual framework – the BPS-spiritual model by Taylor et al. (2013). A summary of
participants’ responses based on the themes developed were presented in detail in this
chapter. In Chapter 5, an interpretation of the study findings, limitations of the study,
recommendations, and social change implications will be discussed.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
This qualitative case study research was conducted to examine SCD patients’ or
their parents/caretakers’ experiences and perceptions regarding exploring alternative
therapies or interventions for pain management aside from opioid analgesics. The utmost
objective of the study was to learn about some of the alternative treatments that
participants had used or were using that had been effective in managing their pain,
including their safety, availability, cost, and transferability, among other concerns. The
case study approach was employed to help answer the research questions. According to
Hyett et al. (2014), “Case studies are designed to suit the case and research question” (p.
2). Content analysis was used in the data analysis”. As Soroko and Dolczewski (2020)
wrote,
Content analysis is systematically applied when describing qualitative data with
the use of rule-bound procedures and human-generated interpretation and may
include identifying patterns in data and in categories for explanation purposes and
relational context obtained from reflection on coding as a human process. (p. 1).
Chronic pain is the hallmark of SCD and a major challenge for SCD patients and
their families that usually impacts their QOL or living standard. Benjamin (2008)
asserted that though SCD patients are living longer now, their lives are impacted even
more by unpredictable intermittent or constant pain that is often poorly managed over a
lifetime. Benjamin (2008) claimed that pain management poses major public health
challenges around the world. Among members of the SCD community, pain management
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in the past occurred mainly through palliative care, with providers employing mostly
opioid analgesics to help patients relax as they went through pain episodes. With the
current opioid crisis, it has become imperative for other treatment options to be
explored—hence the purpose of this study. There is a need to investigate means or
interventions that can be employed to help alleviate pain episodes associated with SCD
and contribute toward improving QOL for patients and their families.
Benjamin (2008) proposed an interdisciplinary team approach that would bring
medical professionals together for optimal compassionate care that is coordinated from
the beginning of life and throughout the patient’s lifespan, adding that the management of
pain in SCD has not been approached in a straightforward manner by practicing
hematologists, pain experts, or generalists. Taylor et al. (2013) also asserted that chronic
pain in adults with SCD is a complex, multidimensional experience that includes
biological, psychological, sociological, and spiritual factors, thus affirming the need for
an interdisciplinary team approach for its management. These declarations also align with
some of the study participants’ propositions for alternative therapies or interventions to
be incorporated into the orthodox way of managing of SCD pains, which was the goal of
this study.
In this chapter, I will interpret the study findings, which I developed after
transcribing and analyzing participants’ experiences and perceptions regarding alternative
treatment options. Additionally, I will present the limitations of the study,
recommendations, study implications, and conclusions.
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Interpretation of Findings
The research findings make a unique contribution to the literature through the
exploration and analysis of SCD community members’ experiences and perceptions
regarding alternative treatment regimens. Study participants shared their diverse
experiences and perceptions related to alternative treatment regimens for managing their
SCD pain or the pain of their charge.
The study findings also strongly correspond to findings from previous research
studies. Yoon and Black (2006) conducted a similar study to investigate the prevalence
and types of both pharmacological and complementary therapies used for SCD pain
management by caregivers and explore caregivers’ interest in using complementary
therapies in the future, presented similar findings. In their cross-sectional, descriptive
study of 63 SCD caregivers, Yoon and Black found that the most frequently used pain
medications for children with SCD were opioid analgesics such as acetaminophen with
codeine and acetaminophen with oxycodone. They reported that more than 70% of
caregivers confirmed using some complementary therapies (coping strategies), including
prayer, spiritual healing by others, massage, and relaxation, and that most of the
caregivers were willing to try various types of complementary therapies for pain
management (Yoon & Black, 2006).
Most of my study participants shared their experiences with using diverse natural
products in managing pain, with most of them attesting that these products were effective
and expressing interest in exploring more of such therapies. Gour et al. (2020) reported,
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In spite of unprecedented advances in modern system of medicine, people in
SCD-prone areas have been taking traditional medicinal plants or plant-derived
products to increase the life span of patients in addition to the numerous clinical
trials that have been going on for the use of natural products and their effect in
pure form or characterized phytoconstituents on particularly inhibition of
hemoglobin polymerization for the symptomatic management of SCD. (p. 1)
Study participants’ verbatim quotes were transcribed from both audio recorded and
online interviews and were analyzed individually, with various themes evolving based on
the theoretical and conceptual frameworks adopted for this study.
Emerging Themes
Various important themes emerged when the study participants’ interview
responses were transcribed and analyzed, depicting the numerous coping mechanisms
and strategies that they had been employing over the years to manage their pain, as
previously discussed in Chapter 4.
Coping Mechanisms
The study participants described the various strategies that had been working for
them in managing pain, which included religion, natural products, medicines, and other
palliative or coping interventions. The majority of the participants had religious beliefs
and had been using various forms of religious practice, especially prayer, during pain
crises, which most of them declared to have been very effective and helpful in sustaining
them through those moments of distress. SP2 stated,
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I pray a lot because if not for God I do not think I will still be here. Praying has
been very effective for me especially during hospitalizations and when my meds
are not working, prayers help a lot by helping me to relax and somehow soothe
the pain.
According to Bediako et al. (2011), positive religious coping was associated with
significantly fewer hospital admissions. SP8, the oldest participant/patient (70 years old),
was a former professor at Harvard University who was doing very well and strongly
supported using religion as a coping strategy. SP8 went further to suggest that fasting
helps to detoxify the body. However, SP7, who declared that she always called on her
pastor and church elders to pray for them whenever her son, the patient, was having a
pain crisis, insisted that prayer was not effective because “it doesn’t really take the pain
away.” Cotton et al. (2012) maintained that children used religion to gain control, make
meaning, and find comfort by praying to get well, to keep from getting sick, and to get
out of the hospital as they described a functional God who made them take their medicine
or took them to the hospital and an emotional God who made them happy and comforted
them when they were sad or scared. Bediako et al. (2011) also asserted that religious
practices have both psychological and physical benefits for patients, examples being
prayers, meditations, and consumption of religious media which were found to be
inversely related to physical health outcomes and patients seemed better adjusted
psychologically if they were religious.
Distraction was another major strategy that the majority of the participants
attested to have been using during pain crises that helped them to relax and take their
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minds off their pain. Examples of distraction strategies were listening to music and
watching wrestling.
According to the participants, one of the major triggers of pain crisis is extreme
weather conditions, especially cold weather, so most of them had adopted the habit of
staying warm by wearing warm clothes, avoiding eating very hot or cold foods, and using
hot pads or taking hot showers, especially at the onset of crisis. Dehydration was also
recognized as a major pain crisis trigger, so most of the participants declared that they
drank a lot of water to stay hydrated at all times. Both stress and fatigue were also
considered triggers for pain crises, so the majority of the participants fought stress and
stated that they tried to get more rest to avoid developing fatigue.
The majority of the participants used diverse forms of natural products, including
nutraceuticals (vitamins, dietary supplements: folic acid, omega-3 fatty acids, etc.), which
they took on a daily basis as a preventative measure to either mitigate pain crisis or
reduce its frequency and intensity. Some of the natural products that the study
participants stated that they had been using were shea butter (because of its antiinflammatory properties), chlorophyl, everyday fruits and veggies, and alkaline water.
According to Ameh et al. (2012), in West Africa where SCD is endemic, the disease has
long been treated with natural products such as herbs, especially in rural communities.
Based on the findings of a study that they conducted, Ameh et al. reported three new antisickling herbs: mahogany (Entandrophragma utile), Mexican tea and wormseed
(Chenopodium ambrosioides), and Guinea henweed (Petiveria alliacea). Mahogany
(Entandrophragma utile) is known for treating rheumatism when it is massaged into
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affected joints to relieve pain. There is a need for more research on medicinal products
that are seen as alternative remedies for SCD pain management and prevention in order to
establish their efficacy and safety, as most of the study participants proposed. As SP3
asserted, “I love and use a lot of natural treatments, they are effective but they come with
a price and side effects and must only be use in extreme cases and if necessary.”
Medications
It was deduced from the participants’ responses that SCD patients rely on both
pharmaceutical and nonpharmaceutical treatments, as well as both prescribed and overthe-counter (OTC) products for either management or prevention of pain crisis. For many
years, SCD HCPs have been using mostly palliative care to manage pain. Painkillers—
primarily opioid analgesics such as Tylenol with codeine, morphine, and oxycodone—are
the most common medications that the participants stated that their HCPs usually
prescribed for pain management. Sadler et al. (2019) maintained that “opioids are the
main therapy for both chronic “steady state” SCD pain and acute pain that results from
vaso-occlusive crisis but they are often ineffective at fully alleviating pain, are associated
with unwanted side effects, and do not target the underlying pain mechanism thus
supporting the need for new pain therapies to be employed for SCD patients” (p.1). Most
of the participants in the current study, however, deemed these opioid analgesics to be
very effective and necessary for SCD pain management and recommended that HCPs
continue to prescribe them. The participants thought that HCPs choose to prescribe
opioid analgesics over other potential medications because opioids are effective, are fast
acting, and help to alleviate pain quickly.
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“SP1 maintained that there is no need to change because the opioids works.”
However, she thought that alternative regimens are also necessary because patients
should have a lot of options to choose from to support their well-being. SP2 stated that
because pain is the mainstay of SCD, pain medications remain necessary. SP7 declared,
“Opioids are very effective because I have been using it personally for years.” SP11
asserted that there is no need to change the practice of prescribing opioid painkillers
because these medications work, especially morphine and hydrocodone. Nonetheless, the
Office of Disease Prevention and Health Promotion (n.d.) maintained that,
Opioid therapy should be delivered in the context of multimodal care and that
physicians should consider additional treatment options as opioid therapy have some
minimal benefit that can be augmented or maximized in the context of other therapies,
stress reduction or emotional or behavioral strategies.
There were other medications that participants stated that their HCPs had been
prescribing to control their pain; examples included NSAIDs such as ibuprofen and
neuropathic pain drugs such as gabapentin and Lyrica, among others. Jadenu was another
medication that some of the patients were taking to prevent iron overload caused by
blood transfusion.
The majority of the patients were taking hydroxyurea to prevent or to reduce the
frequency of pain crises and attributed the reduction in their pain episodes to the
medication. However, one patient who claimed to have been using hydroxyurea for 4
years said that it increases the chance of getting infections. Further, he stated that because
hydroxyurea is supposed to be a chemotherapy drug, it was affecting his hair growth and
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reducing his appetite. SP11 also confirmed that hydroxyurea causes hair loss. In contrast
to these claims, another parent claimed that hydroxyurea helps to prevent infections.
None of the participants indicated using any of the newly approved medications.
“SP11 stated that several patients complained how most of the new meds (adakveo and
oxbryta®, etc.) are not effective, especially an infusion drug and that each drug works
differently for each patient.” She added that the dosage forms for some of the new drugs
deter patients from taking them. For example, she explained, “Endari is a vitamin in a
powder form that needs to be dissolved in water so most patients don’t like it.” Finally,
she stated that the high prices of these new drugs discouraged many parents from seeking
prescriptions for them, declaring, “We cannot afford new meds, especially Endari she
declared.”
The majority of the participants confirmed that they used various OTC
medications, mostly vitamins. In particular, they claimed that folic acid helped them
manage and have an upper hand on the disease. Overall, there were no serious side
effects reported for any of the medications. Nevertheless, the possibility of side effects
was the main reason that most of the participants were skeptical about trying other or new
treatment options.
Concerning whether SCD patients abuse prescription medications, most of the
participants declared that this perception was simply the result of stigma. The majority of
the participants did not think that SCD patients abuse prescription medications. SP11
claimed that it is “a stigma because of race. SCD patients are usually accused of abusing
meds,” adding that “no SCD patient has ever died of overdose of pain medications.”
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Rather, there was a notion among some of the participants that patients may be compelled
to take more of their prescribed medications because SCD HCPs seem not to understand
the extent of SCD-related pain and therefore tend to under prescribe for their patients,
confirming the findings of previous studies by Booker et al. (2006) and others. Labbé et
al. (2005) asserted that many physicians believe that SCD patients are more likely to
become addicted to pain medication than are other patient populations and that these
attitudes affect their pain management practices, potentially leading them to undertreat
their patients’ pain.
Support Systems
As asserted by Telfair and Gardner (1999), not many studies have been done on
the impact of support groups on the psychological well-being (PWB) of adolescents with
SCD. In a study with 99 African American adolescent SCD support group members,
Telfair and Gardner found that PWB was best predicted by fewer physical symptoms and
greater satisfaction with the group. Their study also revealed that belonging to or having
a form of support system plays an important role in the management of SCD-related pain.
Most of the participants in my study belonged to a support group or had a support
system. Often, their support systems involved family members as well as leaders and
other members of religious/spiritual communities, on whom they could lean during times
of crisis and consult for information and resources. One parent stated that she used to feel
very lonely and unsure of herself, but since she had joined a support group, she did not
feel like that anymore; she felt more confident, especially in managing her son’s pains
and in handling related issues. Another parent who happened to be a leader of a support
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group also claimed that when it comes to emotional or psychological issues related to
SCD, most patients prefer to turn to their support group for help instead of their HCP
team. Telfair and Gardner (1999) detected an interaction effect between pain and group
satisfaction. These authors claimed that “support groups have the potential to mitigate the
detrimental effects of living with a chronic disease among adolescents, especially during
times of acute pain and thus proposed health professionals should be encouraged to
promote the active involvement in support groups to adolescents with SCD and other
chronic conditions” (p. 7).
However, one patient stated that he does not like joining support groups because
being around other SCD patients negatively impacts him; it usually makes him more
depressed so he depends solely on his family especially during crisis. His family and at
times hospital chaplains usually pray with him during hospital visits and when his
medicines are not working. SP3 stated that her sister, a surgical technician and her
daughter’s father, who is also a patient, are all she has when it comes to getting the care
and support she needs as they help her with transportation and advice during a crisis. SP6
declared that her daughter has “an amazing support system which includes her family,
friends, school community, and church community and thus they never feel like alone in
this battle and most of them are learning about the condition but for the most part they're
pretty knowledgeable.” She added that her family relies on each other when anything is
needed and that includes childcare for her other child or transportation. SP7 belongs to a
SCD support group who shares information and provides support, care, and experiences
and who also have prayer sessions on every Sunday. She also relies on her pastor, his
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wife, and leaders from church who pray with them whenever her son is having a crisis.
SP11 who is one of the founders of a support group in Virginia stated that they decided to
start this group because initially there was no support for parents and some of the services
they offer to members include education, advocacy, and support on a financial level even
to the extent of paying for rent and groceries when needed, technology, plan of care,
provide supplemental income, emergency COVID assistance, and many other services.
The support group operates on grants from Virginia Commonwealth University , and
there are different organizations that also offer help to the group including the Global
Blood/Drug Therapeutic (GBT).
Education/Creating More Awareness
According to Chakravorty et al. (2018), depending on the findings of a study
conducted, there is a widespread prevalence of poor knowledge about SCD among
healthcare providers and the public reported a poorer experience of care in the emergency
setting compared to planned care, which lacks timely provision of pain relief. According
to SP2, HCPs who are SCD specialist seem to be knowledgeable about the disease but
when he is hospitalized, it seems most of the non SCD HCPs are not that knowledgeable
so they always have to contact his specialist for help. He suggested that every hospital
should try to establish an effective means to communicate better with their patients’ SCD
specialists. Thomas and Cohn (2006) agreed that the use of good communication skills by
healthcare professionals is vital for good healthcare practice and proposed the need for
training in communication skills and cultural awareness for HCPs in SCD which may
have a positive and enduring impact on professionals’ perceived ability and confidence in
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communicating with patients with SCD. SP3 also declared that SCD HCPs are
knowledgeable about the condition but because of racial disposition of most patients
being African American and poor, they are inclined to adopt a certain attitude (not caring
that much) toward their patents. SP11 also affirmed that HCPs do not show care or
concern especially the mental health or status are not well addressed on such issues like
depression. anxiety due to the fear of the disease is the reason most of the patients turn to
or rely on support groups. Chakravorty et al. (2018) declared that SCD adolescents and
young patents reported significantly poorer experience of care in several domains
compared to children or adults according to their study findings. Thomas and Cohn
(2006) also affirmed that many SCD patients felt that they were negatively labeled by the
health care system and are skeptical of opening themselves to an unsympathetic system
and may therefore appear hostile and aggressive when interacting with health care
professionals, which in turn leads to distortions and misunderstandings between both
groups. These authors thus maintained that training especially in communication skills
and cultural awareness for HCPs might be helpful in reducing mistrust and result in
increasing empathetic responses among health care professionals. Chakravorty et al.
(2018) asserted that understanding patient views of their care experience is not optional
but essential to ensure effective delivery of health care and may lead to a better patient
experience which would be associated with improved treatment adherence, better use of
preventive services, and healthcare utilization.
Nevertheless, SP11 strongly believed that SCD HCPs are not well educated on the
disease stating how some practitioners even refused to treat SCD Caucasian patients
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because they do not believe they have the disease. She maintained that HCPs lack
knowledge about the disease and other medications aside from opioids all because of a
lack of education. SP11 requested the need for more HCPs to be educated on the disease.
SP2 rated the level of the knowledge of HCPs in SCD to be about a level of 7 and added
that HCPs treat all SCD cases the same irrespective of the differences in disease types as
they do not try to tailor treatments based on the type or conditions of the patient. Smith et
al. (2005) proposed that the main reason for the poor understanding of pain in SCD is that
adult SCD is a new "epidemic," that is poorly described epidemiologically. According to
these authors, in the past, the estimated median survival for patients was 20 years, so
treating the pain of SCD was primarily left solely to those caring for children
(pediatricians) but with important advances in treatment options such as prophylactic
penicillin for children, mortality rates in children have drastically decreased with median
SCD survival now stretches well into the fourth or fifth decade (Smith et al., 2005). This
has resulted in the relatively new phenomenon of adults with chronic SCD and adult
medical professionals treating pain in a disease for which they have limited training and
experience. SP11 asserted that most SCD patients die during the transition years due to
lack of qualified SCD HCPs so young adult patients tend to rely on non SCD HCPs.
Thus, for an ideal treatment, SP11 wished for a transition team including both a
pediatrician and an SCD HCP adult team that works together. Consequently, Labbé et al.
(2005) proposed that physicians might benefit from additional education regarding SCD,
addiction to pain medication, the pharmacology of opioids, and the assessment and
treatment of pain.
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Limitations of the Study
There were several limitations encountered during the study partly due to
COVID-19. First of all, the sample size of only 11 study participants was small even
though saturation was achieved, and the participants were spread over about five states
which reinforced the generalizability of the study findings. A larger sample size would
have been more beneficial as that would have increased the opportunity of gathering
more diverse experiences and perceptions from a larger spectrum and thus enriched the
study findings more. Secondly, because of COVID, almost all of the study participants
(about 65%) were recruited virtually by posting the study recruitment on some of the
popular social media platforms such as Facebook, and others through snowballing. There
was no prior relationship with participants which affected the communication or rapport
with some of them. More time was needed to build a relationship and establish rapport
with some of the participants which involved communicating with them several times
through e-mail, text, and phone calls to gain their trust and confidence before they
committed to participate in the study. Time was also a major constraint due to the
different time zones because of the different states participants were located created a bit
of confusion and resulted in missing some interviews, rescheduling, or getting
participants to commit to another interview time. This also presented with another
challenge such as participants’ availability for phone interviews and having to resort to
online interviews which lacked personal touch or rapport with participants.
About 45% of the participants opted for online interviews which negatively
impacted the member checking process as some of these participants after submitting the
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interview questions did not respond to any follow up emails or text messages sent to them
for clarification or verification of their responses. Also, only about 37% of the
participants were patients while the rest were mostly parents/caretakers so their
experiences with the SCD pains and hence their management were “secondhand” as
compared to patients sharing or narrating their own experiences. All SPs were all
Africans/Africa Americans. no other ethnicity responded which may impact
generalizability of findings due to cultural differences. Also, all the SPs also have only
two types of SCD: the SS and SC, none of the other types (like the Beta-thalessemia etc)
responded so may affect generalizability.
Recommendations
Based on the study findings and participants’ responses to the interview questions,
the following recommendations ensued. It was detected that most of the participants are
already using some form of alternative treatment or expressed their interest in them.
Nevertheless, they were skeptical and concerned about their safety and efficacy. Thus, it
is recommended that more research should be done on these alternative remedies to
guarantee their efficacy and safety. According to SP3, alternative remedies are effective
but comes with a price and side effects. She stated, “Lots of treatments have side effects
and tax vital organs like the liver” and thus was reluctant to recommend them but agreed
that they should be used in extreme cases if there are no other options. SP2 declared
being open to alternative remedies but usually requests about side effects while SP5 also
asserted his support for them but recommended for more research to be done on these
other alternatives.
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This study targeted mostly patients and parents/caretakers as the study
participants and deemed it imperative to allow SCD HCPs which would include
physicians, nurses, nutritionists/dieticians, pharmacists etcetera to also express or share
their perceptions and experiences on employing alternative treatments for SCD pain
management. Also, with this popular notion among the SCD community that the HCPs
lack knowledge on the caliber of SCD pain and hence its proper management especially
with other treatment options aside from opioid analgesics, it would be appropriate if a
similar study can be conducted with HCPs as the target population is geared toward
creating awareness or educating them. Thus, I highly recommend further studies on
exploring alternative treatment options for pain management purposely for HCPs. Study
participants also requested various ideal treatment options and education for other
stakeholders. For instance, SP3 recommended that schools should have partnerships with
treatment centers for when SCD patients experience a crisis at school or just for
information. She stated how teachers used to treat her daughter “like she was diseased for
a long time until I told them what it was…” thus emphasizing the need to educate
teachers or educational professionals about SCD. SP7 declared that her son’s school has
the 504 Plan for his school district so teachers are aware and send his work, and he can
take makeups of tests when he misses school during crises. Some patients also requested
for education on how to properly manage pains especially at home. SP6 requested for
training in order to be able to manage pain more effectively at home. According to
Dampier et al. (2002), “Recurrent acute pain from SCD can be successfully managed at
home with appropriate training and supervision and suggested several areas for
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intervention to improve patient outcomes” (p. 1). Also further studies, preferably a
quantitative study to analyze the effectiveness of these alternative treatments specifically
in managing and reducing frequency of pain episodes would be in order. Thus, document
the numerical effects or impacts of such therapies on SCD pain management.

Implications
Positive Social Change
One of the main objectives for undertaking this study is that the study participants
shared their experiences and perceptions would contribute toward improving the health
status, living standards, and life expectancy (quality of life, QoL) for SCD patients and
their families. Osunkwo et al. (2020) asserted that “the most common patient treatment
goal is to improve QoL as SCD places a significant burden on patients, mostly or highly
impacting patients' QoL, emotional wellbeing, the high prevalence of self‐reported VOCs
and other symptoms.” (p. 1). Pain crisis in general has a negative impact on SCD patients
and their parents. During a crisis especially if it results in hospitalization, school-aged
patients and their parents and adult patients all end up staying away from or losing school
and working days and even at times lose jobs respectively. This and all the financial
requirements that ensue due to the crisis can easily lead to financial difficulties for the
patients and their families.
Pain crisis is also associated with fear, stress, and distress and negatively impacts
the emotional and mental health of both patients and their families. SCD patients
especially the children generally have very restricted social lifestyle and are not able to
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participate in so many normal or everyday activities such as playing outdoors, exercising,
or engaging in strenuous activities, etc. SP4 stated that her son is not able to go school or
go out to play during a crisis, and generally has a less social life, etc. Edwards et al.
(2005) declared that because of the chronic nature of SCD which is associated with
frequent hospitalizations due to the pains and other medical management, it can
contribute significantly to impaired psychosocial functioning, altered intra- and
interpersonal relationships, and reduced quality of life. SP2, a 23year old male patient
reported how he has never been able to have a job or work and also the challenges he is
having in staying at school because of the frequency of his crisis and hospitalization. At
the time of the interview, SP2 now a college student failed some classes because he was
hospitalized during the school year several times and was in the process of getting a
deferment from the school but sadly the school authorities were not being cooperative.
Fortunately, I was able to introduce him to a support group in his state who is now
helping him with the necessary steps to take to be able to get the deferment from his
school and also will get the chance to do some volunteer work, etc. According to Fuggle
et al. (1996), SCD pain can result in over seven times increased risk of not attending
school and is highly disruptive of social and recreational activities. Barbarin and
Christian (1999) asserted that “there is a high evidence for claims of social deficits
among adolescents and depression and work-related problems among the adults” (p.1).
Barbarin and Christian (1999) also proposed that the “social context of SCD, such as
issues related to socioeconomic status (SES), urbanicity, ethnicity, cultural values, and
racial stigmatization, are important to include in empirical assessments and theoretical
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analyses of the effects of SCD on children and their families” (p. 1). In the nutshell, SCD
pain crisis affect the socio-economic status of the patient and their families and thus their
QoL. As depicted by the data collected, majority of the participants (about 73%)
considered themselves as of the low SES with an average annual household income level
of about $25, 000 dollars. Henceforth, any alternative treatments, interventions, or coping
mechanisms which especially have the capabilities of reducing the frequency of pain
crises, hospitalizations, and associated complications and enhanced the social life and
mental health would be very welcoming and helpful as it can effect positive social change
to the SCD community by enhancing QoL.
It is expected that the results from the study, once published would also aid to
better inform and educate HCPs about the SCD pains, its proper management, and
evidence-based alternative regimen or coping mechanisms (both pharmaceutical and nonpharmaceuticals products; prescribed and non-prescribed medications) with the potential
to offer better pain relief that participants and other stakeholders are using that they can
also incorporate into their practice. Alsayegh and Mousa (2020) claimed the new and
recently approved therapeutic agents for SCD should be used alongside with the available
therapies with potential antiviral activity and must be considered as part of the
management and classical treatment of SCD with COVID-19 for better outcomes. These
authors proposed that this would be of benefit to busy HCPs until evidence-based
management recommendations become available. The SCD community is considered as
one of the most vulnerable communities to COVID-19.
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Conclusions
According to the Healthy People (2020), SCD is an example of a genetic
determinant of health and described it as a condition that people inherit when both
parents carry the gene for sickle cell. Barbarin and Christian (1999) asserted that
“although professionals have failed to reach a consensus about definitions of severity in
SCD, frequency of pain episodes, hospitalizations, infections, fevers, and swellings are
primary markers used to gauge the disease severity” (p. 2). These authors maintained that
“SCD is a well-recognized source of distress in the lives of more than 50,000 African
Americans and their families that often results in enduring psychosocial dysfunction
(Barbarin & Christian, 1999, p. 1). Managing the SCD pain has always being a major
challenge for the SCD community. Thus, any interventions that promises better living
standards for patients and their families can be deemed as a laudable idea. Consequently,
this study was undertaken to investigate such interventions or treatments that can be
better choices for managing pain crisis in lieu of orthodox medicine in order to curb side
effects and the tendency of addictions usually associated with the use of orthodox pain
medications. Employing the appropriate pain management strategies for SCD related
pains is imperative considering the caliber of the pains and all the associated lifethreatening complications that can ensued if not well managed..
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Appendix A: Demographic Questionnaire
Which of the following best describes you? Choose all that apply:
I have sickle cell disease
I am a parent, family member or caretaker of someone
with sickle disease
I work for a sickle cell disease patient support or
advocacy organization
I am a healthcare professional who works with sickle
cell disease patients
Other

What is your age / your child’s age? (Optional)
0–5
6 – 12
13 – 17
18 – 22
23 – 49
50 or greater

Are you / Is your child:
a. Male
b. Female
What is your Educational level? (Optional)
Graduate
College/Some College
High School
None

What is your Race / your child’s Race? (Optional)
Black/African American
Hispanic
Middle Eastern
Asian
Other

What is your SES or income level like (optional)
a)
High
b)
Middle
c)
Low
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Appendix B: Citi Completion Report
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Appendix C: Summary of the Data Collected
Data source

Questionnaire

Stakeholder type
(study participants,
SP)

Qualitative data

Code

Parent (SP1)

Hemoglobin SS

Disease Type

Patient (SP2)
Hemoglobin SS
Parent (SP3)
Parent (SP4)

Hemoglobin SS (not
about this)

Patient (SP5)

Hemoglobin SS

Parent (SP6)

Hemoglobin SS

Parent (SP7)
Hemoglobin SS
Patient (SP8)
Not sure
Parent (SP9)
Patient (SP10)

Hemoglobin SC

Hemoglobin SC

Questionnaire

Parent (SP1)

Interview

Hemoglobin SS
A sickle-cell treatment
center with a
hematologist

Patient (SP2)
Questionnaire

Have SS specialist
Parent (SP3)
Not at a sickle cell
treatment center but with
a hematologist (they treat
mostly cancer there,
maybe a cancer clinic)

Questionnaire

Parent (SP4)

Questionnaire

Patient (SP5)

Parent (SP6)

Parent (SP7)

Patient (SP8)
Questionnaire

Parent (SP9)
Patient (SP10)

A children’s hospital
with a hematologist
At a sickle cell treatment
center but with a
hematologist
At a sickle-cell treatment
center with a
hematologist
Not at a sickle cell
treatment center but with
a hematologist: Children
Medical Center with an
assigned nurse.
A primary care center
(family medicine,
internal medicine): Have
about 4 Specialists.

Treatment Source
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At a sickle cell treatment
center but with a
hematologist.
A
primary care center

Parent (SP1)
Questionnaire

Patient (SP2)

Parent (SP3)

Frequency has decreased;
occurs quarterly now;
used to be at least once a
month; triggered by hot
and cold weather, rainy
days; normally in her
chest, spleen, arms, legs,
stomach and is also
having problems with
spleen, it always prevent
me from going to work.
Frequency reduced; used
to be Monthly: Triggers
by Stress, dehydration,
less rest. Pain can be
anywhere, especially
joints with swelling;
level above 10. Results
in a lot of hospitalization,
lengthy ones at times
about 2 weeks, has never
been able to work,
missing school a lot, has
to defer now because I
failed some courses as I
was sick; school
authorities are not being
cooperative. Affects his
concentration especially
during classes, get easily
irritated and causes him
to be angry at onset of
crisis

May occur Quarterly/
Occasionally and during
growth spurts and
vaccinations. Triggers by
especially by Extreme
cold or hot weather is,
Flu and cold seasons and
when a virus is going
around. I look for little
rashes around the joints
and watch her speech and
focus. Her skin is a dead
giveaway that she is in
pain or got an infection
or inflammation flare up.
Hospitalizations is 1 – 2
times per year, Gets it
during growth spurts and
vaccinations

Pain crisis:
Frequency

Symptoms
Impacts
Triggers
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Parent (SP4)

Occasionally (1 – 2
times): last
episode/hospital visit was
in October last year; son
is doing very well and
hardly get pain crisis.
That was really shocking
to hear considering the
fact that he has the
Hemoglobin SS. But that
was one observation
made; that
patients/parents of higher
educational levels have
better control over the
disease especially
managing their pains as
they employ various
coping strategies and
other treatment regimens.

Patient (SP5)

Parent (SP6)

Parent (SP7)

Patient (SP8)

Occasionally, Usually,
my knee and elbow.
Triggers by exposing my
body or system to cold
weather or food; Weather
changes
It restricts me of
embarking on my daily
activities like working at
the office.
Quarterly.
experiences pain in her
arms, legs, chest, and
stomach most often.
My daughter is not able
to participate in many
activities her friends do
such as swim or run for
long distances.

Quarterly. Eyes draw
back, loss of
concentration. Triggers
by exercise, stress,
allergies, weather.
Terrible pains in bones
and high fever and that is
the sign to go the ER.
Usually experience the
pains in the arms, legs,
feet. He does not go to
school. He is on the 504
Plan for his school
district so the Teachers
are aware and send his
work/assignments home
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and can also take
makeups of tests missed.

Parent (SP9)

Patient (SP10)

Rarely, Frequency
decreased; Last crisis
was in 1994; used to be
very serious requiring
blood transfusion;
Triggers by weather
changes, exercises such
as running, or lifting a
heavy stuff as it affects
my breathing, at times
feel like I am about to
pass out. Usually
experience the pains in
the Joints (arms, elbows,
knees). Crisis were very
acute resulting in
hospitalizing and thus
not going to work.
Occasionally
Used to be mostly in the
limbs (joints, arms, legs )
but of late more in the
abdomen. She was
scheduled to do
ultrasound if that might
be gall stones which we
were told maybe
accumulation of sickle
cells in the gall bladder
but have to cancel
appointment because of
COVID-19.
Is not frequent as it used
to be when she was
young, but it used to be
missed school days and
not going to work,
calling in sick. This
impacted any chances of
promotions and also
financial status on hours
that I and her father too
at times missed from
work. It also impacted us
psychologically as it
always induces fear,
depression and also
sadness or pain to see her
go through so much pain.

Occasionally triggers by
doing too much exercise
and not sleeping enough.
I experience the pain in
my back and legs mostly
I am not able to drive or
engage in physical
exercise during a crisis.
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Questionnaire
Parent (SP1)

Have a pretty good
knowledge on the
symptoms on SCD and
feels HCP are also very
knowledgeable or
understands the condition
very well and feel very
confident.in managing
their chronic pains from
day to day.
Knowledge:

Patient (SP2)

Parent (SP3)

My specialist seems to be
knowledgeable but when
on admission it seems
most of the HCPs may
not be that
knowledgeable unless
they contact my
specialist. Thus, have
experience doubts about
HCP; Believe the doctors
do not really understand
SCD pains very well.
Slightly confident in
managing pains

Slightly confident

Parent (SP4)

Patient (SP5)

Parent (SP6)

Parent (SP7)

They know it well but as
for being African
American and poor,
nope.
In South Carolina, the
hospitals do not know
Sickle Cell Disorder well
and send her home with
fever and pain. In
Virginia it is way better.
Doctors in South
Carolina do not treat
Sickle Cell, well here.
Pretty well, Very
confident
HCPs knowledge on
SCD: less awareness and
misrepresented.
About a level of 7: they
treat all cases the same
way. They do not try to
tailor treatments based
on the SCD type or
conditions of the patient.
There is also the trust
issue between patients
and their HCPs, so
patients prefer turning to
support groups for
especially emotional
support.
Yes, very good
relationship and rapport

Patients/Caretakers
HCPs
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Patient (SP8)

Parent (SP9)

Patient (SP10)

Very well. They do
understand the situation
because they are
specialized personnel
who are there purposely
to take care of sickle cell
patients at the hospital
I think my HCP
understands my
daughter's condition well
and is always researching
new techniques and
treatments
Pretty confident now
after joining a support
group. Used to feel very
lonely and scared with no
one to relate to. It is now
better after joining the
support group.

Have about 4 Specialists
now for different
conditions because of my
age so feel very
confident.

Very confident
HCPs portrayed to be
knowledgeable but
wonders if they really
understand SCD and
what these patients deals
with.

Parent (SP1)

Patient (SP2)

Very well
Very confident in
managing pains.
At the onset of a pain
crisis is getting into
warm water or hot
bathes,
takes Tylenol with
codeine, ibuprofen, Bio
freeze.
Patient however takes
hydroxyurea and iron
vitamins daily which
might have contributed
to the decrease in the
frequency of the pain
crisis.

Pain Management
(First line of Defense;
Maintenance)
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Parent (SP3)

Parent (SP4)

Patient (SP5)

Parent (SP6)

Parent (SP7)

Patient (SP8)

Takes hot baths to
release or relax his rigid
bones.
Uses both prescribed
pharmaceutical and nonpharmaceutical as well as
coping mechanisms to
manage my pains. Takes
Lyrica, Oxycodone,
Tylenol #3; Morphine
daily q12hours etc.
Drink a lot water; staying
warm; folic acid.
Jadenu 360,
Hydroxyurea: but
increases the chances of
getting infections; being
a chemotherapy drug, it
is affecting my hair
growth; I have been on it
for 4 years; it also
reduces my appetite

Hydration, balanced diet,
daily vitamin, and skin
care.
Pain killers are last line
before seeing a doctor.
Tylenol otherwise
doctors give her drugs in
emergency room. I try
not to use it because I
know they tax (destroy)
organs like the liver heart
and such.
Omega 3, Daily vitamin,
skin care, and diet high
in iron.

I give him Tylenol and
Motrin; Use or apply
shea-butter has antiinflammatory properties
and chlorophyll liquid: I
buy it from Amazon
because it increases
Oxygen level. Learn
about it from online
group.
He also uses Air purifier
always in his room so
that he gets the optimum
O2.
I normally take in
painkiller, drink lots of
water and apply hot
ointment at the joints
where am having that
pain. 17. Basically, I
take in painkiller and
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Parent (SP9)

Patient (SP10)

apply ointment
afterwards try as much as
possible to sleep for a
while or lie down.

Since my daughter is still
pretty young, I try to ask
as many questions about
the pain as I can before
making any decisions. I
will then administer over
the counter pain
medications and give her
plenty of water to make
sure she is hydrated
when that doesn't control
her pain, we'll head to
the emergency room.
We watch wrestling;
helps to calm him down:
distraction before we go
to the ER.

Take Folic acid
specifically My health
and overall living
conditions have
improved drastically
since I started eating
healthy and using
alkaline water, I hardly
gets any crisis these
days.

Tylenol #3 alternating
with Ibuprofen every 4
hours, prayers,
massaging at times with
hot ointments like
Bengay, hot pads/towels,
sleep
First line of defense:
Drink water, lay down or
get in bed, take my
ibuprofen, apply my
heating pad to where it
hurts.
Maintenance:
Pharmaceutical:
Ibuprofen (400, 600, 800
mg), Hydrocodone,
Hydroxyurea
Non-pharmaceutical:
rest, heating pad, water,
Aromatherapy with
essential oils with a
diffuser (It relaxes me

189

Parent (SP1)

and helps me to not think
of my pain)
Takes Tylenol with
codeine, ibuprofen, Bio
freeze during crisis and
for prevention
hydroxyurea and iron
vitamins daily for
prevention and
maintenance

Patient (SP2)

Parent (SP3)

Parent (SP4)

Lyrica, Oxycodone,
Tylenol #3; takes hot
baths to release or relax
his rigid bones;
Morphine daily
q12hours; folic acid,
Jadenu 360;
Hydroxyurea,
Gabapentin. My
specialist is aware of
other meds and usually
prescribe them.

Patient (SP5)

Parent (SP6)

Parent (SP7)

Omega 3, Daily vitamin,
Tylenol, Pain killers last
line of treatment before
seeing a doctor.

Tylenol and Motrin;
Chlorophyll liquid
Paracetamol, folic acid,
Vitamin B complex,
multi-vitamin, and
zincovite

Patient (SP8)

Parent (SP9)

Patient (SP10)

My daughter takes
hydroxyurea daily and
Tylenol and Motrin as
needed. My daughter
takes hydroxyurea daily
to suppress crises and
prevent infection
Hydrocodone, morphine,
IV at ER, Tramadol.
OTC: Tylenol and
Ibuprofen but they were
not effective, so we do
not use them anymore.

Enbrel, Eliquix, and
Prednisone are for
rheumatoid arthritis
Tylenol for the eye pains
Folic acid specifically for
SC
Tylenol #3, Ibuprofen

Medications: Prevention, Side
Effects
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Tried Hydroxyurea for
about a month in 2019
but interesting her HgB
level rather dropped so
she lost interest in it and
decided to discontinue
using. When we
discussed this outcome
with her new MD later,
he informed us that
Hydroxyurea works best
for SS patients or those
who gets frequent pain
crises that results in
frequent hospitalizations
as that is one of its main
purposes; to decrease the
frequency of pain crises
and hospitalizations,

Parent (SP1)

Patient (SP2)

Parent (SP3)

Management: Ibuprofen
(400, 600, 800 mg),
Hydrocodone
Prevention:
Hydroxyurea, Oxybryta.
My HCP provides me
with refills of
hydroxyurea for 3 to 4
months
Takes hot bathes which
mother says works well,
thus is very effective,
says a lot of prayers,
heating pads, a lot of
massages, listening to
music as a distraction

Uses massage therapies
including breathing
exercises
such as Yoga but most of
them were not very
effective. But if I do or
apply them early before
it intensifies it helps a bit
but if the pain has
already intensified, they
usually do not work or
help.
Try to stay hydrated by
drinking a lot of water
and staying warm, eating
healthful diets, prayers,
massaging, hot pads
therapy, music,
acupuncture etc.

Hydration, skin
moisturizer, healthful
eating (fruits and
veggies),
nutraceuticals/vitamins

Coping Strategies
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Parent (SP4)

Patient (SP5)

Parent (SP6)

Parent (SP7)

Patient (SP8)

Parent (SP9)

Patient
(SP10)

balanced diet, daily
vitamin, and skin care.
Give her a balanced meal
but she is a picky eater
being autistic… daily
vitamin, omega 3 and
encourage water 100%
juice and smoothies
which includes her
veggies without her
knowing it. Make sure
after shower and washing
hands and face to put on
shea, coconut lotions and
creams. Taking Omega
3, Daily vitamin, skin
care, and diet high in
iron.

Use or apply shea-butter
has anti-inflammatory
properties and
chlorophyll liquid: I buy
it from Amazon because
it increases the Oxygen
level. He also uses Air
purifier always in his
room so that he gets the
optimum or maximum
O2.
Massaging with hot
water and application of
hot ointment at the joints
where am having that
pain., drink lots of water.
Use painkillers like
paracetamol, ointment
massaging, lots of intake
of water, hot food
always, avoiding stress
and fatigue

We currently do not use
any other strategies at
home.

Distraction by watching
wrestling; helps to calm
him down: massaging,
hot pads, listening to soft
music.
Eat more fruits and
veggies; herbals example
lemon, avocado; eat diets
low on peanut and meat
because of the high oil
content. Uses the Kangen
machine to sieve/filter
the water which
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increases the pH level
thus alkaline water. It has
been very effective and
believe has contributed a
lot to why I am doing so
well with my health

Rest by sleeping more at
times massaging with hot
ointments like Bengay,
Prayers, Distraction,
eating healthy.
Rest, applying heating
pad, drinking water,
Aromatherapy with
essential oils with a
diffuser (It relaxes me
and helps me to not think
of my pain).
Multivitamin, Folic Acid
tablets, Heating pad,
Epsom salt
Patient (SP6)
Parent (SP1)
Patient (SP2)

Parent (SP3)

Parent (SP4)

Side Effects
None
Psychological:
depending on location of
the healthcare facility,
some may have
counselors that patients
especially Houston is
very good, they have
psychologists and social
workers. Side effects of
medicine, going to the
hospital always for every
treatment, frequent blood
tests; costs of treatment,
insurance not ready to
cover most cost etc.?
Child’s HCPs do not
address any of the
psychological, financial,
socioeconomic,
sociological issues
associated with SCD etc.
Doctors in South
Carolina do not treat
Sickle Cell well here.
After an emergency
room visit most often my
child’s recovery is way
longer or not complete so
I try to treat her on my
own. That maybe my
fault somewhat but in
South Carolina the

Unaddressed Issues/Concerns
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hospitals do not know
Sickle Cell Disorder well
and send her home with
fever and pain. In
Virginia it is way better
first in and recovery time
is a lot shorter.
Patient (SP5)

Parent (SP6)

Schools should have a
partnership with
treatment center just in
case of a crisis at school
or for information.
Teachers treated her like
she was diseased for the
longest until I told them
what it was.

Parent (SP7)
Patient (SP8)
Parent (SP9)

There is also the trust
issue between patients
and their HCPs, so
patients prefer turning to
support groups for
especially emotional
support.

Patient (SP10)
My concern is about
stigmatization and
support system to help
sickle cell patients.

I do not think my
daughter's current
treatment regimen is as
effective as I would like
it to be. I wish we were
able to get the same
medication she does at
the hospital at home to
manage her severe pain
crises..
None

None
Alternative treatment
options. Psychological
and sociological impact
of SCD on my daughter
and her family.

Parent (SP1)

None
Great, can easily discuss
daughter’s treatment plan
and express concerns
with Dr.

Patient (SP2)
Very good; can easily
discuss treatment plan
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Parent (SP3)

Parent (SP4)

Patient (SP5)

and express concerns
with Dr. I think every
hospital should try to
communicate better with
their patients SCD
specialists.
Not good since we
moved to South Carolina.
It is not easy to discuss
concerns with them.
They ask but you can tell
they do not care. I just do
not believe in my state
and the care they have
for their patients. If I can
get them to care they
would not have such a
hard job.
Yes, very good
relationship and rapport

Parent (SP6)

Parent (SP7)

Patient (SP8)

Well, I only have access
to them only on my visit
to the hospital for
checkups. if am being
attended to by the health
personnel on the day of
visit for checkups, I do
discuss my concerns and
treatment plans with
them and at times other
alternatives will be
advised by them.

Parent (SP9)
Patient (SP10)

The relationship between
my family and my HCPs
is great and I do not have
many complaints. I am
confident I can
communicate with my
HCPs at any time. We
discuss treatment options
with our HCPs during
monthly check-ups

Good and can easily
discuss treatment plans
and other concerns with
my son’s SCD nurse.

Great

Very Good

It is very good, he always
communicates with me

Patient/HCPs relationship
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Parent (SP1)

Patient (SP2)

Parent (SP3)

about my health; Very
easy to communicate
with, I can message them
online
1 – 2 times/yr; She use to
be sick at least once a
month but now it is
quarterly, Missing work
More than 10 times per
year. Can be
unpredictable. A lot of
hospitalization,
Last admission was on
July 7- 20
Usually affects my
parent’s ability to work.
Very stressful for my
parents. has never been
able to work

Hospitalizations:
Duration
Impact:

1 – 2 times/yr.
Parent (SP4)
1 – 2 times/yr.; last
episode in October last
year; Not able to go
school, go out to play,
less social life etc. in the
past when he used to be
sick often when young
Patient (SP5)

Parent (SP6)

3-5 times/year; In my
period of pain crisis, it
restricts me of embarking
on my daily activities
like working at the office

Parent (SP7)

1 – 2 times/yr.
my daughter is not able
to participate in many
activities her friends do
such as swim or run for
long distances
1 – 2 times/yr. He can go
to school but He is on the
504 Plan for his school
district so Teachers are
aware and send his work
and can take makeups of
tests.

Patient (SP8)

Parent (SP9)

None in the past year.
Hardly. The last one was
about 2 years ago Was
admitted at the hospital
for pneumonia and then
diagnosed with
rheumatoid arthritis
which was triggered by a
very cold weather. The
last crisis related one was
in 1994; was very serious
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Patient (SP10)

and required blood
transfusion.
.
No times in the past year.
Last ER visit was
actually somewhere in
2013.
1 – 2 times
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Parent (SP1)

Was not specific but
stated how taking hot
baths have been an
effective first line
defense at an onset of a
crisis.

Patient (SP2)
Yes, being very
successful with
alternative treatments
especially diets, less
stress, staying hydrated
and rest. Recommend
more African foods.
I always encourage as
much natural treatment
as possible before
making opioids an
option.
Parent (SP3)

Parent (SP4)

Constantly moisturize
(Hydration): body and
skin. Dry skin allows
infection to get in… I
also try to give her a
balanced meal, but she is
a picky eater being
autistic…, uses daily
vitamin, omega 3 and
encourage water 100%
juice and smoothies
which includes her
veggies without her
knowing it. Make sure
after shower and washing
hands and face to put on
her on shea, coconut
lotions and creams

Patient (SP5)

Parent (SP6)

Parent (SP7)

Patient (SP8)

Uses or apply shea-butter
on spots of pains because
it has anti-inflammatory
properties and I give him
chlorophyll liquid
because it enhances the
intake of oxygen. Uses
an air purifier in his
room so that he gets the
optimum amount of
oxygen.

That is what am yet to try
out because I have not
used non-pharmaceutical
medication before. Well I
will promote it positively
if it is approved by food
and drugs authority and
if the aim in which it was

Alternative Treatment Options:
Experiences
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used will be achieved.
Purposefully!

Parent (SP9)

Patient (SP10)

We have not yet tried
any alternative
treatments

None, never tried new
medicines
My HCPs/NP have
discussed some of the
new meds but preferred
to stick with the meds we
are using now which are
working for him.
Take Folic acid daily,
have been eating more
fruits and veggies; herbs
example lemon, avocado
etc., eat diets
low on peanuts and meat
because of the high oil
content and sugar and
drinking manly alkaline
water for the past 15
years which I think has
contributed a lot to
improvement in my
health.

Healthy eating, Prayers
and faith in God, resting,
massaging, distraction
must be also be tried
along with any
pharmaceuticals the
patient but this depend
mostly on the type of
SCD a patient has will
determine what regimen
would work best for the
patient.

They are not as effective
as ibuprofen for me, they
only slightly alleviate the
pain.

Parent (SP1)

I will like my daughter to
try them to see which
one helps better. I am
open to other options but
why change when the
one you are currently on
is working. However,
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Patient (SP2)

Parent (SP3)

alternative regimens are
also necessary
So that way patients
would have a lot of
options to choose from
for their wellbeing.
Think more research is
really required about the
source of the pains so
that they can tackle the
problem from its source
and produces meds to
that combat it.
Lack of adequate
research on SCD.
Recommend more
African foods

Parent (SP6)

I love and use a lot of
natural treatments. Think
they must be used only in
extreme cases and if it is
no other options. Lots of
treatments have side
effects and tax vital
organs like the liver.
Thus, must only be used
in extreme case and if
necessary, also thinks I
am sure they would way
more if Medicaid
covered it.

Parent (SP7)

Open to any evidencebased treatments. I think
they should be
incorporated into
treatments plan

Parent (SP4)

Patient (SP5)

Patient (SP8)

I support the use of using
other treatment methods
to curb pain crisis. There
should be more research
on other alternatives.

Parent (SP9)

Patient (SP10)

Not certain
I do think SCD
doctors/nurses should be
willing to try new/other
therapies more so there
can be many options
available for different
families and their choices
Open but don’t deem it
not applicable to her now
as what medications her

Alternative Treatment Options:
Perceptions
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son are working pretty
well, maybe in the future
when her son gets older
and then there is the need
to explore other options
they will then do so.
It is very important and
must be encouraged as
my health and overall
living conditions since I
started eating healthy and
using alkaline water; has
improved drastically.

I think our HCPs should
try other options like
diets, nutrients, hot pads,
massaging, prayers and
others that can also help
in managing pains. Yes,
they should be promoted
since still no cure that
works for all patients.
I am open to new things
if they are safe to use on
my body. I feel like
everyone should give it a
try and explore other
options and HCPs should
be encouraged to
prescribe or try these
new/other therapies
more because I know
there are better therapies.
My HCP only introduces
me to new medication of
it will be beneficial in
significant ways to my
sickle cell (such as
oxybryta) , which he
prescribe to me about 6
months ago.
Parent (SP1)

Patient (SP2)

Hot bathes work is well
They are very effective;
the pain killers that are
usually prescribed for the
pain only serves as a
backing to these
regimens

Parent (SP3)
Parent (SP4)

They are effective but
they come with a price
and side effects.
Very effective

Patient (SP5)
It really helps because
constant intake of the

Effectiveness
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Parent (SP6)

Parent (SP7)

Patient (SP8)

above drugs helps to
boost the immune system
that will eventually
produce good red blood
cells in the blood without
it being sickled or curve
which will apparently
help in the number of
pain crisis. Its effective
like I said, I ensure that I
take in my drugs daily
and not exposing my
body or system to cold
weather or food.

N/A
Parent (SP9)

Patient (SP10)

Current treatment plans
are effective; Prayers
however is not effective
because it does not make
the pain go away.

Very effective

Most can be very
effective as these opioids
are mainly for soothing
the pains it run its cause;
some of these may offer
better treatment options
such as reducing the
frequency or intensity of
pain crisis.

Parent (SP1)

Patient (SP2)

Parent (SP3)

Parent (SP4)

Not as effective
Of a low-income status.
Has an insurance that
covers about 95% of all
medical expenses
Low SES; have a good
insurance but looking for
Medicaid because even
though it fully covers
most of my medical
expenses/treatments,
however, it restrict my
hospital length of stay
even though I may not be
fully recovered and thus
results in being forced to
be discharged early from
hospitals
Very low SES have no
insurance but on
Medicaid and cannot not

Financial: SES; Insurance policy
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Patient (SP5)

really cover or afford
treatments.

Parent (SP6)

High SES have a good
insurance which covers a
lot of the treatments.
Have had no bad
experiences so far.

Parent (SP7)

Patient (SP8)

Very low SES, Insurance
do not cover prescribed
drugs from the doctor or
specialist, it does not
cover most of my
expenses on drugs.
However, it reduces the
lab text fee on both urine
and blood and few drugs
which are not costly.
Financially they are not
helping in that aspect. I
do not get any assistance.

Parent (SP9)

Patient (SP10)

Middle; good insurance;
I have not incurred any
out of pocket expenses
related to my daughter's
condition.
Very low SES. Have an
insurance but not good
though it covers
everything
Of a low-SES status.
Has an insurance.
Probably Medicaid
considering his age;
retired.

Some insurance
companies are not ready
to cover cost of some
treatments; even restrict
some of the health
facilities we are allowed
to go to

Parent (SP1)

Low SES status.
Have an insurance that
covers everything.
None

Patient (SP2)
Parent (SP3)

Lack of adequate
research on SCD

Parent (SP4)

None
Stigmas
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Patient (SP5)

Lack of research and not
ready to work with out

Parent (SP6)
Parent (SP7)

Lack of support system
to help sickle cell
patients.

Patient (SP8)

Parent (SP9)

Patient (SP10)

Parent (SP1)

Patient (SP2)

Parent (SP3)

Parent (SP4)

Patient (SP5)

How the society treats
SCD patients makes
most patients don’t want
to go public about their
condition due to lack of
education/knowledge and
awareness so it is time
for the public to be
educated and more
publicity to create on
SCD.
None
My family: do not really
like being part of support
groups because being
around them always
makes me very
depressed.
They are very
knowledgeable about
SCD and provide both
emotional and physical
support especially during
crisis like praying with
me.
My sister and her father
are all I have really when
it comes getting the care
and support, she needs.
Her father knows it well,
he has Sickle Cell and
my sister use to work as
a surgical tech.
Transportation and
advice
Yes. Actively involved in
a support group; one of
the leaderships ….
Because of trust issues
between patients and
HCPs. Most patients
prefer turning to support
groups for emotional
support

Support Systems:
Knowledge
Type
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Parent (SP6)

Parent (SP7)

Patient (SP8)

I do not have any support
system, though I receive
newsletters and others
from online groups
purposely to educate
myself more and to know
what is going on around
the sickle cell diseases
community.

My daughter has an
amazing support system
which includes her
family, friends, school
community, and church
community and we never
feel like we are alone in
this battle. Our family
relies on each other when
anything is needed
whether that is childcare
for my other child or
transportation.

Parent (SP9)

Patient (SP10)

An SCD support group in
Dallas/TX; have prayers
section on every Sunday.
Leaders from church.
Sharing information and
provide support and care
and share experiences.
Pastor and wife Pray
with/and for us during
crisis.

Part of a Ghanaian-USbased support group.
Provides information and
resources but have to pay
membership fees etc.
which can be high.

Family members;
friends, member of an
SCD support group,
religious/faith-based
organizations.
Family members and
sickle cell support group.
They do their best to stay
informed about my
condition.
My family helps me to
do any task I need done,
remind me to take my
medicine.
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Parent (SP1)

Treat or helps with the
pain faster that is why
HCPs prefer to prescribe
it

Patient (SP2)

Parent (SP3)

Parent (SP4)

Because of the caliber of
the pains that needs to be
curbed causes HCPs
continue to prescribe
them but based on the
type of disease it
determines the type of
med that may need to be
prescribed too. Pain
killers serves as a
backing to the other
regimens so it may still
be necessary for the
HCPs to continue to
prescribe them.

Patient (SP5)

Give her pain killers
before we go to the
hospital. Tylenol and
other doctors give her
drugs in emergency
room. I try not to use it
because I know they tax
organs like the liver heart
and such.

Parent (SP6)

HCPs are more into the
opioids; prescribes them
more

Parent (SP7)

Well they do prescribe
that medication based on
the condition the patient
is going through and I
believe they do employ
different medications too
with that effect.

Patient (SP8)

Parent (SP9)

Patient (SP10)

HCPS chooses to
prescribe opioids
analgesics instead of
other non-opioid
medications as I think
this is because they know
how quick the opioids
will help to alleviate the
pain.

Opioids are very
effective because I have
been using it personally
for years.
Not very sure as my
condition is not that bad I
have not had that
experience.

Opioid Analgesics
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Prescribe mainly opioids
analgesics and nothing
else. Because most HCPs
lack knowledge on the
effectiveness of these
other medications as
most of these are pretty
new and was recently
approved by the FDA.

Very effective, it always
treats my pain.
. I think my HCP chose
to prescribe these things
because he may receive
additional money from
the drug maker to
promote the medicine
versus other therapies.
Parent (SP1)

Patient (SP2)

Parent (SP3)

Parent (SP4)

Patient (SP5)

Not sure if SCD patients
abuses prescription
medicine At least not my
daughter, she only takes
her pain medicines when
she is having crises.
Very false and is sad that
the patients are treated
with such contempt
considering all the
challenges they deal with
and even the side effects
associated with these
meds. Because most of
these meds do not work
or help instantly, some
patients may feel
compelled to take more.
Most of the meds are not
instant relief so it may
seem they do not work
and thus a patient may
end up taking more to be
able to curb the pains.
However, my HCPs
expressed concern about
the threat of
polypharmacy because of
the numerous med I take
but just keeping
switching to new meds.
Yes. She has a family
history of addiction on
both sides so, I always
encourage as much
natural treatment as
possible before making
opioids an option.

Abuse of medical prescription
drugs
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Parent (SP6)

Parent (SP7)
Parent (SP8)

Parent (SP9)

I do not think so, because
the scale of the pain is
not well understood

I think SCD abuses drugs
to curb or relief pain;
perhaps there will be
different issue pertaining
to the pain which might
need different medication
to stop that but due to the
situation of managing
pain they take in drugs at
their own discretion to
minimize the pain

I do not think SCD
patients abuse medical
prescription drugs
because I honestly think
they need a high level of
medication to alleviate
their severe pain
symptoms

I do not believe is true.
Patient (SP10)
Not very sure as my
condition is not that bad I
have not had that
experience

Not my daughter but it
can be possible as it
seems HCPs don’t
actually understand the
caliber of the SCD pains,
they tend to underprescribe for their
patients. Also, these pain
killers they usually
prescribe are not that
potent enough to really
handle the pains, they
wear out easily after
some few hours so the
patient may be forced to
take more than
prescribed by the HCP to
completely control or
stop the pains, and also
they are mainly for
maintenance, purposely
to soothe the pains, help
the patient feel
comfortable during a
crisis but doesn’t really
stop or shortened the
duration of the crisis.
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No, I don’t think we feel
as if it is the only thing
that will help. My HCP
prescribe me extra pain
medicine unless I ask for
it.
Parent (SP1)

Patient (SP2)

Parent (SP3)

Parent (SP4)

Patient (SP5)

SCD have not received
attention as other
diseases like the cancers.
My organization (a
support group) lobbied
for SCD patients in the
state of Virginia to be
treated equally as cancer
patients.

Health/Racial Disparities

Parent (SP6)
Parent (SP7)
Patient (SP8)

HCPs treat cancer way
more than they do with
sickle cell.

Parent (SP9)

Patient (SP10)

Parent (SP1)

Patient (SP2)

Parent (SP3)

Parent (SP4)

Lack of specialized
healthcare facilities that
are specifically for SCD
and so there are few SCD
specialists HCPs.
Problems with spleen
Multiple infections: used
to be very common
especially when under
unsanitized conditions,
Strokes: mild, Growth
problems or delay in
reaching puberty, Iron
overload, difficulty
concentrating, Problems
with spleen, difficulty
with breathings, affects
his concentration
especially during classes
easily causes him to be
angry at onset of crisis.
Chronic daily pain, such
as joint pain or hip pain
Multiple infections,
Difficulty concentrating

Associated Co-morbidities
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Patient (SP5)

Problems with eyesight
(from sickle cell disease),
little rashes around the
joints

Parent (SP6)

Pneumonia, anemia;
Chronic daily pain, such
as joint pain or hip pain,
Acute chest syndrome

Parent (SP7)

Joint pains and at times
headache. In my teens I
experienced priapism but
now it has been years I
experienced and
Abdominal pain

Patient (SP8)

Was not specific
Parent (SP9)

Patient (SP10)

Difficulty concentrating;
Problems with eyesight
(from sickle cell
disease); Acute chest
syndrome; he has
Asthma too, so it makes
it difficult for him. He
gets tired easily
especially because of the
Asthma medicine he
uses.
Problems with eyesight
Breathing Difficulties
especially when doing
anything strenuous
Difficulty concentrating
Frequent abdominal
pains; hematuria when
young, breathing issues,
Asthma, allergies.

Parent (SP1)

Patient (SP2)

Parent (SP3)

Chronic daily pain, such
as joint pain or hip pain.
Yes prayers: I pray
always for my daughter,
very helpful. Prayers
have powers.

Yes, even at the hospital
there is always a chaplain
to pray and counsel me
which helps to release
any fear I may be having.
Prays a lot because if not
for God I do not think I
will still be here. Praying
has been very effective
for me especially during
hospitalizations and
when my meds are not
working, prayers help a

Religion:
Prayers
Meditation etc.
Effectiveness:
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Parent (SP4)

Patient (SP5)

lot by helping me to
relax and somehow
soothe the pain
I do pray. I believe God
can work through the
doctor’s, but they would
have to care about their
patient first.

Parent (SP6)
Prayers: I think it helps a
lot
Parent (SP7)

Not at all…I do not
believe it…superstitions

Patient (SP8)

I do think religion and
spirituality play an
important role regarding
the impact on managing
pains. Have been using
prayers and confiding in
spiritual/religious
leaders.

Parent (SP9)

Prayers but, it is not
effective because it does
not make the pain go
away.
Parent (SP10)
Prayers and fasting
which helps with
detoxification of the
body.
Yes, prayers,
consulting/confiding in
spiritual/religious
leaders, use of some
spiritual/religious
artifacts and they have
been very effective and
have contributed a lot
towards her current
status with SCD.

Parent (SP1)

Prayers to God, I think
prayer can help your
perspective on the pain
you’re having.
Somewhat effective, but
I don’t think about my
pains too much after I
pray.
.
Have a medicine that will
eliminate crises
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Patient (SP2)

Parent (SP3)

Parent (SP4)

Treatment that will help
save their eyesight and
ways to deal during times
of an epidemic and flu
season. Flu shot can
sometimes make them
sick.
Bone marrow: the Gene
therapy currently being
employed uses inactive
HIV cells and also wipes
all the immune system
which renders it unsafe
so if something else can
be developed that would
be less invasive on
organs with no or less
side or adverse effects.
Adhering to basic
strategies like good diet,
enough fluids to avoid
dehydration, not
exposing body or system
to cold weather or foods,
visiting the clinic
regularly etc.

Patient (SP5)

Being able to manage
pain more effectively at
home.

None

Prayers and fasting
which even helps with
detoxification of the
body.
Parent (SP6)

Parent (SP7)

Patient (SP8)

A treatment capable of
curing or eliminating
SCD and its associated
complications entirely.
Treatments that are
affordable and
feasible/conducive
Easy to administer,
convenient, can be
administered at home

Parent (SP9)

Ideal Treatment

212

Patient (SP10)
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Appendix D: Significant or Unique Statements and Their Implications
Compilation of significant or unique statements by participants
At least not my daughter, she only takes her pain medicines
when she is having crises. Very false and is sad that
the patients are treated with such contempt. There is
a family history of addiction on both sides so, I
always encourage as much natural treatment as
possible before making opioids an option.
Takes daily medication of Hydroxyurea, folate and iron
vitamins
Participant thinks opioid analgesics helps with the pain faster
that is why HCPs prefer to prescribe it. The type of
disease determines the type of med that HCPs
prescribed. Pain killers serves as a backing to other
regimens. I try not to use it because I know they tax
organs like the liver heart etc. (side effects). HCPs
treat all SCD cases the same way. They don’t try to
tailor treatment based on the type or conditions of
the patient
I have being very successful with alternative treatments
especially diets, less stress, staying hydrated and
rest
Hot bathes work’s really well. Prayers have powers, are very
helpful. Prayers and counselling help to release my
fears. They are effective but with a price and side
effects. I just do not want anything habit forming
and will have awful side effects
That way patients have a lot of options in their well-being. I
am open to other options “but why change when the
one you currently on is working. I will like my
daughter to try them to see which one helps out
better. Should only be used in extreme cases and if
it is no other options. Lots of treatments have side
effects and tax vital organs like the liver
I pray always for my daughter. Prays a lot because if not for
God I don’t think I will still be here. Prayers help a
lot to soothe the pain. I love and use a lot of natural
treatments. Apply shea-butter because it has antiinflammatory properties and chlorophyll liquid. Air
purifier to gets the optimum amount of O 2.
I was forced to defer by failing a class awaiting medical
withdrawal for deferral. A lot of hospitalization, has
never been able to work, missing work. Gets easily
angry or upset at the onset of crisis.
I have doubts about HCP; believe the doctors don’t really
understand SCD pains very well. In South Carolina
the hospitals/HCPs do not know or treat SCD well
and always send my daughter home with fever and
pain. In Virginia it is way better first in and
recovery time is a lot shorter. they treat cancer way
more better than they do with SCD.
I don’t really like being part of support groups because being
around them always makes me very depressed.
Emotional and physical support. Schools should
have a partnership with treatment center just in case
of a crisis at school or for information.
Have a full insurance coverage but it restrict my hospital
length of stay even though I may not be fully
recovered but I will be forced to be discharged early
from hospitals stays.
They just do not care, no one trying to discuss nothing.

Implications
Participants responses on if SCD patients abuses prescription
medications

Preventative strategies
Participants perceptions on opioid analgesics and why HCPs
prescribes them over others /HCP prescribing habits

Participants experiences with alternative treatments

Participants perceptions of the effectiveness of coping strategies

Participants perceptions/responses to exploring alternative
treatment options

Coping Strategies

Impact of pain crisis.

Participants perceptions about HCPs knowledge on SCD.

Participants perceptions on Support Systems

Participants financial challenges

Participants responses on relationship with HCPs and their
attitude
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